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Abstract
The recognition and phagocytosis of apoptotic cells is not only a physiological
means of waste disposal but can also result in anti-inflammatory and
immunosuppressive effects. Indeed, defective clearance of apoptotic cells (ACs) is
associated with autoimmune and inflammatory disease states such as systemic lupus
erythematosus. To date, relatively few markers have been identified as 'eat me'
signals displayed on AC surfaces despite the great potential for such molecules as
diagnostic or therapeutic reagents. In this work various antibody-based strategies
were employed in an attempt to identify novel AC-specific epitopes. An initial
strategy utilised a phage displayed antibody library containing a repertoire of ~108
antibody fragments encoded by human germline genes as an unbiased source of
binding specificity. An alternative approach was based on the knowledge that
receptors used by macrophages to recognise ACs also recognise pathogen-associated
molecules. By looking for the ability of antibodies raised against pathogens to cross-
react with ACs the hypothesis that cells undergoing apoptosis reveal molecular
patterns that resemble those on pathogen related structures was tested. Screening of
phage-displayed antibodies isolated from in vitro selections performed on both whole
ACs and on preparations of purified AC-associated molecules did not identify any
AC-specific epitopes. However, screening of antibodies raised in vivo, that have
previously been characterised as having specificity for pathogen-associated
molecular patterns (PAMPs) revealed that some cross-react with cells undergoing
apoptosis. One of these antibodies was found to bind an epitope found on the
ubiquitously expressed ~40KDa precursor to Laminin-Binding-Protein (LBP/p40).
These findings suggest that epitopes resembling PAMPs appear on the surface of
mammalian cells as a result of apoptosis and that these epitopes can be found on
endogenously expressed molecules which are normally excluded from the surface of
viable cells. The ability of host receptors to cross-react with host and pathogen-
associated epitopes in this way may lead to a greater understanding of the
progression of inflammatory, infectious and tumoural processes.
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1.1 Requirements for timely clearance
From observations made in vivo, the existing paradigm followed by those who study
programmed cell clearance is that apoptotic cells undergo changes at their cell
surface that act as "eat-me signals" and that engulfment by phagocytes, the
culmination of the apoptosis process, occurs early during this programme such that
the membrane integrity of the dying cell is maintained prior to engulfment. These
beliefs arise from and are supported by the sparseness of apoptotic bodies in
histological sections of healthy tissue (Kerr, Wyllie et al. 1972). Furthermore, if one
follows the development of the nematode, Caenorhabditis elegans, an organism that
lacks macrophages, the so-called "professional phagocytes", swift engulfment of
cells that are pre-programmed to die can be observed before they show visible
evidence of apoptosis (Sulston and Horvitz 1977; Ellis, Jacobson et al. 1991). Under
this school of thought, the work described in this thesis aims to identify novel
apoptotic cell-associated "eat-me signals". Accordingly, the literature reviewed in
the following introduction will describe not only the current understanding of
apoptotic cell-associated ligands and engulfment receptors identified to date but will
also attempt to highlight examples where this paradigm fails to operate for in vitro
investigation of dying-cell engulfment. For example, why are long incubation
periods and huge excesses of apoptotic cells required for engulfment by
macrophages in vitro?
1
1.2 Perspectives on apoptosis
1.2.1 A gardener's perspective
The roles fulfilled by apoptosis in tending to a well-kept body can be likened to the
tasks carried out by a gardener managing his plot. Programmed cell death (PCD) by
apoptosis trims and prunes organs during the development and growth of organisms
in order to create and maintain a defined cellular and tissue landscape. In contrast to
the unplanned necrotic havoc caused by violent changes to a cell's local climate, the
process of apoptosis conscientiously ensures a cell's membrane-bagged refuse is
"flagged" in time for collection by garbage-disposing phagocytes. Thus littering of
the surrounding environment is avoided. The ligation of a cell's death receptors,
"weeds" out transformed or pathogen-infected cells that would otherwise overwhelm
the stable grounds of a tissue.
1.2.2 An historical perspective
Naturally occurring cell death has been noted in publications dating back to the
nineteenth century. The observations of cell death in the notochord of metamorphic
toads by Carl Vogt (Vogt 1842)* were followed by discoveries that included the
massive cell death that occurs in pupating diptera by Weismann (Weismann 1864)*.
Several years passed until phagocytosis associated with cell death was described by
Metchnikoff (1883) in the muscles of metamorphic toads (Metchnikoff 1883)* and
chromatolytic death, akin to "apoptotic" cell death, in ovarian follicles recorded by
Flemming in 1885 (Flemming 1885)* (* cited in Clarke and Clarke 1996). Later,
whilst carrying out experiments to investigate "absorption of the formed elements"
2
Metchnikoff noted, in great detail, the phagocytosis of goose "red corpuscles" that
had been injected into a number of different invertebrates and vertebrates
(Metchnikoff 1905). The attributes of this form of cell death continued to be
recorded with only the changing of name from karyorrhexis or pyknosis until the
formation of the "apoptosis concept" in 1972, by Kerr et al. (Kerr, Wyllie et al.
1972). Since then many components involved in the apoptosis process have been
cloned and characterised, and studies have provided an appreciation of not only the
components of pathways controlling initiation and execution of the these events
(Hengartner 2000) but have led to the understanding of a functional signalling
module linking the apoptotic cell to the phagocyte (Akakura, Singh et al. 2004).
1.2.3 A therapeutic perspective
All steps in the apoptosis programme have been linked to disease - from the abortion
of apoptosis as a mechanism for resistance to cancer therapy (Miyashita and Reed
1992) to roles for the caspases following stroke (Loddick, MacKenzie et al. 1996)
and in heart disease (Buja 1998). Increased apoptosis in the absence of inflammation
is a suggested means for the progression of fibrosis (Henson 2003), whereas an
abundance of apoptosis with defective clearance can lead to autoimmune disease
(Herrmann, Voll et al. 1998).
Theoretically, there are a number of ways in which apoptosis can (and has) been
implicated in loss of self-tolerance and hence autoimmune disease. Defective
apoptosis can lead to a failure to silence or eliminate autoreactive T- or B- cells
(McDonnell, Deane et al. 1989), but it is an excess of apoptosis or failure to clear
apoptotic cells due to compromised phagocytic mechanisms that is central to the
interest of the work described in this thesis.
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Studies of the serological abnormalities in systemic lupus erythmatosus (SLE) have
provided important evidence for the mechanisms linking defective clearance and
autoimmune disease. That is, the association of deficiencies in complement
components and the body's ability to clear dying self (Taylor, Carugati et al. 2000),
and the presence of autoantibodies, which can not only react with apoptotic cells, but
also can induce apoptosis, augmenting tissue damage and potentially leading to
antibody Fc-mediated inflammation (Nakamura, Shidara et al. 1994). Indeed,
mounting evidence suggests that SLE autoantigens are derived from apoptotic cells
(Cocca, Seal et al. 2001; Coleman, Sahai et al. 2001; Cocca, Cline et al. 2002).
Therefore, understanding the molecular interactions operating in apoptotic-cell
recognition will allow the prevention or restoration of many diseased states.
However the identification of numerous SLE-disease-susceptibility genes (such as
those regulating threshold for tolerance and induction and those modifying the
appearance of SLE in specific organs (Mason and Isenberg 1998)), in addition to
those required for antigen clearance raises the question of whether defective
clearance is the causative factor, or whether it serves only to amplify the adaptive
immune response to self antigens.
Animal models offer an ideal means to query the importance of clearance genes in
disease progression (Taylor, Carugati et al. 2000). However, despite the great
potential of these in vivo model systems, there is a risk of inbred strains providing a
"primed" background upon which the effects of deficiency in the target gene can be
amplified over and above that which would occur on a normal genetic background
(Botto, Dell'Agnola et al. 1998; Gillmore, Hutchinson et al. 2004). Such a pitfall has
been exposed recently through studies performed by Botto and colleagues, who have
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identified a susceptibility locus, derived from 129 and C57BL/6 mice, that is
sufficient to mediate the loss of tolerance to nuclear antigens. This phenotype,
which, in many cases had previously been attributed to disrupted "clearance-genes",
demonstrates important epistatic modifiers of autoimmunity in this widely used
strain, and suggests that these background gene influences may account for some, or
even all, of the autoimmune traits described in some gene-targeted models of SLE
(Bygrave, Rose et al. 2004)
1.2.4 A scientist's perspective
1.2.4.1 The choreography and morphology
Although a variety of stimuli can induce apoptosis, two main pathways, that is an
"extrinsic" and an "intrinsic" pathway (see figure 1-1), function to produce the
morphological traits associated with this form of cell death. Given an appropriate
death signal, a conserved and ordered sequence of activities activated post-
translationally from resident molecules leads to irreversible death commitment
through the triggering of several essential elements. The best characterised of these is
a proteolytic cascade of cysteine-dependent aspartate-specific proteases, or caspases
(Alnemri, Livingston et al. 1996). Once activated these cytosolic enzymes cleave
specific substrates, resulting in the ordered dismantling of a cell and giving rise to
the morphological changes that are characteristic of apoptosis.
Proteins of the Bcl-2 family also play an important role in deciding whether a cell
commits itself to die. Members of this family can exert either pro- or anti- apoptotic
outcomes within a cell. The functional attributes of a particular protein relate to the





Figure 1-1. The two main pathways that lead to apoptosis.
The extrinsic pathway begins outside a cell, when conditions in the extracellular
environment determine that a cell must die. Ligation of a death receptor (such
Fas (CD95) with Fas ligand (FasL or CD95L)) results in clustering of receptors
and initiates the extrinsic pathway. Clustering of the TNF-family receptors
("death receptors") recruits FADD and pro-initiator-caspases (such as pro-
caspase 8) to the complex. Concentration of pro-initiator caspases results in its
autocatalysis and activation; activated initiator-caspases cleaves pro-effector-
caspases (such as pro-caspase 3), which then undergoes autocatalysis to form
active effector-caspases. The intrinsic apoptosis pathway begins when a cell
detect stress or injury. Mitochondrial damage, for example, can initiate the
intrinsic pathway, overcoming the effect of the pro-survival protein Bcl2 (not
shown). Cytochrome c (cyt c), released from damaged mitochondria, binds
Apafl, which then activates an initiator-caspase, (such as caspase 9), which
then activates an effector-caspase (such as caspase 3). Other proteins released
from damaged mitochondria, such as Smac/DIABLO, counteract the effect of
lAPs (inhibitor of apoptosis proteins), which normally bind and prevent
activation of caspase 3. The balance between Bcl-2 family members and
proteins such as, lAPs, and Smac/DIABLO is central to the intrinsic apoptosis
pathway.
Both the extrinsic and intrinsic pathways merge at effector-caspases, such as
caspase 3, which then cleave various proteins including endonucleases leading
to DNA degradation.
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four Bcl-2 homology (BH) domains (BH 1-4) and a transmembrane anchor sequence,
whereas the pro-apoptotic proteins lack, at the very least, a BH4 domain, but must
possess a BH3 domain (Adams and Cory 1998). Through the ability of many Bcl-2
members to form heterodimers as well as homodimers, the overall result of their
presence seems to rest upon the absolute level of either pro- or anti-apoptotic
members. Thus cells with more pro-apoptotic proteins allow the release or activation
of downstream pro-apoptotic factors, such as cytochrome c, from mitochondrial
stores into the cytosol (Yang, Liu et al. 1997). Several hours are usually required
from the initiation of cell-death to the final cellular disintegration, although the exact
timing depends on the cell type, the stimulus, and the apoptotic pathway.
Nevertheless, when viewed microscopically, the morphological consequences of
these events are easily followed. Early during the initiation of apoptosis, cells lose
contact with neighbouring cells. Following this, extensions of plasma membrane,
commonly known as blebs can be seen to form, the cells shrink and the blebs
separate, forming apoptotic bodies. The characteristic morphological changes seen
in the nucleus of apoptotic cells are condensation of chromatin starting at the
periphery along the nuclear membrane, leading to the formation of a ring-like
structure before fragmentation.
The end result of this process is the phagocytic removal of the dying cells. In vivo
this clearance serves the purpose of eliminating functionally inappropriate cells
without eliciting either a pathological or inflammatory response (Wyllie, Kerr et al.
1980). Evolutionary conservation of genes both for initiating and executing
apoptosis, and for engulfing corpses is indicative of the value of this process (Bangs,
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Franc et al. 2000; Gumienny and Hengartner 2001; Tosello-Trampont, Brugnera et
al. 2001; Grimsley, Kinchen et al. 2004).
1.2.4.2 Putting it in motion - attachment and phagocytosis
Phagocytosis is an evolutionarily conserved process employed by eukaryotic cells to
ingest both microbial pathogens, and components of "dying-self'. Recent studies
have shown that both cytoskeletal alterations and membrane trafficking are necessary
for the phagocytic event to occur (reviewed in (Greenberg and Grinstein 2002)).
Many molecules controlling the signal transduction pathways leading to cytoskeletal
alterations required for engulfment have been cloned and characterised (table 1-1).
However, before phagocytosis can occur, receptors must recognise ligands on the
approaching particle in order to establish firm adherence (figure 1-2).
Whilst biologists focus on characterising specific receptor and ligand molecules,
physicists have developed theoretical and experimental methods for relating the
interaction energy between the approaching surfaces to their properties. So, in
physical terms adherence cannot occur until an electrostatic repulsion between the
negatively charged surface of a phagocyte and target cell has been overcome. From
the Deryagin-Landau/Verwey-Overbeek (DLVO) theory of colloid physics, the
energy of interaction of two charged particles of like sign and magnitude is the sum
of the electrostatic repulsion and the energy of attraction provided by
electromagnetic interactions due to London-Van der Waal's forces. Although this
theory does not account for the fine molecular details found on a cell-surface,
penetration through the electrostatic repulsive barriers (such as those imparted by a
charged glycocalyx) will be minimised by a small radius of curvature between the







Figure 1-2. Sequential phases of attachment and phagocytosis. The
stages of attachment and engulfment of an apoptotic cell by a phagocyte
are depicted A-D. A: Contact first involves a limited area. B: "Contact
extension" requires cell flattening at the micrometer level for efficient
cross-linking of interacting surfaces by receptors (Pierres, Benoliel et al.
2002) to prevent disruption of non-covalent bonds mediating adhesion. C:
Engagement of signaling receptors allows morphological changes to occur,
a result of cytoskeletal and membrane reorganisation (Gumienny, Brugnera
et al. 2001)(0gden, deCathehneau et al. 2001). D: finally the cell corpse
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Table 1-1. Evolutionarily conserved genes involved in apoptotic cell clearance. Abbreviations: - ELMO;
engulfment and motility. GULP; engulfment and adaptor protein. LRP; CD91/low density lipoprotein
receptor-related protein. PSR; Phosphatidylserine recep
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promoted, in the case of a macrophage, by its rough surface (Mege, Capo et al.
1987).
The study of factors influencing bacterial attachment to phagocytes often includes
characterisation of the gross differences in surface properties such as charge and
hydrophobicity which allow preferential interaction of specific bacterial species
(Dickson and Koohmaraie 1989) (Briandet, Meylheuc et al. 1999). Several
influential studies in the area of apoptotic-cell clearance also explored such
differences; these often led to the identification of interactions centred on specific
receptors and ligands. Examples of such studies include the role of neutrophil
surface-charge in determining recognition by macrophages (Savill and Haslett 1987)
(Savill, Henson et al. 1989) and the measurement of microelectrophoretic mobility
by Morris et al who found that the surface charge-density of apoptotic cells was less
than that of non-apoptotic cells (Morris, Hargreaves et al. 1984).
Through extension of their earliest studies Savill and Haslett identified the
CD36/vitronectin receptor/thrombospondin receptor complex as an apoptotic-cell
recognition system. Similarly, the demonstration that thymocyte recognition by
macrophages is inhibited by N,N'-diacetyl chitobiose and N-acetyl glucosamine
(Duvall, Wyllie et al. 1985) led to the discovery of a role for the asialoglycoprotein
receptor (ASGP-R) in this process. The ASGP-R, which is expressed on the plasma
membrane of hepatocytes, detects exposed galactose residues of asialated
glycoproteins allowing endocytosis of asialoglycoprotein complexes for recycling by
the liver cells. As well as being involved in the general removal of aged proteins, the
ASGP-R provides a classic example of a multifunctional protein that enables the
engulfment of senescent self by bystander cells (Dini, Autuori et al. 1992). Thus, it
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seems that through the process of evolution, phagocytes have obtained sets of
receptors to allow them to recognise specific targets. However, macrophages also
adhere to glass and plastic and can ingest inert particles such as latex beads, yet the
likelihood that specific cell-surface receptors for these ligands exist is slim. In
remembering the early studies by Savill and Haslett or Wyllie and colleagues, it is
interesting to speculate whether "non-specific" forces influence interactions between
apoptotic cells and macrophages, in modes that have been demonstrated for other
cellular attachment systems.
Thus, whilst acknowledging the importance of specific interactions between cell
surface receptors and their ligands for firm adhesion, Bongrand and colleagues have
also shown the influence of nonspecific forces in mediating the kinetics of initial
cellular attachment (Bongrand 1998). For example, in these studies the equilibrium
shape of a cell (an important factor for attachment) adhering to a surface was found
to be a balance between freely diffusible cell surface receptors and repulsion
generated by bulky surface structures composing the glycocaylx (see figure 1-3)
(Bell, Dembo et al. 1984). Furthermore, it has been suggested that numerous
"nonspecific" interactions of wide-ranging affinities between a variety of surface
molecules may play a role in the adhesion when specific adhesion receptors display
low density affinity or accessibility due to their size (Pierres, Benoliel et al. 2002).
However, in the case of bacterial attachment to host surfaces it has been argued that
the same basic, physiochemical forces are responsible for so-called 'non-specific' and
'specific' binding and that from a physiochemical point of view the distinction






Figure 1 -3. Possible mechanisms for an increased adherence of apoptotic
cells.
A As the equilibrium shape of a cell adhering to a surface is a balance
between freely diffusible cell surface receptors and repulsion generated by
bulky surface structures (Bell, Dembo et al. 1984) alterations in
membrane fluidity (i.e ABCA1 (Hamon, Chambenoit et al. 2002)) and
shedding of surface molecules (Hart, Ross et al. 2000) during programmed
cell death may increase adherence through improved accessibility.
Alternatively, in the case of short range interactions at the margin of
contact region (red arrow) increased diffusion of steric repellant cell-
surface molecules on an apoptotic cell might allow greater contact
extension during initial interaction than allowed for viable cell surfaces.
B The deformed surface of an apoptotic cell may also provide an extended
area of contact with phagocyte membranes perhaps enhanced by ligand
receptor interactions leading to additional membrane deformations




consider the existing knowledge regarding such specific sites on the apoptotic-cell
surface.
1.2.5 A macrophage's perspective
1.2.5.1 "Fit for consumption"- a target cell's requirements
In comparison to chaotic changes associated with cell death by necrosis, PCD is an
organised process (Kerr, Wyllie et al. 1972). In keeping with this, an apoptotic cell
must engage efficient mechanisms to take on a guise that is different from its viable
form in order to appear edible to an engulfing cell. To date there is no firm evidence
of either the direct products of the proteolytic cascade that occurs during apoptosis,
ox de-novo synthetic products serving as ligands for recognition and phagocytosis
apoptotic cells. Table 1-2 lists the apoptotic cell-associated ligands for engulfment
which have been identified thus far along with implicated cognate receptors, where
known. These are generated as a result of either (a) changes to cell-surface resident
molecules or (b) arise from a redistribution of intracellular molecules to the cell
surface. Examples of each will be reviewed separately in the following sections.
1.2.5.2 Recognition and repulsion signals previously implicated on
the surface of apoptotic cells
1.2.5.2.1 Changes to cell-surface resident molecules
1.25.2.1.1 Intercellular Adhesion Molecule-3 (ICAM-3)
The discovery that ICAM-3 may be involved in the clearance of apoptotic cells was
made following the observation that certain monoclonal antibodies to leucocyte
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surface molecules block the ability of human-monocyte-derived macrophages
(HMDM) to recognise apoptotic lymphocytes in vitro (Flora and Gregory 1994).
Although being expressed at high levels on the surface of both viable lymphocytes
and macrophages (de Fougerolles and Springer 1992), subsequent studies found this
particular feature of ICAM-3 to be exclusive to the apoptotic-cell associated
molecule as opposed to the macrophage (Moffatt, Devitt et al. 1999).
Despite much structural and functional knowledge (looking at both molecular
interactions, and the consequence of signalling) of receptor-ligand interactions
involving ICAM-3 on viable leucocytes (Vilella, Mila et al. 1990; Cid, Esparza et al.
1994; Landis, McDowall et al. 1994; Bell, May et al. 1998; Serrador, Vicente-
Manzanares et al. 2002), the details of how ICAM-3 mediates macrophage
interaction with apoptotic cells remains a mystery (Shingler 2003). The hypothetical
ICAM-3-associated epitope found solely on apoptotic cells (i.e. an "apoptotic" form
of ICAM-3) is one of the main targets for the phage antibody studies described in
this thesis (results chapters 1 and 2). Thus, in the following sections, whilst
reviewing the mechanisms by which cell-surface resident molecules are known to
become altered during apoptosis, where appropriate, proposals will be made as to
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1.2.5.2.1.2 Oxidation-specific epitopes
Recent studies have demonstrated that the generation of free radical intermediates
and subsequent oxidative stress may be more than unavoidable events of the
apoptotic machinery and that these by-products may act as signals for the execution
of the apoptosis programme and subsequent recognition of apoptotic cells. Early
observations showed that oxidised LDL (OxLDL) can compete with apoptotic cells
undergoing increased oxidative stress for binding by macrophages (Sambrano and
Steinberg 1995). This led to the demonstration that oxidatively modified moieties on
the surfaces of apoptotic cells serve as ligands for macrophage recognition in the
same way as similar moieties on oxidized low-density lipoprotein (OxLDL) (Chang,
Bergmark et al. 1999). Subsequent studies have shown that some oxidized
phospholipids bind to lysine residues of apolipoprotein B100 (apoBlOO) to provide
ligands for macrophage scavenger receptors (Gillotte, Horkko et al. 2000).
Although it will be discussed further in section 1.2.5.2.2.1.1, where the best-known
feature of the surface of apoptotic cells, the exposed phosphatidylserine (PS) will be
considered in detail, it is worth mentioning here that the generation of oxidised PS
from PS during apoptosis may be requisite for its recognition (Kagan, Borisenko et
al. 2003). However, in addition to the formation oxidised PS Podrez et al. have
identified a family of oxidised phosphatidylcholine (PC) homologues that can also
serve as ligands for the apoptotic-cell receptor CD36 (Podrez, Poliakov et al. 2002).
Yet, as will be discussed in section 1.2.6 when looking into receptors that may
recognise these changes, the occurrence of these specific events on the surface of
cells may be a relatively late event of apoptosis.
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1.2.5.2.1.3 Redistribution and clustering
With changes in membrane fluidity known to occur during programmed cell death
(Jourd'heuil, Aspinall et al. 1996) there is great scope for the types of redistribution
of surface molecules that have been observed in other biological scenarios, such as
the removal of erythrocytes from the circulation following oxidation-induced
aggregation of membrane glycoproteins (i.e. band 3) (Beppu, Takahashi et al. 1994).
Evidence that apoptotic cells can transiently cluster surface molecules at an early
stage of apoptosis to provide novel sites for recognition by macrophages has been
provided by studies involving CD43 (Eda, Yamanaka et al. 2004). In the system
used by Eda et al., Jurkat cells treated with etoposide or anti-Fas antibody transiently
became susceptible to binding and phagocytosis by THP-1 cell-derived macrophages
even before displaying chromatin condensation but in a caspase-dependent manner.
Further studies indicated that the sialylpolylactosaminyl sugar chains of CD43 might
provide multivalent-high affinity ligands for recognition by macrophage receptors.
A similar type of redistribution during apoptosis may also occur with ICAM-3, as
redistribution of the glycoprotein to uropods (protrusions at the posterior pole of
cells) has been observed in polarised migrating T lymphocytes (del Pozo, Nieto et al.
1998).
1.2.5.2.1.4 Altered glycosylation
Due to their complexity and diversity, carbohydrate units can convey a great deal of
information and effect important functions in biological systems. Carbohydrate-
containing molecules mediate many types of cell-to-cell interactions; L-selectin on
naive T-cells will only bind the correctly glycosylated form of CD34 (i.e. only CD34
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molecules containing sulfated carbohydrates) and promote the rolling interactions
critical to the selectivity of naive lymphocyte homing (Satomaa, Renkonen et al.
2002). A combination of clustering and differential glycosylation has recently been
held responsible for a process akin to apoptotic-cell engulfment, that is the clearance
of transfused platelets from the circulation (Hoffmeister, Josefsson et al. 2003).
Hoffmeister et al have shown that cooling of blood platelets clusters the von
Willebrand factor receptor complex and have suggested that the macrophage integrin
aM|32 recognises exposed N-acetylglucosamine residues of N-linked glycans of this
complex. Enzymatic galactosylation of chilled platelets was shown to block aM(32
recognition thus prolonging the circulation of functional cooled platelets. The early
studies by Dini et al. eluded to the possible appearance of differentially glycosylated
residues on apoptotic cells (Dini, Autuori et al. 1992; Dini, Lentini et al. 1995).
Rapoport and colleagues who have identified a glycosylation patterns specific to
apoptotic cells have highlighted such a possibility recently. In their system,
monocyte-derived THP-1 cells were shown to engulf the apoptotic bodies from the
MELJUSO melanoma cell line that show a carbohydrate pattern consisting of high
levels of glycans terminated by galactose or sialic acid. The inhibition of binding by
oligosaccharide-specific reagents was observed in this system along with evidence of
binding to siglec and galectin ligands by monocyte-derived THP-1 cell (Rapoport,
Khaidukov et al. 2003). Together these findings led to the conclusion that the Gal(31
- 3GalNAc|3-terminated chains displayed on the apoptotic bodies appeared to be
targets for THP-1 cells.
Changes in glycosylation pattern have also been suggested as a means by which
apoptotic-cell associated ICAM-3 is able participate in clearance (Moffatt, Devitt et
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al. 1999). ICAM-3 is expressed as a type 1 transmembrane protein with five
extracellular Ig domains. Up to two thirds of its molecular weight (110-130kD in T-
lymphocytes and 120-160kD in neutrophils) results from N-linked glycosylation
(Fawcett, Holness et al. 1992; de Fougerolles, Diamond et al. 1995). Deglycosylated
ICAM-3 can still support binding by LFA-1 (Landis, McDowall et al. 1994)
demonstrating that the carbohydrate moieties are not a prerequisite for its ligand
function with this receptor, though the carbohydrates may be important in mediating
its interaction with dendritic cell specific ICAM-3 grabbing non-integrin (DC-SIGN)
(VanderVieren, LeTrong et al. 1995) (Geijtenbeek, Torensma et al. 1999). As a
member of the C-type lectin family, it is capable of binding ICAM-3 with high
affinity in a Ca2+ -dependent, mannan/mannose inhibitable manner (Geijtenbeek,
Torensma et al. 2000). Given that small amounts of the high mannose-type
oligosaccharides were detected during oligosaccharide analysis on ICAM-3(Funatsu,
Sato et al. 2001), it seems plausible that these could provide the epitope for
recognition by DC-SIGN or a similar phagocyte receptor for "apoptotic ICAM-3".
1.2.5.2.1.5 Active detachment
The idea that "eat me" signals (Savill, Fadok et al. 1993) appear on the apoptotic-
cell-surface satisfactorily explains how a dying cell may become desirable to a
phagocyte. Nevertheless, the immunoglobulin superfamily members, ICAM-3 and
CD31, which are recognised by phagocytes for the purpose of apoptotic-cell
engulfment (Moffatt, Devitt et al. 1999; Brown, Heinisch et al. 2002), can also
mediate adhesive interactions between viable cells that do not lead to engulfment.
As has been suggested for ICAM-3 (section 1.2.5.2.1.1), subtle changes to such
molecules may allow a phagocyte to discriminate between "viable" and "apoptotic"
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forms. Yet monoclonal antibodies to epitopes on ICAM-3 and CD31 that inhibit
apoptotic cell clearance also bind to the same molecules on viable cells. An
alternative explanation as to molecules implicated in clearance merely serving as
"eat-me" signals was provided by the studies of CD31 by Brown and colleagues.
1.2.5.2.1.5.1 CD31
CD31 can bind several different partners and function as, amongst other things, an
intercellular adhesion-stabilising molecule on viable endothelial cells to stabilise
intercellular junctions (Newman, Berndt et al. 1990). Through homophilic
engagement, CD31 also functions as an intracellular signal-triggering molecule,
mediating the migration of leucocytes across endothelia (reviewed in (Jackson
2003)) and the active repulsion of viable leucocytes from macrophages (Brown,
Heinisch et al. 2002). Brown and colleagues proposed that by losing the ability to
transmit "detachment" signals during apoptosis, CD31 promotes tethering of dying
cells to phagocytes.
1.2.5.2.1.6 Conformation and homophilic/heterophilic association
Despite providing compelling evidence of a detachment signal, the means by which
CD31 loses its function remains undefined. A change in conformation of the
extracellular domain of this and other immunoglobulin superfamily members (such
as ICAM-3) could well lead to an alteration in their functioning. Indeed Johnson and
colleagues have suggested such a mechanism for similar cell-adhesion molecules.
Using direct force measurements to investigate how Ig domains contribute to the
adhesive interactions of the neural-cell-adhesion molecule (NCAM), as a
representative of this protein class of adhesion molecules Johnson and colleagues
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demonstrated that NCAM binds in two spatially distinct configurations. Following
studies of various Ig-domain deletion mutants it was suggested that a combination of
multiple bound states and internal molecular flexibility allows synergistic bond
formation and the ability to accommodate different intercellular spaces (Johnson,
Fujimoto et al. 2004).
Together, these examples illustrate that the surface of an apoptotic cell is sensitive to
factors that may generate novel epitopes for recognition. However many of these
observations originate from studies in vitro where a degree of cytolysis is
constitutively present within cultures. This is likely to cause release of enzymes and
reactive oxygen species to the extracellular milieu modifying surface molecules to an
extent that may not occur in vitro.
1.2.5.22 Redistribution of intracellular molecules to the cell-surface
It appears that apoptosis allows the exposure of molecules that are usually forbidden
from leaving the intracellular environment of viable cells. Given that the innate
immune system recognises microbial structures both by virtue of their dissimilarity
to host structures, and through the existence of conserved molecular patterns, it is
enticing to think that recognition by pattern-recognition-receptors (PRRs, see also
section 1.2.6) is through common determinants that exist on both microbial and
normally "hidden" intracellular-self derived host molecules.
1.2.5.2.2.1 Anionic phospholipids and loss ofmembrane asymmetry
In its resting state in viable cells, the plasma membrane retains aminophospholipids
such as phosphatidylethanolamine (PE) and phosphatidylserine (PS) in the inner
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leaflet of the plasma membrane, whereas choline-containing phospholipids such as
phosphatidylcholine (PC) and sphingomyelin are found mostly in the outer leaflet.
The asymmetric distribution of phospholipids is achieved by an ATP-dependent
aminophospholipid translocase that specifically transports aminophospholipids from
the outer to the inner leaflet. Relocation from the inner-leaflet is a result of
decreased aminophospholipid translocase activity and activation of a calcium-
dependent lipid scramblase (Tilley, Cribier et al. 1986; Bevers, Comfurius et al.
1999).
1.1.3.2.2.1.1 Phosphatidyl serine
The most well-known surface change common to the vast majority apoptotic cells is
the appearance of phosphatidylserine on the outer-leaflet of the plasma membrane
(Fadok, Voelker et al. 1992). Fadok and colleagues eluded to the possibility that the
recognition and removal of the apoptotic cell by phagocytes is a direct consequence
of this change after observing the stereospecific inhibition of apoptotic-cell
phagocytosis by phosphatidylserine and its structural analogues, but not by other
anionic phospholipids.
1.1.3.22.1 A.1 PS is PS is PS
Although there is no doubt that many phagocytic receptors bind PS, there is growing
evidence that changes to phosphatidylserine in addition to its externalisation are
required for the engulfment of target cells (Sambrano, Terpstra et al. 1997).
Oxidative stress is a well-known component of apoptotic signalling (section
1.2.5.2.1.2). By labelling cellular phospholipids with an oxidation-sensitive,
fluorescent fatty acid (c/.v-parinaric acid) it has been possible to characterise
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phospholipid oxidation during oxidative stress-induced apoptosis (Hedley and Chow
1992). These studies revealed that preferential oxidation of PS as a result of
apoptosis leads to its externalisation (Arroyo, Modriansky et al. 2002). Furthermore,
inhibition of PS oxidation in cells during apoptosis has been demonstrated to block
phagocytosis of dying cells by macrophages (Kagan, Gleiss et al. 2002). As a
consequence of these findings it has been proposed that a combination of PS and
oxidised PS may be essential for recognition and uptake of apoptotic cells (Kagan,
Borisenko et al. 2003), although the exact amounts of oxidised PS actually present or
required on the cell surface to facilitate recognition of apoptotic cells is unknown.
1.2.5.2.2.1.2 Phosphatidvlethanolamine
The early studies of Fadok et al. emphasised the importance of PS in preference to
other anionic phospholipids for apoptotic-cell recognition. Several molecules since
implicated in the process also appear to bind to PE. Human serum amyloid P
component (SAP), a glycoprotein structurally belonging to the pentraxin family of
proteins (section 1.2.6.2.2), was originally noted as having a role in controlling the
degradation of chromatin following the observation that mice lacking SAP develop
antinuclear antibodies (Bickerstaff, Botto et al. 1999) and autoimmunity (see also
section 1.2.6.1.5 for discussion on strain dependency) (Gillmore, Hutchinson et al.
2004). However, SAP also binds to apoptotic cells via exposed PE, an interaction
which is strongest on late, permeable apoptotic cells (Familian, Zwart et al. 2001).
Binding to PE is also likely to be a significant contributing factor to the affinity of
the opsonin milk fat globule-EGF-factor 8 (MFG-E8) to apoptotic cells (Hanayama,
Tanaka et al. 2002)
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1.2.52.3 Translocation ofcellular compartments
In 1984 Wyllie and colleagues noted both small irregular blebs of cytoplasm and
deep surface pits during their electron microscopic analysis of apoptotic thymocytes
(Morris, Hargreaves et al. 1984). Since then, the former of these morphological
changes has received much more attention than the latter. Such surface protrusions,
or blebs, have been shown to contain fragmented endoplasmic reticulum (ER) and
ribosomal components as well as nucleosomal DNA and ribonucleoproteins and have
been held as the proposed site for exposure of autoantigens (Casciola-Rosen, Anhalt
et al. 1994). However, it was the surface pits that Wyllie and colleagues suggested to
be caused by accelerated fusion of membranes from endoplasmic reticulum.
Recently Lowe et al. have observed the very type of impaired membrane trafficking
during apoptosis that could cause such events (Lane, Lucocq et al. 2002) (Lowe,
Lane et al. 2004). They have shown caspase-dependent cleavage of the Golgi-
associated transport factors giantin and syntaxin 5, which is accompanied by a
cessation of vesicular transport between the ER and the Golgi complex, and first
manifests itself as a block in ER exit (Lowe, Lane et al. 2004). They propose that
such interdomain cleavage of fusion and tethering factors would not only inhibit
normal trafficking pathways but may allow "inappropriate" fusion reactions to occur
(Lowe, Lane et al. 2004). Perhaps surface expressed ER or Golgi-derived molecules
from the apoptotic cell could provide ligands compatible with the molecules from the
endoplasmic reticulum on the side of the macrophage, a source of membrane that has
been shown to be used for phagosome formation (Gagnon, Duclos et al. 2002).
However, many of these phenomena appear late during apoptosis (personal
communication- Jon Lane) and a function in apoptotic-cell clearance has yet to be
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ascribed to them. On the other hand, following the discovery that Annexin I is
exposed on the cell surface following translocation from the cytosol during
apoptosis, Arur et al. have shown its colocalisation with phosphatidylserine on
surface blebs and, in the nematode Caenorhabditis elegans, downregulation of an
annexin I homologue prevents efficient engulfment of dying cells (Arur, Uche et al.
2003). More recent work has shown that annexin 1 can be presented on the surface
of apoptotic cells prior to the externalisation of PS (Macasev, Weyd et al. 2004)
Although not being studied with respect to functioning as a ligand for engulfment, a
similar type of exposure of another intracellular protein, actin, has been noted on the
surface of apoptotic cancer cells prior to loss of membrane integrity and
demonstrates that this phenomenon is a property of cytoskeletal components
(Hansen, Nielsen et al. 2001). These studies demonstrated that actin can be
recognised by tumour-infiltrating B cells in the context of a dying cell's surface.
These findings are not confined to proteins originating from the cytoplasm as was
demonstrated originally following the discovery that human anti-DNA
autoantibodies can bind to blebs of apoptotic Jurkat cells (Cocca, Seal et al. 2001).
This interaction was found to be dependent on the activity of both caspases and
ROCK I kinase, a stimulator of nuclear fragmentation and distribution and bleb
formation (Cocca, Cline et al. 2002).
1.2.5.2.4 Chemotactic factors
The clearance of dying cells that takes place in the interdigital zones during
development is a classical example of macrophage accumulation at sites of apoptotic
lesions (Saunders 1966). Recent in vitro studies have reinforced the long-held
suspicion that apoptotic cells draw macrophages to sites of cell-death by releasing
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chemotactic factors. Following the detection of a chemoattractant activity for
primary human macrophages in the supernatants of apoptotic cells, Lauber et al.
identified lysophosphatidylcholine, which is released from dying cells as a factor
responsible for this activity (Lauber, Bohn et al. 2003). Thrombospondin too, has
also been shown to actively recruit macrophages when released from apoptotic
fibroblasts (Moodley, Rigby et al. 2003). Although not explicitly being
demonstrated as chemoattractants for mature macrophages, apoptotic cell-derived
blebs and cross-linked homodimers of S19 ribosomal proteins attract monocytes
suggesting that dying cells may release a cocktail of factors to draw macrophages to
the sites of an apoptotic lesion in vivo (Horino, Nishiura et al. 1998; Segundo,
Medina et al. 1999). Through observing C. elegans mutants of CED-5 or CED-12
the importance of the same cellular adjustments required to effect engulfment has
also been realised for the process of migration (Wu and Horvitz 1998) (Gumienny,
Brugnera et al. 2001) (Grimsley, Kinchen et al. 2004).
1.2.6 Engulfment receptors and mechanisms
Unearthing the receptors used by phagocytes for the recognition and clearance of
apoptotic cells has revealed remarkable parallels between the receptors used by the
innate immune system to detect pathogens. These include both membrane-bound
receptors and soluble opsonins or binding-proteins that bridge apoptotic cells with
phagocytes. In their role as microbial receptors, these molecules were collectively
referred to as "pattern recognition receptors" (PRRs) (Medzhitov and Janeway
2000), due to their ability to recognise conserved molecular patterns shared by large
groups of microorganisms, allowing the innate immune system to discriminate self
from the pathogen-associated molecular patterns (PAMPs) found on non-self
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(Janeway 1989). It has also been proposed that the use of PRRs for recognition of
effete self is due to the presence of apoptotic-cell-associated molecular patterns
(ACAMPs) by these cells (Franc, White et al. 1999).
At this point it is useful to define what is understood by a "molecular pattern" in this
context. Any molecule can be identified by a three dimensional arrangement of
chemical elements which gives rise to a unique structural "fingerprint". Therefore
microbes will have countless "molecular patterns" in addition to the pathogen-
associated-molecular-patterns (PAMPS) customarily referred to in the context of
immunological recognition. The structural basis by which single PRRs recognise
both "molecular patterns" on microbes (PAMPs) and apoptotic cells (ACAMPs) is
not known, that is whether the PRR recognises the same pattern present on different
molecules or whether it has evolved different sites capable of recognising different
patterns. The ability of these receptors to interact with such a broad range of ligands
(Aderem and Ulevitch 2000) (Jack 2000) (exemplified below in the case of CD 14
section 1.2.6.1.1) has been attributed to the presence of a specific configuration of
ionic charge arising from a particular complementary "molecular pattern" on a
molecule which determines if it may serve as a ligand for a given receptor.
Table 1-2 shows a summary of membrane receptors and bridging molecules
identified along with their associated ligands on the apoptotic-cell-surface, where
known. Depending on the ligand some of these can participate in the clearance of
apoptotic cells that are at an early stage of programmed cell death (for example by
the PSR following the appearance of PS, section 1.2.6.1.5) whereas for others
interaction appears to be during later stages of death (for example by C-reactive
protein following loss of membrane integrity, section 1.2.6.2).
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1.2.6.1 Membrane bound receptors
1.2.6.1.1 CD14
CD14 was first implicated in the clearance of apoptotic cells during the screening of
mAbs to leucocyte antigens for the ability to inhibit the recognition of apoptotic cells
by human monocyte-derived macrophages. Monoclonal antibody 61D3 was
identified as a blocking antibody (Flora and Gregory 1994). However, several years
passed before the epitope recognised by 61D3 was successfully identified as CD14
(Devitt, Moffatt et al. 1998), a 55kDa glycosylphosphatidylinositol (GPI)-linked
plasma membrane glycoprotein of mature myeloid cells or a soluble serum
glycoprotein lacking the GPI-linked anchor (Bazil, Baudys et al. 1989; Simmons,
Tan et al. 1989).
1.2.6.1.1.1 CD14 Ligands
Together, numerous studies have suggested that CD 14 has an affinity not only for
microbial-associated molecules of various species but also for molecules associated
with self. Table 1-3 is a summary listing these ligands. In considering these ligands,
it should be appreciated that classification of individual molecules as ligands for
CD14, has, in many cases, been based on signalling responses merely dependent on
the presence of the receptor, without demonstrating a direct interaction with the
"ligand" being studied. Thus, in many cases the absence of contaminants capable of
inducing a CD14-dependent response, such as LPS, has not been confirmed.
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1.2.6.1.1.1.1 Lipopolvsaccharide
The first functional role assigned to CD14 was as a cellular receptor for
lipopolysaccharide (LPS) that enables mediation of LPS-induced pro-inflammatory
responses (Wright, Ramos et al. 1990). The definitive mechanisms of LPS induced
signalling through CD 14 are unclear but the most widely accepted model is that
CD 14 in some way facilitates the delivery of LPS to Toll-like receptor-4 (TLR-4)
(Qureshi, Lariviere et al. 1999) promoting its dimerisation with the assistance of
MD-2 (Shimazu, Akashi et al. 1999) to form a signalling complex containing
myeloid differentiation factor 88 (MyD88) leading to activation of the MAP kinase
and NF-KB-inducing cascades, (reviewed Beutler, Hoebe et al. 2003). The binding
of LPS to CD 14 is enhanced by the LPS-binding protein (LBP), a 60kDa acute phase
serum glycoprotein, (Tobias, Soldau et al. 1986; Schumann, Leong et al. 1990)
however the potential for LBP to enhance apoptotic-cell recognition has not been
investigated.
i .2.6.1.1A A A LPS structure
Structural characterisation of many LPSs has shown them generally to conform to a
structure, shown schematically in figure 1-4, which can be divided into three separate
regions. Lipid A is the hydrophobic and endotoxically active part of the molecule
(Tanamoto, Galanos et al. 1984). Covalently attached to this is the core section that
can itself be divided into an inner and outer core. The inner core, nearest to lipid A,
contains a high proportion of unusual sugars such as 3-deoxy-D-manno-octulosonic
acid (Kdo) and L-glycero-D-manno heptose (Hep). The outer core extends further
from the bacterial surface and is more likely to consist of common sugars such as
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hexoses and hexoseamines. Onto this is attached, in most cases, a polymer of
repeating subunits called O-polysaccharide, or O-chain, also typically composed of
hexoses. However the O-chain is often truncated giving rise to lipo-oligosaccharide
(LOS) in certain rough strains of bacteria (Erridge, Bennett-Guerrero et al. 2002).
1.2.6.1.1.2 CD14-dependent clearance of apoptotic cells.
Even though numerous eukaryotic host-associated ligands for CD14 have been
proposed (shown in table 1-3) the component(s) of apoptotic cells which CD 14
engages during their engulfment remains unspecified. Observation that CD 14-
dependent clearance of apoptotic cells operates in both human and murine systems
using feed cells of a number of different lineages (Devitt, Moffatt et al. 1998;
Schlegel, Krahling et al. 1999; Devitt, Pierce et al. 2003) (Fadok, Konowal et al.
1998) suggests that the ACAMP(s) recognised by CD14 are relatively conserved
structure(s). As a classical pattern recognition receptor (PRR), CD 14 appears to
recognise numerous, often seemingly unrelated molecules in addition to LPS, both
from microbes and non-microbial origin that can be lipid, protein or carbohydrate
(table 1-3). As transient transfection of CD 14 in COS cells conferred increased
phagocytic ability to these cells it is unlikely that CD 14 requires other macrophage-
specific receptors to function in apoptotic-cell clearance (Devitt, Moffatt et al. 1998).
These studies also provided evidence that CD 14 acts in a separate pathway from the
av|33/TSP/CD36 complex and more recent work has shown that, although CD 14 can
bind phospholipids of eukaryotic cells including PS, it does not function
preferentially as a PS-receptor in apoptotic-cell clearance (Devitt, Pierce et al. 2003).
A link between the ICAM-3 dependent clearance pathway and CD 14 pathway was







Figure 1 -4. Schematic representation of the structure of Lipospolysaccharide (LPS)
Ligand Reference
Bacterial
Lipopolysaccharide Wright, Ramos et al. 1990
Cell wall components (not LPS) Fichorova, Cronin et al. 2002
Rhamnose glucose polymers Soell, Lett et al. 1 995
Uronic acid polymers Espevik, Otterlei et al. 1 993. Jahr, Ryan et al. 1 997
Teichuronic acids Yang, Sugawara et al. 2001
Lipotechoic acid Schwandner, Dziarski et al. 1999
Peptidoglycan Weidemann, Schletter et al. 1997
Synthetic muramyl dipeptide Weidemann, Schletter et al. 1997
Lipoarabinomannan Pugin, Kravchenko et al. 1998
Flavolipin Gomi, Kawasaki et al. 2002
Glycolipids Schroder, Opitz et al. 2000
Soluble Tuberculosis factor (STF) Medvedev, Henneke et al. 2001
Outer membrane lipoproteins Wooten, Morrison et al. 1998
Acylpolygalactoside Flmama, Mey et al. 1994
Group B Streptococcus (released soluble factor) Flenneke, Takeuchi et al. 2001
Components of Staphylococcus aureus Kusunoki, Flailman et al. 1995
Components of gram positive organisms Pugin, Fleumann et al. 1994
Other prokarvotic/viral
Wl-I Yeast cell wall protein Newman, Chaturvedi et al. 1995
RSV fusion (F) protein Kurt-Jones, Popova et al. 2000
Hyphal fragments Wang, Warris et al. 2001
Fucoidan Fleinzelmann, Polk et al. 1 998
Non-microbial
Taxol Perera, Vogei et al. 1997
Chitosans Otterlei, Varum et al. 1994
Lipopetides Sellati, Bouis et al. 1998
lnterleukin-2 Bosco, Espinoza-Delgado et al. 1 997
Fleat Shock proteins Kol, Lichtman et al. 2000
Phospholipids Wang, Kitchens et al. 1998
Ceramide Pfeiffer, Bottcher et al. 2001
Surfactant-proteins A and D Sano, Chiba et al. 2000
Lactoferrin Baveye, Elass et al. 1 999
Minimally modified low density lipoproteins Miller, Viriyakosol et al. 2003
Table 1-3. Ligands of CD14. Many of these molecules have been classified as ligands for CD14 based on
signalling responses in the presence of the receptor, without demonstrating a direct receptor ligand interaction.
That is, the absence of contaminants capable of inducing a CD14 dependant cellular activation, such as LPS, has
not been confirmed.
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However, recent studies, although not excluding this possibility have failed to
demonstrate a direct interaction between these two molecules (Shingler 2003).
Despite the fact that not all CD 14 ligands share gross structural features, one may
propose that CD14 recognises conserved patterns of ionic charge representing parts
of microbial and self molecules (including exposed ACAMPs) (Ulmer, Dziarski et
al. 1999). In making this assumption, however, one may then ask why the response
to apoptotic cell engulfment is anti-inflammatory (Fadok, Bratton et al. 1998;
McDonald, Fadok et al. 1999) whereas that of CD14 dependent LPS recognition is
pro-inflammatory. An answer to this may lie in the interaction of these ligands with
receptors subsequent to tethering by CD14. For example, evidence suggests that
signalling through toll-like receptors (TLRs), despite being critical for maturation of
microbial containing phagosomes, is not implicated in apoptotic cell clearance
(Blander and Medzhitov 2004) (Cvetanovic and Ucker 2004).
1.2.6.12 Scavenger receptors
The scavenger receptor (SR) group consist of a broad range of transmembrane
molecules containing, amongst others, collagenous, cysteine-rich and C-type-lectin
domains (Brown and Goldstein 1990; Kodama, Freeman et al. 1990). SRs that have
been implicated in the uptake of apoptotic cells are SR-A, SR-B1, lectin-like
oxidised LDL-receptor 1 (LOX-1), CD36 and CD68 (oxLDL receptor or
macrosialin) (Savill, Hogg et al. 1992; Ramprasad, Fischer et al. 1995; Fukasawa,
Adachi et al. 1996; Piatt, Suzuki et al. 1996; Oka, Sawamura et al. 1998). They can
be found not only on professional phagocytes such as macrophages and dendritic
cells but also differentially expressed on some endothelial, cerebral and retinal cells,
where they are involved either directly or indirectly in the binding and phagocytosis
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of unwanted self, such as oxLDL and apoptotic cells in addition to many classes of
microbial pathogens and their products. They provide an excellent example of tissue
specific-usage with respect to apoptotic-cell clearance as cells of immune privileged
sites such as Mato cells (granular epithelial cells of neural tissue), astrocytes,
cerebral microvascular endothelial cells, and retinal pigment epithelial cells
selectively employ one or more of these receptors for the engulfment of dying self
(Mato, Ookawara et al. 1996; Husemann, Loike et al. 2002).
CD36, one of the first engulfment receptors to be implicated in the recognition of
apoptotic cells, was formerly studied with respect to platelet aggregation, as a
receptor for thrombospondin (Asch, Barnwell et al. 1987). A role in apoptotic-cell
clearance was demonstrated by anti-CD36 antibody blockade and through observing
conferred ability to non-phagocytic cells to engulf apoptotic cells following CD36
gene transfer (Savill, Hogg et al. 1992; Ren, Silverstein et al. 1995). CD36 appears
to work in association with the vitronectin receptor (av(33 integrin, CD51/CD61) to
bind the 420 kDa adhesive glycoprotein, thrombospondin, which itself forms a
bridge by binding to unknown sites on the apoptotic cell. (Savill, Hogg et al. 1992).
Studies have also shown CD36 to be a necessary cofactor in PS-mediated recognition
of apoptotic cells in some systems (Fadok, Warner et al. 1998).
The importance of SRs for the recognition of apoptotic cells is seen through their
usage by Drosophila melanogaster and C. elegans. The haemocytes of Drosophila
melanogaster use Croquemort (Crq), a homologue of the mammalian CD36 to
remove cells undergoing apoptosis during embryogenesis (Franc, Dimarcq et al.
1996). The C. elegans homologue to CD91 (class-F scavenger receptor from
endothelial cells (SREC)) (Zhou, Hartwieg et al. 2001) (Su, Nakada-Tsukui et al.
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2002) was originally identified by failure of cells in mutants of CED-1 protein to
cluster around cell corpses in mutants also defective in the engulfment gene ced-7
(see also table 1-1).
The general lack of insight into the structural basis for apoptotic-cell recognition is
emphasised by studies examining the epitope recognised by the classical receptor for
oxLDL, CD68, as it has been shown that lipid micro-emulsions prepared from
oxLDL can inhibit the binding of both intact oxLDL and apoB from oxLDL
supporting the conclusions that at least some of the macrophage receptors for
oxidized LDL can recognize both the lipid and the protein moieties (Bird, Gillotte et
al. 1999).
1.2.6.1.3 Calreticulin
Originally identified as an intracellular calcium-binding protein, calreticulin also
functions as a chaperone for proteins synthesised in the endoplamic reticulum
(Fliegel, Burns et al. 1989; Wada, Imai et al. 1995). Furthermore, calreticulin can
also be found at the cell surface (White, Zhu et al. 1995), and it is here that the
molecule appears to be involved in the clearance of dying self through it's
association with CD91 and engagement of Clq, MBL, SPA or SPD (Ogden,
deCathelineau et al. 2001; Vandivier, Ogden et al. 2002). On the other hand, when
released from necrotic cells, calreticulin is recognised by SR-A in prefernce to CD91
(Berwin, Hart et al. 2003).
1.2.6.1.4 Lectins
As mentioned in section 1.2.4.2 early studies into apoptotic-cell clearance suggested
»
involvement of macrophage lectins (Duvall, Wyllie et al. 1985) (Morris, Hargreaves
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et al. 1984). In addition to a role for the asialoglycoprotein receptor (Dini, Autuori et
al. 1992), it has been shown that increased cell surface expression of mannose
receptors in the liver can also enhance the recognition of apoptotic lymphocytes
(Dini 2000). However aside from the soluble binding proteins that display lectin-like
properties (section 1.2.6.2.1) other candidates for membrane bound receptors
mediating these events include CD68 and CD14 both of which display lectin-like
properties (Holness and Simmons 1993; Weidemann, Schletter et al. 1997).
1.2.6.1.5 The phosphatidylserine receptor
Many membrane receptors and indeed opsonins (see table 1-2) involved in apoptotic
cell clearance can bind to PS, although only the recently described
phosphatidylserine receptor (PSR) appears to be specific for this phospholipid.
Originally discovered as an activity expressed on macrophages stimulated with
digestible particles such as beta-glucan (Fadok, Laszlo et al. 1993) Fadok et al went
on to clone the PSR (Fadok, Bratton et al. 2000) as a protein expressed on the surface
of macrophages, fibroblasts and epithelial cells and which when transfected into B-
and T-lymphocytes, enables them to recognise and engulf apoptotic cells in a
phosphatidylserine-specific manner. Prior to the discovery of the PSR, several other
candidates were proposed, including CD 14, an oxLDL receptor (CD68), CD36,
annexins, beta 2 glycoprotein I, milk fat globule-EGF-factor 8, and gas-6. Although
studies suggest that CD 14 does not appear to contribute to PS dependent apoptotic-
cell recognition (Devitt, Pierce et al. 2003), it is possible that these candidates
(suggested recently for annexins I and II (Fan, Krahling et al. 2004)) may recognise
PS in vivo.
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Observations that psr-1, the Caenorhabditis elegans homologue of the PSR, is
important for cell corpse engulfment and that in vitro psr-1 binds preferentially to
phosphatidylserine or cells with exposed phosphatidylserine (Wang, Wu et al. 2003),
along with evidence that in PSR-deficient mice, dead cells accumulated in the lung
and brain, causing abnormal development (hyperplasic brain phenotype) and
neonatal lethality (Li, Sarkisian et al. 2003) was initially interpreted as proof for a
universal role for the receptor in corpse clearance during development. Conversely,
recent data, which also demonstrated perinatal lethality, growth retardation and a
delay in terminal differentiation of the kidney in PSR knockout mice, found
engulfment of apoptotic cells to be normal. However, PSR-deficient macrophages
were impaired in pro- and anti-inflammatory cytokine signalling after stimulation
with apoptotic cells or with lipopolysaccharide, suggesting that the PSR may be
essential for the development of organs but not for apoptotic cell removal (Bose,
Gruber et al. 2004). These latter disclosures are in keeping with earlier reports that
the PSR can localise to the nucleus through multiple nuclear localisation signals
(Cui, Qin et al. 2004).
Observation that overexpression of "the PSR" confers a phagocytic capacity that is
sterospecifically inhibited by PS (Fadok, Bratton et al. 2000) is in keeping with
initial studies which provided unequivocal evidence for the existence of a receptor
capable of sterospecifically recognising PS on the surface of apoptotic cells (Fadok,
Voelker et al. 1992). However, whether the molecule, currently refered to as "the
PSR", plays a physiologically relevant role in apoptotic-cell clearance remains to be
confirmed or refuted.
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1.2.6.1.6 ATP binding cassette transporter (ABCA1)
ABCA1 (or ABC1), the first of a subclass of 12 ABC transporters which is involved
in the outward redistribution of PS at the plasma membrane (Hamon, Broccardo et
al. 2000) has been implicated in programmed cell-clearance on both the side of the
macrophage and the apoptotic cell. Evidence for a role of phagocyte-associated
ABCA1 in engulfment was provided by the impaired ability of peritoneal
macrophages to engulf apoptotic thymocytes following antibody blockade of the
molecule (Luciani and Chimini 1996) and the close structural resemblance to the
nematode engulfment gene ced-7 (Moynault, Luciani et al. 1998; Wu and Horvitz
1998). Although no formal demonstration of direct transport of PS by ABCA1 has
been reported it has been proposed that this molecule favours engulfment via the
generation of lipid-determined directional forces sufficient to promote membrane
sprouting around the particle to be ingested (Hamon, Chambenoit et al. 2002).
1.2.6.2 Opsonins
In addition to direct engagement of apoptotic cells by membrane bound receptors, a
number of soluble opsonins have been shown to bridge apoptotic cells with
phagocytes. Whilst many of these molecules, such as (32 glycoprotein I, milk fat
globule-EGF-factor 8, and gas-6 have been shown to bind PS (section 1.2.6.1.5), the
binding-site for other opsonins, such as thrombospondin (section 1.2.4.2) is
unknown. Members of the collectin and pentraxin family, and complement factors,
which have been implicated in apoptotic cell clearance will be discussed in more
detail below.
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1.2.6.2.1 Complement components and collectins
Clq, the initiating factor of the classical pathway of complement activation binds
directly to apoptotic cells via its globular head domain (Korb and Ahearn 1997).
This event may also induce complement activation with subsequent deposition of
C4b and C3b (Nauta, Trouw et al. 2002) which can lead to an immunosuppressive
switch following internalisation by dendritic cells via complement receptors 3 and 4
(Mevorach, Mascarenhas et al. 1998; Morelli, Larregina et al. 2003). In addition,
Clq has been shown to link apoptotic cells to phagocytes via the binding of natural
antibodies or mannose binding lectin (MBL) (Ogden, deCathelineau et al. 2001).
Structurally, Clq resembles the coliectin family of proteins although it shares no
sequence homology with these C-type lectins. Examples of other members of this
family implicated in apoptotic-cell clearance include the lung surfactant protein (SP)
A, SP-D and C-reactive protein (CRP) (Schagat, Wofford et al. 2001) (Chang,
Binder et al. 2002; Vandivier, Ogden et al. 2002). In the case of CRP, the epitope
recognised on the surface of dying cells has been partially characterised as oxidized
phosphatidylcholine, but for other opsonins, such as Clq, MBL, SP-A, and
pentraxin-3 (PTX3), the ligand on the apoptotic-cell surface is currently unknown.
1.2.6.2.2 Pentraxins
Members of this protein family are characterised by their pentameric organisation
and include the glycoprotein serum amyloid P component (SAP). Mice which lack
the SAP gene develop autoantibodies to nuclear antigens, which was originally
interpreted as evidence for a role of SAP in controlling the degradation of chromatin
(Bickerstaff, Botto et al. 1999). However, as SAP was also known to bind to
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phosphatidylethanolamine (section 1.2.5.2.2.1.2) Familian et al performed studies to
demonstrate that this specificity allows SAP to opsonise apoptotic cells
independently of its nuclear binding. Calcium-dependent binding of SAP was
observed in early, nonpermeable apoptotic Jurkat, SKW, and Raji cells (Familian,
Zwart et al. 2001).
The role of opsonins in the uptake of early apoptotic cells remains to be established
as data suggest that Clq, MBL and the pentraxins are primarily important in the
clearance of apoptotic cells in later stages of the cell death process, after they have
become leaky (Nauta, Raaschou-Jensen et al. 2003) (Nauta, Trouw et al. 2002).
Therefore, in the normal clearance of early apoptotic cells, other clearance
mechanisms must operate, involving recognition of molecules which can detect early
changes. Nevertheless, the contribution of Clq to the clearance system is apparently
important as Clq-deficient mice show impaired clearance of apoptotic cells, and
since both Clq-deficient mice and humans are strongly susceptible to autoimmune
disease (Botto, Dell'Agnola et al. 1998).
Although dogma states that free late apoptotic cells rarely occur in vivo, there is the
possibility that in situations when the load of apoptotic cells exceeds the local
available phagocytic ability cells will proceed to late stages of apoptotic death (often
referred to as necrosis secondary to apoptosis) prior to clearance, for example,
following incidents of infection or inflammation. Such observations have been made
through attempts to experimentally induce inflammation in vivo (Medan, Wang et al.
2002; Devitt, Parker et al. 2004)
Therefore systems may exist to manage clearance in either case (Fujii, Shiratsuchi et
al. 2001; Wiegand, Corbach et al. 2001; Shiratsuchi, Mori et al. 2003). As the
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induction of apoptosis in vitro results in a concoction of cells at early and late stages
of death it is not easy to know exactly what stage a particular cell is at when the
phagocyte or purified receptor meets it. What is more, a cell may progress to later
stages of death following "assessment of apoptosis" during treatment for assays (see
results chapter 3).
It is not surprising that for a process so physiologically important as apoptotic-cell
clearance, evolution has designed multiple receptors capable of recognising a
multiple apoptotic-cell associated ligands to be used for both tethering and signalling
for engulfment of the dying cell. Collectively, the organised multi-protein
interactions involved in connecting a corpse to an engulfing cell has been termed a
"phagocytic synapse" (Savill, Dransfield et al. 2002; Ravichandran 2003)
Proposals as to why so many receptor/ligand interactions are involved include
redundancy or that different sets of receptors are used for ligands as they appear on a
cell during different phases of apoptosis. Alternatively it could be that that the
presence of multiple low-affinity receptors allows for sensitivity during the initial
binding stage, such that just one or two molecules initiate tethering followed by a
more complicated union during engulfment. This is the case for molecules involved
in T-cell:APC interactions which characteristically have weak affinities, (in the low
micromolar range) but yet with apparent specificity (Davis, Krogsgaard et al. 2003).
Indeed it has been shown that multiple cell-surface interactions giving an affinity
greater than 10 micromolar cannot be disrupted without damaging membranes
(Leckband, Muller et al. 1995). Thus, low-affinity interactions may be useful, for
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example, in slowing down a fragile corpse in the circulation by phagocytic epithelial
cells.
1.2.7 Examining and explaining apoptotic cell clearance:
Consensus and confusion
It is clear that different phagocytes (professional/non-professional,
stimulated/activated or unactivated, lineage origin) use different receptor systems to
accomplish apoptotic-cell clearance (Fadok, Laszlo et al. 1993) and that the vast
numbers apoptotic cells generated in vivo are scarcely detected. Yet, it is not clear
why many of the phagocytic receptors implicated in this process recognise structures
that appear only on cells during later stages of death. Paying detailed attention to the
type of phagocyte, the type of apoptotic cell (Hart, Jackson et al. 2003), how death is
induced (Wiegand, Corbach et al. 2001), at what stage in the death programme the
feed cell is at, how long the phagocyte and feed are left co-incubated, the
environment in which interaction is allowed to take place in (Mevorach,
Mascarenhas et al. 1998), may provide an explanation as to why there are conflicting
views on issues such as the phase of apoptosis (i.e."early" vs. "late") reached before
cells are engulfed (Gregory and Devitt 2004) (Devitt, Pierce et al. 2003).
1.2.7.1 The "standard" phagocytosis/interaction assay
Whilst some authors report preferential clearance of "late apoptotic" cells in vivo
(Devitt, Pierce et al. 2003) others observe clearance during earlier phases (Jersmann,
Dransfield et al. 2003). The way in which an apoptotic cell interaction assay is
performed and recorded may have dramatic effects on the apparent outcome of a
given experiment. Let us examine some of the features of these assays, using a
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monolayer of HMDMs in a 24-well format as an example (Fadok, Voelker et al.
1992). Wells of this size typically hold a maximum of 70,000 mature macrophages
and commonly, between lxlO6 and lxlO7 feed cells are added potentially providing
between 15 and 150 feed cells per macrophage. What is more, commonly, not all
HMDMs within a given population appear "competent to eat" which further
increases the ratio of feed cells to phagocytically competent macrophages. Now,
considering the stage of death amongst the feed cell population - cultures of early
apoptotic cells are often described as being >95 % negative for the uptake of vital
dyes before an assay. However 5 % in a population of only 2xl06 provides every
macrophage with atleast one membrane compromised cell and given that cells are
likely to progress to later stages of death through their handling and during the period
of the assay the number of "late apoptotic" or "secondarily necrotic" cells available
to each macrophage may be even higher by the end of the interaction. Such an effect
will be more marked when assays are extended for long incubation periods, which
may explain the results of Kurosaka and colleagues who observed inefficient
engulfment by macrophages following a 1 hour co-culture with 6 hour post apoptotic
cells compared to 3 hour co-culture with cells 4 hours post induction (Kurosaka,
Takahashi et al. 2003). Additional factors, such as the shear force imparted during
wash steps and the temperature at which they are carried out may explain differences
in the resulting number of bound or phagocytosed cells recorded following an assay.
"Extensive washing" (Devitt, Pierce et al. 2003) (6 assertive plunges into PBS) may
remove more bound feed cells (and macrophages) than "gentle washing" (Eda,
Yamanaka et al. 2004) of loosely bound cells. Furthermore, the inclusion or
exclusion of serum may have profound effects through opsonisation of the apoptotic
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cell or activation state of the macrophage (Takizawa, Tsuji et al. 1996). However,
although apparently conflicting results in the literature may be a consequence of
varying assay conditions, such assays may well be measuring interactions pertinent
to those found in vivo, but simply in different contexts.
1.2.7.2 Defining the type of clearance being modelled
In vivo, the conditions surrounding an apoptosing muscle cell found deep within its
closed tissue (lacking abundance of serum) are likely to be very different to those of
a senescing neutrophil in the vasculature, with a consequent effect on the
mechanisms used for phagocytosis. Such differences could be further exaggerated in
vitro where following induction, apoptosis is usually left to ensue with cell cultures
incubating statically. It may be that the "enzymatic" changes occurring inside a
dying cell in vitro cell do not automatically result in the membrane changes found in
vivo, where a dying cell is exposed to additional factors such as compressive forces
through normal bodily movement or constant shear forces in the blood. Refinement
of apoptotic-cell recognition assays to measure specific aspects of clearance (such as
that developed by Brown et al see also section 1.2.5.2.1.5.1) (Brown, Heinisch et al.
2002) may lead to a greater understanding of the kinetics of clearance.
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1.2 Phage antibody display technology
The following sections aim to provide background information to one of the
technologies, namely phage antibody display, employed for the work described in
this thesis aimed at identifying novel markers of apoptosis.
1.2.1 Bacteriophage-displayed recombinant antibody fragments
Due to the almost limitless permutations of amino acid arrangements that are
possible within an antigen-binding site, antibodies can, in theory, be produced to
interact with almost any substance. In addition to their role engineered by evolution,
as part of the immune system in facilitating the clearance of their specific antigen,
antibodies have become invaluable for medical and laboratory applications.
Recombinant DNA technology has allowed the engineering of antibodies which
overcome both the inherent disadvantages of using polyclonal antisera such as
unexpected cross-reactions, and the formation of "human anti-mouse antibody"
(HAMA) complexes following therapeutically or diagnostically administered mouse
monoclonal antibodies. With "recombinant antibody technology" antibodies are no
longer produced in mammals by immunisation with antigen, but in bacteria or cell
cultures, in vitro. To obtain higher yields only the antigen-binding portion of the
antibody is produced.
Prior to recombinant technology, the smallest possible antigen-binding unit
obtainable was the Fab fragment, created by protease digestion of normal antibodies.
However the smallest molecule that retains the antigen-binding site, named variable
region fragment (Fv), consists of only the variable regions of the light and heavy
chains (figure 1-5). These must be stabilised by a peptide link, joining the variable
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ScFv fragment
Figure 1-5. Schematic representation of an immunoglobulin antibody
and antigen-binding fragments. ScFv; single-chain variable region.
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domains forming a single-chain Fv fragment (ScFv).
The expression of these antibody fragments on the surface of bacteriophage (virus
particles that infect bacteria) as fusions to their coat proteins provides a physical link
between the antibody product and the gene that codes for it. By displaying libraries
of these Ab fragments in this way it is possible to mimic the humoral immune system
in bacteria. Most recombinant antibody technology using phage display uses the
non-lytic filamentous phage M13 or the closely related phage fd. The antibody
fragments can be fused to the N terminus of the minor coat protein 3 (gp3) of the
phage or to the C-terminal domain of gp3 (Barbas, Kang et al. 1991) as Fab
fragments or as ScFv fragments.
1.3.2 Sources of antibody library complexity
Combinatorial libraries of antibody fragments rely on the ability to clone antibody
heavy and light fragments independently and recombine them in the desired
expression system. Repertoires of antibody fragments weie first generated by
polymerase chain reaction (PCR) from rearranged V-genes (Orlandi, Gussow et al.
1989) of populations of lymphocytes, from the spleens of immunised mice, blood of
immunized humans, and the bone marrow of infected humans (Barbas, Kang et al.
1991) leading to isolation of antibodies with excellent binding affinities
(Hoogenboom, Griffiths et al. 1991). Repertoires can also be built from human V-
gene segments rearranged in vitro ("synthetic repertoires") yet these often yield
antibodies of only moderate binding affinity compared with immune repertoires of
the same size. However higher affinity antibodies can be obtained by random
mutation or chain shuffling (Riechmann and Winter 2000) of antibodies selected
from these repertoires.
46
1.3.3 Selecting the desired phages
The process of selection to extract members of a phage library with desired binding
properties is crucial with affinity-based selections (often referred to as biopanning)
being the most common (Marks, Hoogenboom et al. 1991; Hoogenboom, de Bruine
et al. 1998). Typically the selective agent (antigen) is incubated with the phage
library to allow binding between the target and the appropriate phage. After a
suitable incubation time, unbound phages are lemoved and washing steps are done to
remove non-specifically bound phage. The elution is necessarily harsh since the
objective is to recover members of the library with the highest affinity. As required,
eluted phage can be amplified, and repeated selection cycles undertaken until
enrichment of the desired phage is observed.
Despite there being no published reports of phage-displayed libraries being used to
select for apoptosis-specific markers, antibodies with specificity towards viable cell
surface molecules, such as epidermal growth factor (EGF) receptors, CD14, CD98
and CD40, have successfully been obtained using this approach (Schier, Bye et al.
1996; Pierce 2000; Itoh, Inoue et al. 2001; Ellmark, Ottosson et al. 2002).
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1.4 Purpose of this study
The work carried out in this thesis centres around the aim of improving our
understanding of how innate mechanisms recognise dying self. Using two antibody-
based strategies, attempts are made to probe the apoptotic-cell surface for previously
uncharacterised engulfment ligands. Initially a phage-displayed antibody library
containing a repertoire of ~108 antibody fragments encoded by human germline
genes was utilised as an unbiased source of binding specificity. An alternative
approach was based on the knowledge that receptors used by macrophages to
recognise apoptotic cells also recognise microbial epitopes. Looking for the ability
of antibodies raised against microbe-associated molecules to cross-react with
apoptotic cells in this way could help confirm or refute the hypothesis that ACAMPs
revealed by cells undergoing apoptosis present molecular patterns that resemble
PAMPs.
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2 Materials and Methods
Chemicals and Reagents
4,6-diamidino-2-phenylindole(DAPI) Sigma
4-well glass slides Hendley, Essex





Ammonium persulphate (APS) Sigma
Ampicillin Sigma
Annexin V-(FITC conjugated or biotinylated) BioWhittaker
BactoTM agar BDH Chemicals
Biorad Protein assay Biorad
Biotinylation Kit Sigma
Boric acid Sigma




Complement CI q Sigma
Cycloheximide Sigma
DePeX mounting medium BDH Chemicals
Dextran 500 Amersham Biosciences
Dihydroxyvitamin D3 Leo-pharma, Belgium
Dimethyl sulphoxide(DMSO) Sigma
ECL reagents Amersham Biosciences
ECL reagents Amersham Biosciences
EDTA Fischer
EndoTrap-Endotoxin removal system Profos, Germany
Ethanol BDH Chemicals
Ethidium bromide Sigma
Ethylenediaminetetra-acetic acid disodium salt(EDTA) Fischer
Etoposide Sigma
Formaldehyde BDH Chemicals
Gene pulser electroporation cuvettes ( 0.4cm) BioRad






Jenner stain BDH Chemicals
Kanamycin Sigma
Laminin from human placenta Sigma
Lipopolysaccharides Sigma





Non-fat skimmed milk powder Tesco
Percoll Amersham Biosciences
Phorbol 1 2-myristate 1 3-acetate(PMA) Sigma
Polyoxyethylene sorbitan monolaurate (Tween 20) Sigma
Polyoxyethyleneglycol (PEG-8000) Sigma
Ponceau S solution Sigma
Potassium acetate Sigma
Potassium chloride Fischer
Propidium iodide Bender Medsystems
Protease inhibitor cocktail Sigma
PVDF membrane Amersham Biosciences






Sodium phosphate dibasic anhydrous Fischer
Sodium phosphate monobasic anydrous Fischer
Tetracyclin Sigma
TRAIL Affiniti research products
Tri-reagent Sigma
Tris(hydroxymethyl)methylamine(T ris) BDFI Chemicals
Trisma base Fischer
Triton-X-100 Biorad
Tryptone peptone BDH Chemicals
Yeast extract BDH Chemicals
ZBoc-Fmk Calbiochem
Cell culture
Dulbecco's modified eagle medium(DMEM) Gibco
Foetal Bovine serum(FBS) Biowhittaker
G418 sulphate Gibco
Goat-anti-mouse coated beads Sigma
Flybridoma medium animal component free Sigma
Iscoves modified Dulbecco's medium (IMDM) Gibco
L-Glutamine Gibco
Nickel-NTA paramagnetic agarose beads Qiagen
Non essential amino acids Gibco
Normal goat serum(NGS) Harlan Sera-labs
Penicillin-streptomycin(P/S) Gibco






10 mM dNTP solution Invitrogen
Big-Dye Terminator sequencing Kit Applied Biosystems
DNA lOObp ladder Invitrogen
DNA 1 Kb ladder Invitrogen
DNA oligonucleotide Primers MWG-Biotech
Dnase Invitrogen
Bac-to-Bac aculovirus Expression Sytsem Invitrogen
HisTrap nickel-NTA kit Amersham Biosciences
HiTrap Protein G column kit Amersham Biosciences











Taq polymerase Roche, USA
Antibodies




































































































































































































Beckman GS-6R Beckman, UK
Beckman J2-HS with JA1 4 and JA21 rotors Beckman, UK
Rotina 46-R Hettich, Germany
Sigma 1 -1 5K Sigma, USA
Cell culture
BS748 improved neubauer haemocytometer Weber, UK
Incubator LEC,UK
Microflow class II hood Walker safety cabinets, UK
Orbital shaking incubator SANYO Gallenkamp, UK
Static incubator SANYO Gallenkamp, UK
Microscopes
Flourescence microscope , Axioskop 2 Zeiss , Switzerland
Leica inverted TCS-NT microscope Leica Microsystems, UK
Leica upright TCS-NT microscope Leica Microsystems, UK
Olympus CK2 light microscope Olympus, Japan
TCS-NT laser scanning unit Leica Microsystems, UK
General
800 W microwave Proline, UK
Anthos lt-2 plate reader Anthos Labtec Instruments , Austria
Cecil-200 spectrophotometer Cecil instruments, UK
Coulter EPICS XL-MCL flow cytometer Beckman Coulter, USA
Conical polypropylene tubes (1 5ml and 50ml) BD Biosciences, UK
Tissue cell culture flasks and plates Nunc International, UK
Decon sonicator Decon labs, UK
Gene Pulser TM Electroporation apparatus Biorad, UK
Grant waterbath Grant instruments, UK
Horizon gel tanks (size 58 and 11.4) Life Technologies, USA
Mini protean II gel system Biorad, USA
Peristaltic pump , type 505S Watson Marlow , Falmouth , UK
Power Pac 300 Biorad, UK
PTC-100 thermal cycler GRI, UK
Transilluminator UV products Ltd, UK
Computer packages
Amplify 1.0 Bill Engels, University of Wisconsin




All DNA manipulations were carried out as described in (Sambrook, Fritsch et al.
1989).
2.1.1 Plasmid vectors used in this work
Refer to Fig. 2-1 for maps of plasmid vectors used for DNA cloning during this
work.
2.1.2 Extraction and purification of plasmid DNA from bacterial
cells
Plasmid DNA was purified using alkaline lysis followed by alcohol precipitation as
described below.
2.1.2.1 Small scale preparations of plasmid DNA
1.3ml of a 5ml overnight bacterial culture was placed in a sterile Eppendorf tube and
pelleted at 13000g for 2 minutes to pellet the cells. After discarding the supernatant
cells were resuspended in 200pl of glucose/Tris/EDTA buffer (GTE, see appendix 2-
1), to which an additional 400pl of 1%SDS/0.2M NaOFl was added. The solution
was mixed by inversion and then left for 5 minutes during which time cell lysis
occurred. Following lysis 300pl of potassium acetate buffer (3MK75MAc", see
appendix 2-1) was added per tube before mixing by inversion. The resultant white
precipitate was pelleted by centrifugation at 13,000g for 7 minutes before adding the
supernatant to a fresh sterile Eppendorf containing 600pl of isopropanol. Tubes
were mixed by inversion before centrifugation at 14,000g for 5 minutes to pellet the
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DNA. The supernatant was discarded and the pellet washed in 500pl 80% ethanol,
before allowing to air dry. The final pellet was resuspended in 30pl of dH20 or
Tris/EDTA buffer (TE, see appendix 2-1).
2.1.2.2 Large scale preparations of plasmid DNA
500pl of a 5ml bacterial culture (grown overnight) was added to 100ml of LB
containing the appropriate antibiotics and allowed to grow overnight at 37°C. The
following day cells were pelleted from the culture by centrifugation at 6,000g for 10
minutes in sterile 300ml centrifuge tubes (Nalgene). The pellet was resuspended in
12ml of GTE to which an additional 16ml of 1%SDS/0.2M NaOH was added. The
two were mixed by inversion and left for 5 minutes to allow lysis to occur.
Following lysis 18ml of 3MK75MAc" was added and the solution mixed by
inversion. After 5 minutes incubation on ice the resultant white precipitate was
pelleted at 10,000g for 10 minutes and the supernatant added to 40ml of ice-cold
isopropanol. After a further 5 minutes on ice the DNA preciptate was pelleted in a
fresh sterile centrifuge tube at 10,000g for 15 minutes. The resultant pellet was
resuspended in 500pl of TE before adding RN-ase A (Promega) to 80p,g/ml and
incubating at 37°C for 45 minutes. Finally the sample was phenol/chloroform
extracted before storage at -20°C.
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Figure 2-1. Maps of plasmid vectors used for DNA cloning during
this work.
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2.1.3 Strategies for cloning in plasmid vectors
2.1.3.1 Ligation of plasmid DNA
Following digestion with the appropriate restriction endonucleases, DNA samples
were separated by electrophoresis in a 1% agarose gel. The amount of DNA in a
sample was quantified by visual comparison of band intensity with a standard. The
required DNA fragments were excised and DNA extracted from the gels by silica-
based purification using the QIAquick® Gel Extraction Kit (QIAGEN) accordingto
manufacturer's instructions. Considering that the in-gel method used to quantify the
DNA was not entirely precise, three ligation reactions with varying ratios of vector
DNA to foreign insert DNA were assembled in separate sterile Eppendorf tubes, as
detailed in table 2-1. The ligation reactions were allowed to proceed for between 4-
16 hours at 16-21°C.
2.1.3.2 Preparation and transformation of competent Escherichia
coli.
Refer to table 2-2 for the specific strains of Escherichia coli (E.coli) used for
individual cloning applications.
Below are typical protocols for preparation and transformation of competent
Escherichia coli.
2.1.3.2.1 Preparation of competent E. coli.
A single colony of E. coli was allowed to grow to saturation in 5mls of LB overnight
at 37°C. 1ml of the resultant overnight culture was added to 50mls of fresh LB. The
culture was grown until a 0.4-0.5 OD600 was reached, then incubated on ice for 10
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A
minutes. Cells were then harvested at 2000g for 20 minutes before resuspending in
25ml of ice cold 0.1M CaCl2 and incubating on ice for 30 minutes. Subsequently the
cells were centrifuged at 2000g for 20 minutes before resuspending in 5ml of ice-
cold 0.1M CaCl2/15% glycerol and a further 30 minute incubation on ice prior to use.
A
2.1.3.2.2 Transformation of competent E. coli with plasmidDNA
5-10pl of the ligation reaction was added to lOOpI of freshly prepared competent
cells. Tubes were left on ice for 30 minutes and then heat shocked at 42°C for 30-
120sec depending on bacterial strain. 250pl of SOC medium (NZY for XI1 Blue)
was added to each tube and incubated with shaking at 37°C for an hour to allow
expression of the antibiotic resistance gene. 200,ul of the bacterial culture was spread
onto LB agar plates containing the appropriate selective antibiotic(s) before
overnight incubation at 37°C.
On each occasion the following two control transformations were included; (a)
Competent cells without plasmid DNA and (b) Competent cells plus a known
amount of closed circular plasmid DNA lacking the desired insert.
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Molar ratio - vector DNA:foreign DNA
1:3 1:1 3:1
Vector DNA (ng) 25 50 75
Foreign insert DNA (ng) 75 50 25
T4 DNA ligase (Weiss units) 1 1 1
Nuclease free water to 20 ul to 20 pi to 20 ul
Table 2-1. Reaction components for ligation of plasmid DNA.







cDNA cloning into pCDNA3.1 D/V5-His-
TOPO and subcloning into





Site directed mutagenesis of




MCI 061/p3 Subcloning into pHAT11 and pTrcHis2C 30 2.1.10.2
SCS110 Subcloning into pEGFP-C3 120 2.1.10.1
DHIOBac Generation of recombinant Baculorius 45 2.1.10.4
TG1 Phage display na 2.12
Table 2-2. E.coli strains used for transformation of vectors. Refer to materials




RT transcription buffer 2ptl
10mM dNTP mixture 2 pi
RNAse inhibitor 0.5pil
oligo dTs 0.5pil
AMV RT enzyme 2pi
Table 2-3. Components of the reaction used for
reverse transcription (RT)
59
2.1.3.3 Identification of bacterial colonies that contain recombinant
plasmids by restriction analysis
A small number of colonies (typically 5-20) from those returning from a
transformation were used to inoculate 5ml of LB containing the appropriate
antibiotic and grown overnight at 37°C. The resultant cultures were used for small-
scale isolation of plasmid DNA, and analysed by digestion with restriction enzymes
and electrophoresis through a 1% agarose gel containing 0.5pg/ml ethidium bromide
and visualised under UV light (254-366 nm).
A
2.1.3.4 Strategies for cDNA cloning
2.1.3.4.1 Preparation ofmRNA
1 x 107cells were harvested by centrifugation and washed twice in ice cold PBS. The
final pellet was resuspended in 1ml of TRI-Reagent™ , left to stand at RT for 5
minutes before adding 200pl chloroform and vortexing gently for 15 seconds.
Following a further 10 minutes incubation at RT samples were centrifuged at
13,000g for 15 minutes at 4°C. The aqueous phase was removed and added to 500pl
of isopropanol. The solution was mixed by inversion and allowed to incubate for 10
minutes at RT before pelleting the precipitated RNA by centrifugation at 13,000g for
10 minutes at 4°C. The resultant pellet was washed with 1 ml of 75% ethanol before
air-drying. Pellets were dissolved in 50pl of nuclease free dH20 before use or stored
at -80°C. The quality and quantity of RNA was assessed by electrophoresis through
a 1% agarose gel containing 0.5pg/ml ethidium bromide and visualised under UV
light (254-366 nm).
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2.1.3.4.2 Reverse transcriptase synthesis of cDNA
To 5[a,g of mRNA was added 0.5pl RNAse inhibitor and nuclease free dH20 to 7pl.
Samples were heated for 5 minutes at 95°C to denature the RNA then placed on ice
whilst the reaction components (detailed in table x) were added. The reaction was
incubated at 42°C for 1 hour. In order to check for contamination by genomic DNA a
control reaction containing the same components with the exception of AMV reverse
transcriptase (RT) was included for each mRNA sample. Following transcription the
enzyme was heat inactivated at 95°C for 5 minutes before adding 80p,l of nuclease
free dH20. Sample quality was assessed by PCR amplification of the DNA encoding
GAPDH. Table 2-4 lists primer sequences and table 2-5 provides details of a typical
programme for PCR (see also section 2.1.4).
2.1.4 Amplification of DNA by the polymerase chain reaction
(PCR)
Refer to table 2-4 for details of specific primer sets for PCR. To aid design of
primers that minimised the chance of primer dimer formation and that possessed
suitable melting temperatures the PCR outcome was simulated using the Amplify 1.0
software (University of Wisconsin). When PCR products were to be used for
cloning, amplification reactions were carried out using Pfu Polymerase (QIAGEN)
or for Site directed Mutagenesis Pfu Turbo (Stratagene)
Table 2-5 details a typical programme used for amplification of DNA in a PTC-100
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2.1.5 Cloning of LBP/p40 and NEDD5 cDNA into the
pCDNA3.1 D/V5-His-TOPO© vector
The pCDNA3.1© Directional TOPO ® Expression Kit (Invitrogen) was used for
directionally cloning blunt-end PCR products into pCDNA3.1D/V5-His-TOPO©
vector.
Table 2-4 lists the combined primer sets, pCDNA3.1D/LBP/p40-V5-His and
pCDNA3.1D/NEDD5-V5-His used for amplification of laminin-binding protein
(LBP/p40) and NEDD5 genes respectively, from Mutu I cDNA. The oligonucleotide
primer sequences were designed to amplify the complete coding sequence of the
genes cited in the records obtained from the primary result of MALDI-TOF analysis
for LBP/p40 (Yow, Wong et al. 1988) and NEDD5 (Strausberg, Feingold et al.
2002) (accession no.s X61156.1 and BCO 14455.1 respectively). The addition of four
bases, CACC, to the 5' end of forward primers allowed PCR products to be
directionally cloned into the pCDNA3.1D/V5-His-TOPO© vector. In order to fuse
the C-terminus of the open reading frames for each gene in-frame with the V5
epitope and 6xHis tag contained within the pCDNA3.1 vector, reverse primers were
designed to exclude the stop codons of their corresponding genes.
The resulting plasmids were named pCDNA3.1D/LBP/p40-V5-His and
pCDNA3.1D/NEDD5-V5-His, the multiple cloning sites (MCSs) of which are
represented in figure 2-2.
Following identification of plasmid DNA containing inserts of the expected size by
restriction analysis (section 2.1.3.3), sequences were confirmed as described in
section 2.1.8 employing primer sets specific for sites flanking the LBP/p40 cDNA
insert (T7 and BGH, Table 2-4).
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2.1.6 Site directed mutagenesis of cloned LBP/p40 DNA
A
A QuikChange® mutagenesis kit (Stratagene) was applied for removing the internal
Hind III consensus sequence by introducing a silent point mutation at the position
corresponding to nucleotide 140 of the LBP/p40 gene (accession no.s X61156.1.)
according to manufacturers' instructions. The PCR programme, and components of
the reaction used for site directed mutagenesis are detailed in table 2-6 and 2-7
respectively.
The plasmid pCDNA3.1 D/LBP/p40-V5-His was used as a template for constructing
the point mutation through PCR. The primer pair pCDNA3.1D/LBP/p40-pm (Table
2-4) was synthesised to exchange change codon CTT (bps 142-144 -leucine) for
codon CTC (leucine). The resulting plasmid was named pCDNA3.1D/LBP/p40-pm.
Mutations were confirmed by sequencing as described in section 2.1.8 employing
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Figure 2-2. Schematic representations of multiple cloning sites
for recombinant plasmids produced during this work (mammalian
expression systems). See figure 2-1 for maps of parental plasmid
vectors.
A; pCDNA3.1 D/LBP/p40-V5-His and pCDNA3.1 D/NEDD5-V5-His,
see section 2.1.4
B; pSecTag2/HygroA-LBP/p40 and pSecTag2/HygroA-NEDD5 see
section 2.1.6.3.
C; pEGFP-C3-LBP/p40, see section 2.1.6.1.
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2.1.7 Subcloning of LBP/p40 and NEDD5 DNA
2.1.7.1 Production of LBP/p40 as a green fluorescent protein
(GFP) fusion construct
DNA containing the LBP/p40 insert was isolated from pCDNA3.1 D/LBP/p40-V5-
His by double digestion with BamHl and Xbal and further subcloned into the
pEGFP-C3 (Clontech) at the same restriction sites. The MCS of the resulting
plasmid, which was named pEGFP-C3-LBP/p40, is represented schematically in
figure 2-2.
2.1.7.2 Subcloning of LBP/p40 for expression in a bacterial
expression system.
The DNA insert containing the LBP/p40 plus V5 and 6xHis-tag coding sequences
was isolated from pCDNA3.1D/LBP/p40-pm by double digestion with f/mdIII and
PmeI and further subcloned into the pHATl 1 (Clontech) digested with Hindlll and
Smal.
The MCS of the resulting plasmid, which was named pHATl 1-LBP/p40-pm, is
represented schematically figure 2-3.
This vector introduced an EcoRl restriction site allowing further subcloning of the
insert LBP/p40 plus V5 and 6xHis-tag coding sequences into the vector pTrcHis2C
(Invitrogen) for high level expression in a bacterial system. This was achieved by
double digestion of pTrcHis2C and vector pHATl l-LBP/p40-pm with BamHl and
EcoRl. The MCS of the resulting plasmid, which was named pTrcHis2C-LBP/p40-


























1 1 1 II II II LBP/p40>


















































Figure 2-3. Schematic representations of multiple cloning sites
for recombinant plasmids produced during this work (bacterial
and insect expression systems). See figure 2-1 for maps of
parental plasmid vectors.
A; pHATI 1-LBP/p40-pm, see section 2.1.7.2.
B; pTrcHis2C-LBP/p40-pm, see section 2.1.7.2.
C; pFastBac-LBP/p40, see section 2.1.7.4.
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2.1.7.3 Production of LBP/p40 and NEDD5 constructs for expression
as secreted proteins.
The DNA inserts containing the LBP/p40 and NEDD5 each with V5 and 6xHis-tag
coding sequences were isolated from pCDNA3.1 D/LBP/p40-pm and
pCDNA3.1 D/NEDD5-V5-His respectively by double digestion with Hindlll and
Pmel and then subcloned into the pSecTag2/HygroA (Invitrogen) digested with
Hindlll and EcoRV.
The MCSs of the resulting plasmids, which were named pSecTag2/HygroA-LBP/p40
and pSecTag2/HygroA-NEDD5 respectively, are represented schematically in figure
A
2-2.
Confirmation that target DNA had been subcloned in-frame with the leader sequence
provided by pSecTag2/HygroA vector was achieved by sequencing as described in
section 2.1.8 employing primer sets specific for sites flanking the DNA inserts (T7
and BGH, Table 2-4).
2.1.7.4 Production of LBP/p40 in insect cells.
The Bac-to-Bac® Expression System (Invitrogen) was used to generate recombinant
baculovirus, containing the DNA encoding LBP/p40, for expression of the protein in
Spodeoptera frugiperda Sf9 insect cells according to manufacturers' instructions.
A
The DNA inserts containing the LBP/p40 plus V5 and 6xHis-tag coding sequence
was isolated from pCDNA3.1D/LBP/p40-V5-His by double digestion with BamHl
and Pmel and then subcloned into the pFastBac™ 1 (Invitrogen) digested with
BamHl and Still. The MCS of the resulting plasmid, which was named pFastBac-
LBP/p40, is represented schematically in figure 2-3.
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To generate recombinant bacmid DNA, DH lOBac™ E.coli were transformed with
pFastBac-LBP/p40 (see section 2.1.3.2.2). Confirmation that target DNA had been
transposed into the bacmid vector was achieved by PCR as described in section 2.1.4
employing primer sets specific for sites flanking the DNA inserts
(pCDNA3.1 D/LBP/p40-V5-His for and M13 rev, Table 2-4).
2.1.8 DNA sequencing
Cloned DNA was sequenced using the BigDye® v3.1 Kit (Applied Bioscience)
which is based on the Sanger method (Sanger, Nicklen et al. 1977) of chain
termination using fluorescently labelled dideoxynucleoside triphosphates. Reaction
components were assembled according to the protocol provided by the manufacturer
and the reaction performed in a PTC-100 thermal cycler (MJ Research inc). Refer to
table 2-8 for details of the reaction components used for sequencing. Table 2-4 lists
details of plasmid/promoter specific primers used for sequencing. 2.0pl 3M sodium
acetate (pH 4.6), 50pl 100% ethanol and lOpl dH20 was added to each of the
completed reactions before incubation at room temperature for 20 minutes. The
resultant DNA precipitate was pelleted by centrifugation at 13,000g for 50 minutes at
4°C. DNA pellets were washed with 70% ethanol and air dried prior to being sent
for electrophoretic analysis using an ABI prism sequencer.
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Step name Step no. Temp (°C) time (min)
initial denaturation 1 95 2
denaturation 2 95 0.75
anneal 3 primer specific 1
extend 4 72 2
goto to step 2 (x 25) 5 - -
cool 6 4 hold
Table 2-5 Example of a typical programme used for amplification of
DNA in a PTC-100 thermal cycler (MJ Reasearch INC)
Step name Step no. Temp (°C) time (min)
denaturation 1 96 0.5
anneal 2 50 0.25
extend 3 60 4
goto to step 2 (x 25) 4 - -
cool 5 4 hold
Table 2-6 Details of the programme used for site-directed
mutagenesis by PCR
Component Amount
pCDNA3.1 V5His LBP/p40 1 Ong
sense primer 1 5pmol
antisense primer 1 5pmol
lOx PCR Reaction Buffer 2.5 [xl
dNTP mix (10mM) 1 |il
distilled water To 50f.il
Pfu Turbo DNA Polymerase 1 fil
Table 2-7 Components of the PCR reaction




5x sequencing buffer 2.0fil
BigDye terminator 2.5 fil
distilled water To 1 Opl
Table 2-8 Details of the reaction components used
for sequencing using the BigDye® v3.1 Kit (Applied
Bioscience)
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2.1.9 Expression of cloned genes in cultured mammalian cells
2.1.9.1 Transient transfection into human embryonic kidney (HEK)
293T cells
Plasmid DNA was introduced as a coprecipitates of calcium and phosphate to
resuspended HEK 293 T cells as follows:-
In a 50ml conical polypropylene tube (Becton Dickinson) air was bubbled through
K
t
the 2xHBS whilst an equal volume of 0.25M CaCl2 containing the desired plasmid
was added drop-wise (refer to table 2-9 for the quantity of each reagents used per
lxlO6 cells. Reactions were scaled up as appropriate). The resultant mixture was
incubated at room temperature for 10 minutes to allow precipitate formation before
adding to the cell suspension and seeding onto tissue culture plastic or Teflon-coated
4-well slides. After 24 hours the medium was removed, the adhered cells washed
with serum-free DMEM and replaced with an identical volume of fresh medium.
The composition of the medium used as a replacement varied between experiments
and was supplemented with varying concentrations of Serum Supreme (Cambrex)
(refer to table 2-10 for details). When downstream purification of Fc-tagged
A
recombinant proteins was intended, medium was filtered through a Hitrap™ protein
G (Amersham Biosciences) column, as described in section 2.2.1 to remove bovine
immunoglobulin. For production of fusion proteins, cells were left for a further 4-5
days.
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2.1.10 DNA transfection by electroporation
Cells were harvested and resuspended in culture medium as listed in table 2-11. 10pg
of plasmid DNA was added to an electroporation cuvette and the resuspended cells
added. The cuvette was placed on ice for 10 minutes before subjecting cells to the
electroporation conditions listed in table 2-11 using a Gene Pulser (Biorad). The
cuvette was returned to ice for 10 minutes before transferring the cells to a 25cm2
tissue culture flask containing 10ml of culture medium. Electroporated cells were
incubated overnight at 37°C before the addition of the appropriate drug for selection
of cells stably expressing plasmid-encoded resistance genes. Prior to transfection a
drug titration was carried out on each cell line to determine the optimal dose of drug
to select for stable transfection. For suspension cell lines, the minimal dose that
killed all cells of a non-resistant culture within 2-3 passages was chosen. For
adherent cells, the minimal dose that killed all cells between 4 days and 2 weeks
(dependent on cell line) was chosen.
2.1.11 Expression of cloned genes in Escherichia coli
lml of a 5ml overnight culture of E. coli cells (TOP-10) transformed with
pTrcHis2C-FBP/p40-pm was added to 250ml of FB containing ampicillin (100
pg/ml) and allowed to grow with shaking at 37°C. When OD600 of the culture
reached 0.5, isopropyl-1-thio-B-D-galactoside (IPTG) was added to a filial
concentration of 1 mM and the cells were harvested by centrifugation 4 hours later.
Aliquots of total cell extracts were collected before and after induction with IPTG for




5mg of plasmid DNA
312.5
2xHBS 312.5
cells at 1.6x105/ml in
complete DMEM
6250
Table 2-9. Components of transfection reaction used to introduce
plasmid DNA as a coprecipitate of calcium and phosphate to cells.
Refer to methods section 2.1.8.1 for a detailed protocol.
Quantities given are those used per million cells. Reactions were scaled
up as appropriate.
Protocol Section Ref Medium replacement
ICAM-3 Fc 4.1.3.1
1 % Protein G adsorbed SS
supplemented DMEM
His-tagged ICAM-3 4.1.3.2.1 complete DMEM
His-tagged ICAM-3 4.1.3.2 Animal component free medium
His-tagged LBP/p40 7 Animal component free medium
Table 2-10 Composition of the cell culture medium used as a
replacement for transfection mixtures. SS; serum supreme.
Cell type Volts HF Cell density Medium Volume
B-JAB 650 25 1x1 07/ml RPMI 600fxl
MCF-7 245 960 3x1 06/ml DMEM 800^1
K562 650 25 1x1 07/ml RPMI 600ptl
Table 2-11 Conditions used for DNA transfection by electroporation.
Refer to methods section 2.1.13 for a detailed protocol
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2.2 Protein Protocols
2.2.1 Purification of Fc-fusion proteins by adsorption to Protein G
Culture supernatants were harvested from HEK-2937 cells 5-6 days post transfection,
and filtered through a 0.45pm pore filter before dialysing against 20mM sodium
phosphate buffer (pH7.0). Supernatants were passed through a 1ml Hitrap™ protein
G column (Amersham Biosciences) for purification, according to manufacturers'
instructions. Firstly, the columns were equilibrated with 10ml of 20mM sodium
phosphate buffer (pH7.0) prior to applying the dialysed supernatant. Secondly, the
columns were washed with 10ml 20mM sodium phosphate buffer (pH7.0) to remove
any unbound protein before eluting the bound protein by the addition of 0.1M
Glycine-HCl (pH 2.7). 1ml fractions were collected in Eppendorfs containing 50pl of
1M Tris-HCl (pH 9.0) for neutralisation.
Fractions containing eluted protein were identified using a modified Bradford
Reagent (Bradford 1976) assay (Biorad) according to manufacturers instructions.
Briefly, 200pl aliquots of Biorad Reagent diluted to 20% in dHzO and passed
through a 0.45pM filter before adding to wells of an ELISA plate containing lOpl of
samples. Protein containing fractions were pooled and dialysed against PBS before
determining total protein concentration by comparison of their absorbance at
to IgG standards in the Bradford Reagent assay. For long-term storage fusion
proteins were kept at -20°C.
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2.2.2 Purification of His-tagged proteins by nickel affinity.
2.2.2.1 Preparation of cell lysates
All steps were carried out at 4°C with ice-cold solutions. Cell pellets were
resuspended in binding buffer (20 mM potassium phosphate, pH 7.4, 0.5 M NaCl,)
and lysed by sonication using 5 pulses at an amplitude of 4-6 microns and at a
nominal frequency of 20kHz. The insoluble debris was removed by centrifugation at
A
lOOOg for 15 minutes and the cleared supernatant passed through a 0.45pM filter
prior to use for protein purification.
2.2.2.2 Preparation of culture supernatants
Culture supernatants were dialysed against binding buffer and passed through a
0.45pM filter prior to use for protein purification.
2.2.2.3 Purification
The His-Trap™ columns (Amersham Biosciences) were first equilibrated with 0.1 M
nickel sulphate to charge the column with nickel ions followed by 5 column volumes
A
of dH20 to remove unbound nickel ions from the column, and then by 5 column
volumes of binding buffer (20 mM potassium phosphate, pH 7.4, 0.5 M NaCl) to
equilibrate the column. Imidazole was added to the prepared sample at a final
concentration of 5-10pM before applying to the His-Trap column. The column was
washed with 5 column volumes of binding buffer before elution of bound protein
with elution buffer (20 mM potassium phosphate, pH 7.4, 0.5 M NaCl, and 500 mM
imidazole). Fractions containing protein were identified as described in section 2.2.1.
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Protein-containing fractions were combined, dialysed against PBS and stored at 4°C
or -20°C (long term).
2.2.3 Cell lysis and fractionation
All centrifugation and incubation steps were carried out at 4°C with ice-cold
solutions.
Cells were washed twice in PBS by centrifugation at 200g for 5 minutes. The final
pellet was resuspended in solubilisation buffer (lOmM Hepes, pH7.4/lmM
EDTA/1% TritonX-100 containing lpl of mammalian protease inhibitor cocktail
(Sigma) per million cells) and left on ice for 20 minutes before sonication using 5
pulses at an amplitude of 4-6 microns and at a nominal frequency of 20kHz. Lysates
were centrifuged at lOOOg for 15 minutes to pellet insoluble and nuclear material
(fraction N).
The resultant supernatant was either used directly for analysis by SDS-PAGE or
subjected to further fractionation by sequential centrifugation at 27,000g for 30
minutes (fraction PI) and finally 100,000g for 50 minutes (fraction P2). The final
supernatant (fraction S) was also reserved. Pellets were resuspended in an equal
volume to that recovered from the final supernatant.
2.2.4 Production of proteoliposomes
A
All centrifugation and incubation steps were carried out at 4°C with ice-cold
solutions.
1x10s cells were washed twice in PBS by centrifugation at 200g for 5 minutes. Cells
were resuspended at a density of 20xl06/ml in lysis buffer (lOmM Hepes,
pH7.4/lmM EDTA/1% containing lpl of mammalian protease inhibitor cocktail
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(Sigma) per million cells). Cells were lysed by 2-3 cycles of freeze-thawing before
sonication using 5 pulses at an amplitude of 4-6 microns and at a nominal frequency
of 20kHz. Lysates were centrifuged at lOOOg for 15 minutes to pellet insoluble and
nuclear material. The resultant supernatant was subjected to further fractionation by
sequential centrifugation at 27,000g for 30 minutes and finally 100,OOOg for 50
minutes. The final supernatant was removed and the pellet resuspended in a
combined volume of 6ml HBSS and briefly sonicated before use or storage at -20°C.
2.2.5 SDS-polyacrylamide gel electrophoresis
Supernatants from cell lysates (prepared as described in section 2.2.2.1) were added
an equal volume of 2x Laemli sample buffer and the solution heated to 95°C for 5
minutes. Samples (typically 15pl for mini-gels and ~100pl for large gels) were
k
loaded into lanes of 10% acrylamide gels and separated by SDS-PAGE. This was
achieved using the Biorad Mini-Protean II System (mini-gels) or a Sigma large
vertical electrophoresis unit (large gels). Electrophoresis was allowed to proceed for
40 minutes (mini-gels) or ~3 hours (large gels) at 200V.
2.2.6 Transfer of proteins from SDS-Polyacrylamide gels to solid
support
For the purpose of Western blotting, proteins from SDS polyacrylamide gels were
immobilised on nylon PVDF membrane (Amersham Biosciences) by transfer at
400mA for 45 minutes in lxTowbin using the Biorad Mini-Protean II System.
77
2.2.7 Protein identification by matrix-assisted laser
desorption-ionization/ time-of-flight-mass spectrometry
(MALDI-TOF-MS) analysis.
Protein bands of interest were excised from SDS-PAGE gels (see section 2.2.5) and
sent to the Edinburgh Protein Interaction Centre for analysis by peptide mass
fingerprinting. Briefly, excised gel bands were subjected to in-gel digestion with
trypsin. The resultant peptides were extracted from the gel pieces and peptide mass
lists generated from the spectrum obtained by MALDI-TOF Mass Spectrometry
(Applied Biosystems Voyager DE STR MALDI-TOF mass spectrometer). These
masses were submitted to a database search engine such (SwissProt and Mascott) to
identify a list of potential identities.
2.3 Mammalian cell culture
All mammalian cells were maintained at 37°C in a humidified incubator under 5%
C02 and were generally passaged three times every week. Refer to table 2-12 for
details of the mammalian cell-lines used in this work.
2.3.1 Adherent cells
Adherent cells were cultured in Dulbecco's Modified Eagle Medium (DMEM)
supplemented with 10% v/v Serum Supreme, 100 U/ml penicillin (Gibco), 100 pg/ml
streptomycin (Gibco) and 2mM L-glutamine (Gibco). Sub-confluent cultures were
trypsinised (trypsin-EDTA; 0.05% trypsin, 0.53M EDTA-4 Na) for ~3 minutes and























































Cells were passaged by sub-culturing into fresh growth medium (RPMI 1640
supplemented with 10% v/v Serum Supreme, 100 U/ml penicillin, 100 pg/ml
streptomycin and 2mM L-glutamine).
2.3.3 Induction and assessment of apoptosis
Table 2-13 lists dose and incubation periods for the apoptosis-inducing agents used
during this work. Cells were checked by microscopy under a bright field for gross
morphological changes such as cytoplasmic shrinkage and membrane blebbing prior
to making one or more of the assessments described in sections 2.3.3.1 to 2.3.3.3
inclusive.
2.3.3.1 Visualisation of condensed chromatin.
4',6-diamidine-2'-phenylindole dihydrochloride (DAP1) or TO-PRO-3 was added, to
cells to a final concentration of 0.25pg/ml or 3pM respectively. Samples were
analysed by fluorescence microscopy. For quantitative analysis ~200 cells (fixed in
1% formaldehyde, BDH Chemicals) per sample were scored for apoptosis by the
presence of condensed chromatin.
2.3.3.2 Annexin V detection of cell surface exposed
phosphatidylserine.
2.5x10s cells were aliquoted to FACS tubes and washed in 1 ml of Annexin V
A
binding-buffer (see buffers and solutions for composition) and pelleted before
incubating on ice for 5 minutes with lpl of fluorescein isothiocyanate (FITC)
80
labelled annexin V (diluted in lOOpl annexin V binding buffer). Following
incubation, cells were washed once more in annexin V binding buffer before
assessment of cell-associated fluorescence by flow cytometry. In cases when
membrane integrity was being assessed, propidium iodide (PI) was added
immediately prior to analysis to a final concentration of 20pg/ml.
2.3.3.3 Light scattering properties
Flow cytometric analysis of forward (FS) and side-light-scatter (SS) was used to
discriminate viable and apoptotic cells by virtue of their differing cell diameter and
granularity (Dive, Gregory et al. 1992).
2.4 Insect cell culture
All insect cells were maintained at 27°C in a non-humidified ambient air-regulated
incubator and were generally passaged three times every week by sub-culturing into
fresh unsupplemented growth medium (Sf-900 II). Refer to Table 2-12 for detailsAof
the insect cell-lines used in this work.
2.5 Production of liposomes
These small lipid vesicles were prepared by sonication of an aqueous solution of
phospholipids. The liposomes were composed of, L-a-phosphatidylcholine (PC), L-
a-phosphatidylserine (PS), or a combination of the two at a ratio of 70% PC/30%
PS. The phospholipids were added to glass tubes and the solvent evaporated under
nitrogen. The resultant solid was mixed in DMEM and sonicated for approximately
20 minutes (sonicator bath) until the solid had disappeared and the solution had










































Table2-14Assayspecificconditionsusedf rELISAs.PBS;phosph tebuffereal n , NGS;ormalgoatserum,2%MPBS;%Skim edilkpowderinPBS.
2.6 Isolation of human peripheral blood monocytes and
neutrophils.
Mononuclear cells were isolated under sterile conditions from peripheral blood of
normal healthy human donors by density centrifugation on a Percoll® (Amersham
Biosciences) gradient at room temperature. Sodium citrate was added to 120 ml,of
blood to a final concentration of 15.5 mM and centrifuged at 325g for 20 minutes
with no brake. Half of the resulting supernatant (plasma) was removed and
centrifuged at 2000g for 15 minutes to pellet the platelets. The resulting platelet-
poor plasma (PPP) was reserved. Calcium chloride was added to the remaining
platelet-rich plasma (PRP) to a final concentration of 40 mM before incubation at
37°C for 1 hour or until a tight clot had formed (reserved for monocyte culture). 5ml
of 6% (w/v) dextran-500 and 20 ml of saline were added per 25 ml of plasma-poor
blood in a 50ml conical polypropylene tube (Becton Dickinson). The solution was
mixed by gentle inversion and incubated at room temperature for 30 minutes to allow
A
sedimentation of red blood cells. Following sedimentation the upper white blood
cell layer was removed and centrifuged for 10 minutes at 200g. The cell pellets were
combined, resuspended in a total of 4ml PPP before dividing between two fresh 15ml
polypropylene tubes. 42% and 51% solutions of Percoll® were prepared in PPP. A
2ml aliquot of the 42% Percoll® solution followed by 2ml aliquots 51% solution
were used to underlay the white blood cell suspensions before centrifugation at 225g.
Cells from the resulting monocyte and neutrophil layers were removed by pipette and
washed twice in serum-free RPMI prior to use.
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2.7 In vitro differentiation ofmonocytes to macrophages
Isolated monocytes were resuspended in Iscoves Modified Dulbeccos' Medium
(IMDM) at 2xl06 cells/ml. 200pl aliquots of cell suspension were added per well of
a Teflon coated 4 well glass slide and incubated at 37°C to allow adherence of the
monocytes to the glass surface. Following 1 hour of incubation the slides were
washed with serum-free RPMI to remove non-adhering cells. The remaining cells
were cultured for 7 to 8 days in IMDM supplemented with 10% autologous serum
(PRP prepared as described in section 2.6) and penicillin/streptomycin at lOOU/ml
A
and 100pg/ml respectively. Slides were washed with serum-free RPMI and fresh
growth medium replaced every second or third day.
2.8 In vitro differentiation of THP-1 cells to macrophages
200pl of THP-l cells at density of l.5xl06/ml in complete DMEM (see section 2.3.1)
containing dihydroxyvitamin D3 (VD3) (250nM), and phorbol 12-myristate 13-
acetate (PMA) (lOOnM) were seeded onto wells of round 4 well Teflon coated slides.
VD3 and PMA stimulated cells were allowed to incubate for ~60 hours prior to use.
2.9 Culture ofmouse peritonealmacrophages
Peritoneal cells, harvested by lavage with ice-cold PBS, were cultured in complete
DMEM supplemented with conditioned medium from mouse L-cell cultures (10%
v/v) for 24 hours prior to use.
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2.10 Macrophage interaction assays
Cultures of cell lines induced into apoptosis (feed cells) were washed twice with
serum-free RPMI, by centrifugation at lOOOrpm for 5 minutes before resuspending at
lxlO7 cells/ml in serum-free RPMI containing 0.2% bovine serum albumin (BSA)
(assay medium). Antibodies, inhibitors or control samples were diluted to twice the
final required concentration in Eppendorf tubes using assay medium before adding
an equal volume of feed cells at lxl07/ml. Sample tubes were covered and inverted
gently to mix. Differentiated THP-lcells, monocyte-derived macrophages, or
mouse peritoneal macrophages were prepared by washing Teflon-coated slides in a
bath of pre-warmed serum-free RPMI immediately before adding 200pl of the
A
desired sample to each macrophage-containing well. Slides were incubated for 1
hour at 37°C, 5% C02 for interaction assays or 45 minutes at RT for binding assay
before washing away unbound feed cells by dipping slides a total of 6 times in two
baths of ice-cold PBS. The slides were fixed in methanol for 10 min at RT and air-
dried. For scoring assays by light microscopy, cells were stained by immersing in
diluted Jenner stain (BDH Chemicals) for 4.5min, washing in a bath of
Jenner/Giemsa buffer (see appendix 2-1), and immersing in diluted Giemsa stain
(BDH chemicals) for 9.5min. The slides were washed once more in a bath of
Jenner/Giemsa buffer followed by distilled water. After air-drying the slides were
mounted in DePeX (BDH Chemicals) prior to examination by light microscopy. The
number of feed cells both phagocytosed and/or bound by macrophages was scored
using previously established criteria (Flora and Gregory 1994) in duplicate wells for
each sample with a minimum of 200 macrophages being assessed in each well.
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2.11 Immunoglobulin based detection, measurement and
characterisation techniques
2.11.1 Enzyme-linked immunosorbent assays (ELISAs)
Wash steps were carried out with PBS containing 0.05% Tween-20 (PBS-T) bu PBS
alone for liposome ELISAs. In all cases peroxidase-conjugated antibodies were used
in the final detection step. For analysis, optical densities of the assay solutions were
read at 490nm using an Anthos It 2 plate-reader (Labtech).
2.11.1.1 Plate preparation
Refer to table table 2-14 for details of assay-specific antigen concentrations and
buffers. lOOpl of diluted antigens were used to coat wells of microtitre plates.
Samples containing protein antigens or LPS were incubated overnight at 4°C,
liposome samples were incubated for 45 minutes at 37°C. Following incubation the
solutions were tipped out before blocking any non-occupied binding sites on the
plastic by adding 200pl of blocking buffer (see table 2-14) and incubating for 1 hour
at room temperature. Wells were emptied and washed 3 times before the further
addition of reagents.
2.11.1.2 Assay procedures
To make an assessment of non-specific signals, wells containing all possible
combinations of coating antigens/target capture antibodies and detection antibodies
were included. During any given step an equal volume of reagent diluent was added
to wells which did not require sample/antibody.
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2.11.1.2.1 Direct ELISA
lOOpl of diluted primary antibodies were added per well of prepared plates and
incubated for lhour at room temperature. Wells were emptied and washed 3 times
before adding lOOpl of diluted secondary antibody to the appropriate wells and
incubating for a further lhour at room temperature. On occasions when a tertiary
antibody step was required for detection, wells were emptied and washed 3 times
before adding the appropriate diluted antibody for an additional incubation of lhour
at room temperature. Prior to completion of the final incubation step the o-
phenylenediamine-based substrate, SIGMA-FAST™ (Sigma) was prepared
according to manufacturers' instructions. Following 4 more washes, lOOpl of
substrate was added per well. Once an adequate colour change was seen the reaction
was stopped by the addition of 50pl 2.5M HC1 per well.
2.11.1.2.2 Antigen-capture ELISA
lOOpl of diluted antigen-containing sample were added per well of prepared plates
and incubated for 2 hours at room temperature. Wells were emptied and washed 3
times before adding lOOpl of diluted primary detection antibody to the appropriate
wells and incubating for a further lhour at room temperature. Following incubation,
wells were emptied and washed 3 times before adding lOOpl of secondary detection
antibody to the appropriate wells and incubating for a further lhour at room
temperature. On occasions when a tertiary antibody step was required for detection
wells were emptied and washed 3 times before adding the appropriate diluted
antibody for an additional incubation of lhour at room temperature. Prior to
k
completion of the final incubation step the o-phenylenediamine-based substrate,
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SIGMA-FAST™ (Sigma) was prepared according to manufacturers' instructions.
Following a 4 more washes, lOOpl of substrate was added per well. Once an
adequate colour change was seen the reaction was stopped by the addition of 50pl
2.5M HC1 per well.
2.11.2 Immunofluorescence for flow cytometry
5% normal goat serum (Harlan Sera-Labs) in PBS (NGS/PBS) or 1% BSA was used
for diluting antibodies. All wash steps were carried out using NGS/PBS or 1% BSA
in PBS by centrifugation at 225g for 5 minutes at 4°C then discarding the
supernatant. Cultured cells were harvested by centrifugation at 225g for 5 minutes at
4°C then discarding the supernatant. Cells were washed using a volume equal to that
harvested from before resuspending at a density of 5 x 10 6/ml in wash buffer. 50pl
aliquots of cell suspension were added per well of a 96-weli round-bottomed cell
A
culture plate. A volume of 200pl was used for all subsequent washes. Cells were
incubated with 50 pi of diluted primary antibody for 30 minutes at 4°C. After
washing twice, 50 pi of secondary antibody was added and incubated for a further
15-30 minutes at 4°C. On occasions when a tertiary antibody step was required two
more washes were carried out before incubating cells with 50pl of diluted antibody
for 15-30 minutes. Two final washes were performed before using 200pl of 1%
formaldehyde in NGS/PBS to transfer cells to FACS tubes containing an additional
300pl of 1% formaldehyde in NGS/PBS.
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2.11.3 Immunofluorescence analysis by confocal laser
scanning microscopy
200pl cells in complete DMEM at density of 1.5x106 were seeded on wells of round
4 well Teflon coated slides 24 hours prior to analysis. Cells were washed once with
PBS and fixed at RT in 3% formaldehyde/5% sucrose/0.2% Triton X-100 in PBS for
2 minutes then for I hour in the same buffer without Triton X-100. After 3 washes'in
PBS excess free aldehyde groups were quenched with 50mM NH4C1 in PBS for 15
minutess. Cells were washed 3 times in PBS before incubating with primary
antibodies diluted in NGS/PBS 20-30 minutes at 4°C. After washing cells in PBS,
bound antibodies were revealed by incubating with conjugated secondary antibodies
diluted in NGS/PBS for 20-30 minutes in the dark at 4°C. After 3 washes in PBS
and one wash in dH20 samples were allowed to air dry before mounting in Mowiol
with 10 mm round coverslips and viewed using confocal laser scanning microscope
(CLSM) systems (Leica and Zeiss) coupled with Ti:Sapphire lasers.
2.11.4 Immunological detection of immobilised proteins
2.11.4.1 Western blotting on PVDF membrane
All wash steps were carried out using 10ml PBS with lOOmM extra NaCl (PBS+) for
5-10 minutes at room temperature. All antibodies were diluted in 5% Skimmed Milk
Powder in PBS (5%MPBS). A volume of 4ml was typically used per membrane.
PVDF membranes were blocked overnight in 5%MPBS milk at 4°C and washed
three times before probing with antibodies. Blocked membranes were incubated with
primary antibodies for 2 hours at 4°C, followed by three washes and incubation with
peroxidase-conjugated secondary antibody for 1 hour at room temperature.
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Following three final wash steps, bound HRP-conjugated antibodies were detected
using one of two methods.
2.11.4.1.1 a) Chemiluminescence
Membranes were immersed in ECL reagents (Amersham Pharmacia Biotech)
following manufacturers' protocol before dark exposure to autoradiography film for
variable lengths of time and developing in an automated developer (Konica SRX-
101A).
2.11.4.1.2 b) Colourimetric
A solution containing 30mg of 4-chloronapthol (4-CN) in 10ml of absolute methanol
at -20°C was prepared and added to 50 ml of ice-cold TBS. 30pl of H202 was added
immediately prior to incubation of membranes in the solution. When the desired
band(s) could be seen the reaction was stopped by washing membranes in dHzO.
2.11.4.2 Dot blot quantification of M13 coat protein
All wash steps were carried out using 10ml 5% TBS containing 0.05% Tween-20
(TBST) for 5-10 minutes at room temperature. The concentration of phage particles
in samples was determined by titration. Two-fold serial dilutions of test samples or
standard were prepared in TBS. Diluted samples were pipetted directly onto pre-
equilibrated PVDF membrane and allowed to adsorb for ~1 minute. Membranes
were blocked for lhour at RT with 5% milk powder/TBS (5%MTBS). Blocked
membranes were washed three times before incubating with peroxidase-conjugated
a-M13 monoclonal antibody for 1 hour at room temperature. Following three final
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wash steps, bound detection antibodies were analysed by chemiluminescence as
described above.
2.11.4.3 Immunopreciptation
All wash steps were performed by placing the incubation vessels next to a magnetic
separator for 1 minute before removing the supernatant from the beads with a pipette.
All wash steps were performed using PBS containing 1% v/v Trition-X-100 and
0.7% w/v deoxycholic acid.
2.11.4.3.1 Bead coating
16p.l of resuspended magnetic a-mouse IgG-coated beads (Sigma) were equilibrated
by washing three times before incubating with 15pg the desired antibodies in a total
of 0.5 ml in PBS for 30 minutes at 4°C with rotation.
2.11.4.3.2 Antigen capture
Cell lysates were prepared as described in section 2.2.2.1 with the exception that
PBS containing 1% v/v Trition-X-100 and 0.7% w/v deoxycholic acid was used as a
solubilisation buffer allowing lxlO7 cells per bead sample. Cell lysates were pre-
cleared by incubation with uncoated beads for 45 minutes at 4°C with rotation.
Coated beads were allowed to incubate with pre-cleared cell lysates for 4 hours at
4°C with rotation. Following incubation beads were washed three times before
adding to Laemli sample buffer in preparation for analysis by SDS-PAGE as
described in section 2.2.5.
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2.12 Phage antibody display techniques
2.12.1 The bacteriophage library
The phage display library used for the work described in this thesis was constructed
from 49 previously cloned, human germline immunoglobulin heavy-chain variable
(VH) genes fused to a heavy-chain joining segment 4 and partly randomised
complementarity-determining region 3 (CDR3) sequences of 6 to 15 amino acid
residues in length. The VH segments were cloned into seven vectors containing light
chains encoded by members of the VK1 to VK4 and VX1 to Vx3 gene families.
Individual libraries were then combined to form a single library of approximately
3.6x10s clones(Dekruif, Boel etal. 1995).
2.12.2 Amplification of phage antibodies
2.12.2.1 Large scale
50ml of LB with 5% glucose (Sigma) and 100^g/ml of ampicillin (Sigma) were
inoculated with phage infected TGI cells and grown with shaking at 37°C to an
ODgoonm of 0.4-0.5 before sub-culturing 5ml into 50ml of fresh LB with 5% glucose
A
and 100^g/ml ampicillin and adding 5xl0'°plaque forming units (pfu) of VCS-M13
helper phage. The cultures were incubated statically at 37°C for 45 minutes followed
by 45 minutes with shaking before centrifugation at 2000 g for 20 minutes. The
resulting bacterial pellet was resuspended in 250 ml LB with 100/rg/ml ampicillin
and 25/tg/ml of kanamycin (Sigma) and grown overnight with shaking at 30°C.
Phage particles were purified from the bacterial culture supernatant by two
successive precipitation rounds using polyethylene glycol (PEG8000) (Sigma) as
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follows; overnight cultures were centrifuged at 6000g for 10 minutes at 4°C and the
supernatant incubated in a fresh vessel on ice for 1 hour with 1/5 volume of 20%
(w/v) PEG 8000 in NaCl (2.5M) (PEG/NaCl). The precipitate was harvested by
centrifugation at 2000g for 30 minutes, resuspended in 40ml PBS and incubated on
ice for 30 minutes with 1/5 volume PEG/NaCl. The precipitated phage particles
were again harvested by centrifugation at 2000g for 30 minutes before resuspending
in 3.6 ml of 1% (w/v) BSA in PBS. Resuspended phage solutions were passed
through a 0.45/rm filter for sterilisation before storing at 4°C.
A
2.12.2.2 Small scale growth of monoclonal phage antibodies
Individual colonies from agar plates were inoculated into wells of 96-well microtitre
plates containing lOOpl LB with 5% glucose and 100pg/ml of amp. The plates were
incubated overnight at 37°C, with shaking. The following day lOpl of the cultures
were inoculated into wells of freshly prepared plates containing lOOpl of LB with
5% glu and lOOpg/ml of ampicillin. Following 2 hours of incubation at 37°C with
rotation, lOpl of LB containing 109 pfu of VCS-M13 helper phage was added to each
well. Plates were incubated statically at 37°C for lhour before centrifugation at
2000g for 20 minutes to pellet the infected bacteria. The supernatant was discarded
A
and the bacteria resuspended in 250pl of LB with lOOpg/ml ampicillin and 25pg/ml
kanamycin for incubation overnight at 30°C.
2.12.3 Growth and purification of the library
2.12.3.1 Purification by PEG precipitation
The complete library supplied from Prof. Ton Logtenberg was amplified from
glycerol stocks of 12 sub-libraries. Each sub-library was amplified as described in
section 2.12.2.1 (Large scale amplification of Phage Antibodies) before pooling and
storage at 4°C.
2.12.3.2 Phage purification on caesium chloride gradients
This method, adapted from Smith and Scott (Smith and Scott 1993) is effective in
removing residual PEG, nucleases, proteases and other contaminants from PEG-
purified phage and is recommended for long-term storage.
4.83g of caesium chloride (CsCl) was resuspended in 10ml of freshly grown and
PEG-purified phage library (from section 2.12.3.1). TBS was added to the resultant
solution to a final weight of 10.75g giving a 31% (w/w) solution of CsCl with a
density of 1.3g/ml. The solution was aliquoted to 12-ml polyallomer tubes and
A
centrifuged at 58,000 rpm for 20 hours at 4°C using a Beckman 70.1 Ti rotor.
Following centrifugation the faint, bluish upper phage bands were removed from
each tube using a sterile glass pipette combined and resuspended in 26ml of TBS
before centrifugation at 48,000 rpm for 4 hours at 4°C using a Beckman 50.2 Ti
rotor. The final pellet was resuspended in 12ml TBS containing 0.1% (w/v) gelatin,
0.02% NaN3 and stored at 4°C.
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2.12.4 Selection of monoclonal phage antibodies
2.12.4.1 Whole cell-based selections
2.12.4.1.1 Selection on K562 cells
All washes were carried out using 5 ml of 1% BSA in PBS by centrifugation at 1000
rpm for 3-5 minutes at 4°C then discarding the supernatant.
1 ml of PEG-purified phage particles (~5xl0" c.f.u.s) blocked in 2.25 ml of 4% non
fat milk powder in PBS (4% MPBS) for 15 minutes at RT were incubated with
7.5xl06 of pre-washed cells resuspended in 3 ml of 4%MPBS for the required time at
4°C with gentle inversion. After incubation the cells were washed to remove non-
binding phage antibodies from the cells. The final wash was carried out in 1 ml of
1%BSA in PBS before eluting phage from the cells by resuspending in 100/rl of PBS
and 150/rl of 76mM citric acid (pH 2.5) in PBS and incubating for 5 minutes at RT.
The cells were pelleted and the phage-containing supernatant transferred to a fresh
Eppendorf with 200/^1 of 1M Tris HC1 (pH 7.4) added for neutralisation. Eluted
phages were used to infect E. coli strain TGI as described in section 2.12.5.
2.12.4.1.2 Flow cytometry whole cell-sorting-based selections
All washes were carried out using 5 ml of 1% BSA in PBS by centrifugation at 1000
rpm for 3-5 minutes at 4°C then discarding the supernatant.
lxlO7 pre-washed viable ICAM-3 negative Mutu I cells (~10% apoptotic as assessed
by Annexin V/PI staining) were added to 3xl05 pre-washed ionomycin-induced
ICAM-3 positive Mutu I cells (~80% apoptotic as assessed by Annexin V/Pl
staining) in a total of 2ml of 4% BSA/PBS (hence a total of ~25% apoptotic cells in
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the entire population). Cells were added to 0.5 ml of CsCl-purified phage particles
(~2.5xl0" c.f.u.s) that had previously been blocked in 0.6ml of 4%BSA/PBS for 15
minutes at RT and incubated for 20 minutes on ice, with occasional mixing by
inversion. After incubation the cells were washed once to remove non-binding phage
antibodies before using light-scattering properties as a criteria for collecting
apoptotic cells by flow cytometry (see section 2.3.3.3). Phages were eluted from the
cells of the sort sample by resuspending in 100/rl of PBS and 150//1 of 76mM citric
acid (pH 2.5) in PBS and incubating for 5 minutes at RT. The cells were pelleted
and the phage-containing supernatant transferred to a fresh Eppendorf with 200//1 of
1M Tris HC1 (pH 7.4) added for neutralisation. Eluted phages were used to infect E.
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2.12.4.2 Selections on immunotubes
2.12.4.2.1 Coating of immunotubes
A
For each target antigen optimal coating concentrations were determined empirically
by titration in an ELISA. 4 ml of diluted antigen was added to immunotubes (Nunc)
and incubated for the required time using identical buffers to those used for
determining optimal coating concentration. Refer to table 2-15 for selection-specific
buffers and incubation periods. Following incubation, tubes were washed 3 times
with PBS then filled with the appropriate blocking buffer and incubated for 0.5-2
hours at RT (see 2-15). Tubes were washed 3 times with PBS before the addition of
phage library for selection.
2.12.4.2.2 Selection
lml of purified phage library (~5xl0" c.f.u.s) in a total volume of 3.5 ml blocking
buffer was added to pre-blocked immunotubes and incubated with rotation for 30
minutes (for ICAM-3-Fc selections tubes were left to stand for an additional 90
minutes at RT). Following incubation, the tubes were emptied and unbound phages
were removed by washing as follows;
For first-round selections tubes were washed 10 times with PBST (PBS only for
liposome selections), then 10 times with PBS. For second and subsequent rounds of
selection, tubes were washed 20 times with PBST (PBS only for liposome
selections), and 20 times with PBS.
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2.12.4.3 Selections using His-tagged antigen bound to nickel-
charged beads
AH wash steps were performed by placing the incubation vessels (1.5ml Eppendorf
tubes for selections or 96-well plates for bead-coating-optimisation) next to a
magnetic separator for 1 minute before removing the supernatant from the beads with
a pipette. 50 mM sodium phosphate, pH 8.0, 0.3 M NaCl with 0.005% Tween-20
was used for all wash steps (1ml for selections, 150pl for bead-coating-optimisation).
A
2.12.4.3.1 Bead coating
Nickel-nitrilotriacetic acid magnetic agarose beads (nickel-charged beads) (Qiagen)
were washed twice before incubating with the desired volume of His-tagged ICAM-3
for 30 minutes at RT with rotation (Eppendorf tubes) or gentle rocking (96-well
plates).
Beads were washed three times before the addition of phage library for selection.
2.12.4.32 Selection
lml of purified phage library (~5xl0n c.f.u.s) in a total volume of 3.5 ml blocking
buffer was added to pre-coated beads and incubated with rotation for up to 30
minutes. Following incubation, the beads were washed 10 times with PBST and a




2.12.5 Infection of E. coli with phage particles.
Cultures of E. coli TGI were grown to an OD600nm of 0.4-0.5 at 37°C in LB.
Solutions of phages were added to 2ml of the log phase E. Coli, and pre-warmed LB
in a total volume oflOml and left to incubate statically for lhour at 37°C. The culture
was then centrifuged at 2000g for 15 minutes at RT. The bacterial cell pellet was
resuspended in 1ml LB and serially diluted aliquots spread onto agar plates
containing LB with 100^g/ml amp and 5% glu for incubation overnight at 37°C.
The following day, colonies from the plates were counted and used for one of three
purposes. Lor the purpose of screening individual colonies were picked for
monoclonal production as described in section 2.12.2.2. Alternatively colonies were
scraped into a total of 2ml of LB and aliquots used either to make a polyclonal stock
in 15%glycerol for storage at -80°C or used to inoculate 50ml of LB with 5%
glucose and 100^g/ml ampicillin for large-scale amplification and purification for
further rounds of selection.
2.12.6 Cell-based screening of phage antibodies.
Immunofluorescence staining of cells was carried out as described in section 2.11.2
for assessment by flow cytometry or microscopy with the exception that phage
antibodies were diluted in 10% NGS in 2xPBS as opposed to instead of
5%NGS/PBS.
2.12.7 Screening of phage by ELISA
ELISAs were carried out as described in section 2.11.1 using the conditions shown in
table 2-14.
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3 Selecting for Apoptotic-Cell-Surface Markers from
a Phage-Displayed Antibody Library.
The molecular identities of the endogenous ligands of apoptotic cells that can be
used by phagocytes for recognition and engulfment are poorly understood. The work
A
described in following sections specifically attempts to profile novel surface
molecules appearing during apoptosis using a library of antibody fragments
displayed on the surface of bacteriophage particles.
3.1 Results Chapter 1 - Using Whole Cells to Select for
Specific Markers ofApoptosis
The work described in this section was targeted towards the use of phage display and
whole cells to select antibody fragments with specificity towards Intercellular
A
Adhesion Molecule-3 (ICAM-3), a cell-surface-expressed molecule implicated in
apoptotic-cell recognition. However the screening strategies for testing the binding





Using the surface of whole cells as a source of target antigen for selection has several
inherent problems. The cell surface is a highly heterogeneous fabric with most
individual epitopes being expressed at relatively low concentration. Therefore, of
those antibodies selected which are specific to the cell surface, only a minority are
likely to be specific to molecules or certain epitopes distinctly found on the apoptotic
cell.
Selecting on apoptotic cells imposes additional challenges. As will become apparent
from the discussion below, an unavoidable situation arises in which selection of
phage antibodies on cells of the most appropriate physiologically relevant stage of
death (where they are recognised and ingested by phagocytes) requires the cells to be
in a fragile state. For selection purposes this is inconvenient, as a cell that has lost its
membrane integrity will provide a wealth of undesired intracellular antigens as
potential phage targets. Moreover, its fragility at this stage does not lend the
apoptotic cell to the rigorous washing conditions necessary for the recovery of only
A
the highest affinity, specific antibody fragments.
3.1.1.2 Choice of selection strategy
For planning the selections described in the following section, the results of former
work using the phage library employed for these studies were considered. A phage
antibody against CD 14, clone Ce3, had been previously isolated from the library
used in the present studies by successive rounds of negative and positive selection on
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CD14 negative and positive cells respectively (Pierce 2000). However, attempts by
Pierce to extend these studies by following a similar strategy for cell-based selections
failed to enrich for the desired binders. Furthermore, initial work carried out for this
thesis in which a number of single-round positive selections were carried out on
several different populations of apoptotic cells detected very few phage clones at the
screening stage capable of binding to the cell type used for selection, either in viable
or apoptotic states (data not shown). The reasons behind the lack of cell reactivity
were not known, and there was no way of determining whether the particular
conditions used during a selection had successfully enriched for cell-binding clones
before launching large-scale screening exercises. Therefore it was necessary to set
up a system for monitoring the effectiveness of: -
(a) the conditions used during a selection (i.e. a means to evaluate the relative
number of phage particles obtained following a selection).
(b) the enrichment efficiency of sought-after phage, (i.e. a means of evaluating how
well clones that bind to the target were separated from clones that do not).
In order to gauge the effect of the different selection conditions being tested (point
a), the number of phage clones returning from a selection was calculated by titrating
aliquots of phage-infected E. coli TGI on bacterial culture plates and counting drug-
resistant colony forming units (c.f.u.). To determine the efficiency of a given
selection strategy (point b), polyclonal phage preparations were made after each
selection and analysed for binding to cells by flow cytometry (i.e. if a significant
proportion of the clones obtained from a selection are cell-reactive, a polyclonal
mixture of such phage should consequently stain cells).
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Additional features included in the experimental design were: -
A
(i) raising the target antigen (ICAM-3) concentration present on each cell by using
the K562 cell line overexpressing ICAM-3 (K562/ICAM-3). However it was
understood that such high levels of expression in combination with the asynchronous
nature of apoptosis amongst in v/tro-induced populations might not have resulted in
all ICAM-3 being present in the "apoptotic form".
(ii) optimisation of selection conditions using viable K562/ICAM-3 cells prior to
transfer of the system to apoptotic cells in order to obtain a pool of cell-binding




3.1.2.1 Assessing the effects of incubation time and wash stringency
on the recovery of phage particles from selections
The enrichment efficiency of the desired phage from a selection is dependent on a
number of factors. These include concentration of target antigen and phage,
temperature, buffer pH and ionic strength, incubation time and severity of washing
procedures. The decision was made to test the effect of varying just two selection
conditions. Firstly, the effect of washing severity was tested as previous work using
this library for selecting on cells had suggested that washing cells more rigorously
A
after the selection decreases the number of non-specific phage returning (Sarah
Pierce, Andrew Devitt personal communication). Secondly, the effect of decreasing
incubation periods from those previously used during a selection was assessed. It
was hypothesised that shorter incubations would allow selection of only the highest
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affinity antibodies and reduce non-specific binding of phage which is a problematic
phenomenon known to occur during selections (Dekruif, Boel et al. 1995).
Following each selection, recovered phage were used to infect Escherichia coli TGI
A
and colony forming units (c.f.u.) were used as a device for measuring phage number
returning from each selection to enable a comparison to be made between selections
of differing stringency.
Preliminary studies showed there to be a clear reduction in the number of phage
particles recovered as selection stringency increased. However no selection of cell-
binding phages was seen following single rounds of positive selection (data not
shown). As a result a decision was made to try several rounds of positive selection
in combination with more stringent conditions.
3.1.3Enrichment of cell binding phage using K562 cells
A
transfected with ICAM-3
A marked reduction in the number of eluted phage clones was seen from selections
carried out with 'harsh' washing (8 wash steps with vigorous mixing) compared to
selections carried out with 'gentle' washing (2 wash steps with gentle mixing)
(Figure 3-1 panel A). There were slightly, but consistently fewer clones returning
from selections with 2-minute incubation periods compared to 1-hour (Figure 3-1
panel B). The relative difference in c.f.u./ml between panels A and B of figure 3-1
is a reflection of adding a different number of phage particles at the beginning of
each selection for the two experiments. For all cell-based selections subsequent to
those presented in panel B of figure 3-1 a constant number of phage particles and
cells were used (see materials and methods section 2.12.3.1). Screening of individual
105
2min 2min 1 hr 1 hr












2 min 1 hour
Incubation time/washing stringency Incubation time
Figure 3-1. Results from single rounds of selection of phage
antibodies on viable K562/ICAM-3 cells.
A,B; Phage were titred by infection of eluted particles into Escherichia
coli TGI and plating onto ampicillin-containing agar plates. A
Selections were performed with short (2 min) or long (1 hour)
incubations and the cells subsequently washed with differing severities
(gentle or harsh). B Example of the difference in numbers of phage
returning from selections with different incubation periods using harsh
washes. Representative of 3 similar experiments. For panel B data
points represent the mean +/- SD for duplicate titrations, c.f.u.;
colony-forming units.
C-E; Phage antibodies were analysed for the ability to bind viable
K562/CD14 cells (panel C) or viable K562/ICAM-3 cells (panels D&E)
by flow cytometry. C Binding of phage antibody clone Ce3 (anti-
CD14) to K562/CD14 cells was included during screening as a
positive control for cell-staining. D Polyclonal phage antibodies
prepared from the single-round selection on viable K562 cells using a
1 -hour incubation period followed by harsh washing. E Example of a
monoclonal phage antibody isolated from a single round of selection
on viable K562 cells using a 1-hour incubation period followed by
harsh washing. Red histograms represent control staining with mouse
anti-M1 3 and goat anti-mouse-FITC antibodies.
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phage clones from the selections referred to in figure 3-1 panels A and B identified
no strongly-binding phage antibodies (Figure 3-1 panel E) and supernatants from
polyclonal phage antibody preparations of the selections did not produce a
significant signal when used to stain the same cells as those used for selection
A
(Figure 3-1 panel D). It appeared that, despite more stringent selection conditions,
phages were not being enriched usefully. With this in mind, the decision was made
to return to multiple rounds of selection in an attempt to gain further enrichment.
Four rounds of selection were carried out on viable K562/ICAM-3 cells with both 2-
minute and lhour incubation times. Two main points regarding the profile obtained
from titrating the number of c.f.u.s returning from each selection are worth
highlighting. Firstly, as was observed for the single-round selections mentioned
previously, consistently fewer colonies returned from selections carried out using a
2-minute incubation period compared to a 1-hour incubation period. Secondly, the
profile showed a similar trend for both incubation times, namely a slight decrease
after the second round of selection followed by a sharp increase for the third round
and an apparent levelling off after the fourth round. The assumption that a plateau is
reached by round four is supported by the number of c.f.u. for a 2-minute incubation
period "catching up" with the number of c.f.u. for a 1-hour incubation period (figure
3-2 panel A, B).
This trend could be explained by the persistence of non-specifically-selected phage
in the sub-library following the first round of selection that are lost during the second
round. After the third round, the increase in titre can be explained by duplication of
the same clones during the amplification step between selections. The polyclonal
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Figure 3-2. Results from multiple rounds of selection of phage
antibodies on viable K562/ICAM-3 cells.
A,B; Profiles of phage returning from 4 successive rounds of selection
(panel B displays the same data as A using a log10 scale for c.f.u./ml).
Phage were titred by infection of eiuted particles into Escherichia coli
TG1 and plating onto ampicillin-containing agar plates. Data points
represent the mean +/- SD for duplicate titrations.
C-E; Phage antibodies were analysed for the ability to bind viable
K562/ICAM-3 cells by flow cytometry. C Polyclonal phage antibodies
prepared from the 1st of 4 rounds of selection on viable K562 cells. D
Polyclonal phage antibodies prepared from the 3rd of 4 rounds of
selection on viable K562 cells. E Example of a monoclonal phage
antibody from the 3rd round of selection on viable K562/ICAM-3 cells
that demonstrated cell binding .The histograms shown in panels D-E are
example of phage prepared from selections carried out with 2-minute
incubations, however similar results were obtained with phage from
selections using 1 -hour incubations. Red histograms represent control
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staining profile supported this explanation as there was no significant signal after the
first round (Figure 3-2 panel C), a diffuse signal after the second round (suggesting
the presence of high, low and non-specific phage), followed by a strong, clean signal
by the third round (Figure 3-2 panel D) that did not strengthen after round four (data
not shown for rounds two and four). 40 monoclonal phage antibodies from each of
the third rounds (2-minutes and 1-hour incubation periods) were screened for their
ability to bind K562/ICAM-3 cells. Of these, 8 clones from selections with 2-minute
incubations and 9 clones from selections with 1-hour incubations demonstrated cell
binding (example shown in figure 3-2 panel E).
3.1.4 Selection and screening of phage using apoptotic ICAM-3-
transfected cells.
Following the success of the selections on viable cells, the same selection system
was applied using apoptotic cells. Whilst appreciating that apoptotic-target cells may
behave differently to their viable counterparts in this system, a 2-minute incubation
time was chosen as there was no significant difference between the recovery of high
affinity clones using this short length incubation than from the selections with l-hour
incubations for viable cell selections (8 and 9 clones respectively out of 40 tested for
each incubation period). A shorter incubation would also help minimise the numbers
of fragile apoptotic cells becoming permeabilised. Two cell types over-expressing
A
ICAM-3 were chosen as apoptotic targets for phage selection. These were
K562/ICAM-3 as used in the optimisation stage, and in addition CHO/ICAM-3 (see
materials and methods section 2.3).
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Figure 3-3. Results of selection of phage antibodies on apoptosis-
induced cells. Phage were titrated by infection of eluted particles from
each round of selection into Escherichia coli TGI and plating onto
ampicillin-containing agar plates. Selections on apoptotic CHO/ICAM-3
and K562/ICAM-3 cells followed the same trend as selections on viable
K562/ICAM-3 cells. (A and B; linear and log10 scaie representation of
data respectively). Data points represent the mean +/- SD for duplicate
titrations.
110
Four rounds of selection were carried out on each cell type. The profile for the
number of c.f.u. returning from successive rounds matched that of viable cells.
However the total number of colonies was slightly lower by the 4th round compared
with viable cell selections (figure 3-3) despite using a fixed number of cells in each
case. This may have been due to a lower amount of antigen being present on the
A
apoptotic cell. In addition, the cell pellets were observed to decrease in size during
the sequential wash steps, which apart from a continuation of apoptosis-associated
cell-shrinkage (Benson, Heer et al. 1996), could have been due to the cells beginning
to disintegrate (discussed in more detail, section 5.3).
The staining profile of polyclonal phage preparations was tested on various apoptosis
induced and viable cell lines (figure 3-4). The polyclonal phage prepared from the
third round of selection on CHO/ICAM-3 did not stain any cell line significantly
(data not shown). The polyclonal phage antibodies prepared from the selections on
K562/ICAM-3 cells stained viable and to a lesser extent apoptotic K562/ICAM-3
cells. The same preparation also stained viable K562/vector cells (ICAM-3 negative
cell line) and unrelated Mutu I BL cells (figure 3-4 panels C-F). This suggests that
the majority of selected phage were to antigens common to both viable and apoptotic
cells. However, the possibility that a minority of clones amongst the selected
population were specific for epitopes exclusively found on apoptotic-cell surfaces led
to analysis of binding specificity of individual clones.
The approach taken for screening was to test each phage clone on either ICAM-3
positive or negative cells that were either induced into apoptosis or left untreated,
thus allowing identification of phage specific to either "viable ICAM-3", "apoptotic
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Figure 3-4. Binding of phage antibodies to various cell lines.
Polyclonal phage antibodies prepared from selections on apoptosis-
induced K562/ICAM-3 cells were analysed for their ability to bind
various cell lines by flow cytometry. A Polyclonal phage antibodies
prepared from the 1st, 2nd and 3rd round of selection on induced
K562/ICAM-3 cells. B A combination of TRAIL and CHX induces
classic apoptotic nuclear morphology in K562 cells as visualised by
staining with DAPI. C,E,F Polyclonal phage antibodies prepared from
the 3rd round of selection on viable K562/vector, induced Mutu I BL
and viable Mutu I BL cell lines respectively. D Discrimination of viable
and apoptotic Mutu I BL cells by measurement of forward (FS) and
side (SS) light scatter. Red histograms represent control staining




















Figure 3-5. Schematic representation of predicted patterns of staining for
different theoretical phage clones arising from selection on apoptosis induced
ICAM-3 expressing K562 cells.
K562 cells either transfected with ICAM-3 (K562/ICAM-3) or with
empty expression vector (K562-vector) were either induced into
apoptosis (apoptotic) or left untreated (viable). The reactivity of
individual clones from the third round of selection on apoptosis-induced
K562/ICAM-3 cells was characterised by analysing the ability to bind
each cell type by flow cytometry.
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Figure 3-6. Binding activity of isolated phage antibodies to various
cell lines. Individual clones from the third round of selection on
apoptosis-induced K562/ICAM-3 cells were analysed for the ability to
bind various cell lines by flow cytometry. Clone A1 2 is an example of a
phage which bound preferentially to viable cell populations (blue
histograms). Clone A17 is an example of a phage showing a bimodal
pattern of binding to cell populations(green histograms). A Expression
of ICAM-3 on viable K562/ICAM-3 cells as determined by Bu65 (a-
ICAM-3 mAb) binding. B The phage antibody clone Ce3 binds to CD14
and was used as a negative control for background staining by phage
antibodies during screening (red histograms). Black histograms
represent control staining with mouse anti-M13 and goat anti-mouse-
FITC antibodies.
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cells), an alternative apoptotic-cell associated epitope or common cell epitope (figure
3-5). Figure 3-6 shows an example of two cell-binding clones subjected to such
analysis. Approximately 90 cell-binding clones were identified from over 200
tested. All of these were capable of binding viable ICAM-3-negative cells so were
A
not of interest for further analysis. What is more, for all cell-binding phage, a much
lower signal was seen on apoptosis-induced populations. This suggests that the
antigens selected for were present at lower levels on cells as a result of programmed
cell death.
Two common patterns of binding by flow cytometry were observed - clones which
gave a bimodal peak and clones which appeared to stain the entire population of
viable cells (Figure 3-6, top half).
It was of interest to find out whether the selected sub-library contained a wide range
of clones or if just a few clones had been repeatedly chosen and amplified during the
multiple rounds. To make an assessment of clone diversity, DNA-fingerprint
analysis of the ScFv regions of 45 cell-binding phage was performed. Twenty-five
different restriction patterns were observed (see figure 3-7 for examples). Three
common restriction patterns were seen, 20 (44%) of which belonged to one group of
phage, 3 (7%) to a second and 2 (4%) to a third. Thus clonal variety amongst the
selected sub-library, albeit limited, was confirmed.
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Figure 3-7. Diversity of individual cell-binding phage antibodies from
the third round of selection on K562 cells by DNA fingerprint
analysis of the scFv genes. The scFv DNA insert of isolated binders
was amplified by PCR using plasmid preparations from individual clones
as a template. The PCR products were digested with the frequently-
cutting restriction enzyme BstNl and the resulting fragments
separated on a 3% agarose gel. A diverse banding pattern was
observed, with each unique pattern representing a unique antibody
sequence. Stars indicate genetically identical clones. First and last
lane is a 100-bp DNA size marker.
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3.1.5 Selection of apoptotic-cell-binding phage using populations
of mixed viability.
The results from the previous section suggested a requirement for the removal of
phage that bind to common cell markers in order to allow for efficient selection of
apoptotic-cell or ICAM-3-specific targets. Because of the difficulty in obtaining a
pure population of viable cells to use for a standard negative selection one may
anticipate the loss of some apoptosis-specific-binding phage on dead cells
contaminating the viable cell culture. This section describes a competitive selection
approach employed to increase the signal-to-noise ratio for target apoptotic cells, i.e.
to increase the number of phage binding specifically to apoptosis-associated epitopes
on the cell surface relative to phage binding in an unwanted fashion.
To achieve this, a minor sub-population of "apoptotic" cells was separated from an
excess of viable cells in a phage selection mixture. Initial attempts to this effect were
made using an excess of viable K562/ICAM-3 cells spiked with a small number of
apoptotic K562/ICAM-3 cells. The whole sample was stained with biotinylated
Annexin V and the apoptotic subpopulation retrieved using streptavidin-coated
beads. However, examination of the cells recovered revealed a substantial number of
"trapped" viable cells (results not shown). Instead of optimising the bead-based
approach, the decision was made to apply a flow-cytometry based cell-sorting
method in order to achieve the same result. This approach has been employed for
selections using peripheral blood leucocytes to isolate phage antibodies specific for
subsets of B-lineage cells. (Dekruif, Terstappen et al. 1995)
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3.1.5.1 The use of Mutu I Burkitt's lymphoma cell line for selection.
Recent studies have failed to show a contribution by ICAM-3 in the clearance of
apoptotic K562 cells when the molecule is over-expressed (Shingler 2003). There are
many possible explanations for this finding, such as an inadequacy in processing of
the molecule by this cell line (which does not usually express ICAM-3) as it dies to
bring about the necessary changes for the recognition in its "apoptotic form".
Alternatively, the presence of excess ICAM-3, as a result of the over-expression
system, could have the effect of masking important epitopes. Nevertheless,
populations of Mutu I cells selected for ICAM-3-negativity show decreased
interaction with macrophages compared to their wild-type counterparts (Shingler
2003).
For these reasons, Mutu I were chosen for subsequent cell-based phage selections as
their engulfment by macrophages in an ICAM-3-dependent manner whilst
undergoing apoptosis is well established. In this case, one can be assured of the
presence of ICAM-3 in the desired form for the selection.
The approach taken was to sort a minor sub-population of apoptosis-induced ICAM-
3 positive Mutu I cells from an excess of non-induced Mutu I cells in a phage
selection mixture by flow cytometry.
3.1.5.2 Results
A number of theoretical and practical issues were considered during the experimental
design of cell-sorting selections. For example, when deciding the desired overall
ratio of apoptotic target cells to viable cells it was important to consider the
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contribution of dead cells due to spontaneous apoptosis (which can range from 5-
20% in culture of Mutu I cells) amongst the culture used to provide the "viable cell
A
sink". Potential criteria for sorting the dead ICAM-3-positive "target cells" from
viable ICAM-3-negative "absorber cells" by flow cytometry considered were: (1)
discrimination by light-scatter properties, (2) Annexin V positivity, and (3) ICAM-3
positivity. Initial attempts whereby staining for Annexin V was performed
subsequent to incubation with the phage library (carried out on an orbital rotator) led
to a significant loss of membrane integrity and cellular fragmentation during the
succeeding sort and therefore an inefficient sample collection. Thus, in order to
reduce the degradation of cells during the phage selection and cell-sorting, mixing of
the selection solution was minimised (by using only gentle inversion of the selection
vessel) and apoptotic cells were discriminated on the basis of the light scatter
properties. A further modification to previous cell-based selections was the use of
4% w/v BSA in PBS in preference to 4% non-fat dried milk in PBS as a blocking
solution after consideration of the potential for structural similarity between ICAM-3
and the numerous glycoprotein structures in milk that could block the specific
binding of phage to the target.
The profile obtained from titrating the number of c.f.u.s returning from four rounds
of selection on apoptotic Mutu I cells by flow cytometry (figure 3-8) did not mirror
the trend observed previously for cell-based selections (figures 3-2 and 3-3).
Furthermore, no signal was observed when either polyclonal or monoclonal
preparations of phage were tested for their ability to bind either viable or apoptotic
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Round of Selection
Figure 3-8. Results of selection of phage antibodies by flow
cytometric cell sorting of apoptosis-induced Mutu I cells. Phage were
titred by infection of eluted particles from each round of selection into
Escherichia coliTG1 and plating serial dilutions onto ampicillin-containing
agar plates. The profile for sequential rounds of selections by flow
cytometry did not mirror the profile observed previously for cell-based
selections (figures 3-2 and 3-3).
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Upon reflection, it was suspected that the choice of whole apoptotic Mutu I cells as a
selection target was destined to be problematic as this cell-line became very fragile
during later stages of death. It is possible that loss of membrane integrity consequent
to the physical stress of a selection process allowed phage to enter and be retained
within cells, hampering enrichment of the desired clones. Considering this, and in
light of the results of selections on K562 cells, the decision was made to discontinue
A
whole-cell-based selections and place focus on selections employing purified
preparations of apoptotic-cell-associated molecules, results of which are presented in
the following chapter.
The findings of this chapter can be summarised as follows:-
• Phage antibody selections on K562/ICAM-3 cells demonstrated the
successful enrichment of antibody fragments with high affinity for cell-
surface epitopes.
• Characterisation of the specificity of cell-binding phage from these revealed a
selection of common cell-binders had occurred.
• Furthermore, of the epitopes selected for, all proved to be present at higher
levels on viable cells than apoptotic cells.
• Targeting selection to apoptosis-specific epitopes using cell populations of
mixed viability proved difficult.
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4 Results Chapter 2 - Selection Of Phage Antibodies
Using Purified Target Antigens and Cell-Derived
Liposomes
4.1 Selections of Phage Antibodies Using Purified
Recombinant ICAM-3
4.1.1 Introduction
Data presented in the previous chapter demonstrates that the phage library used for
these studies can be manipulated in a way suitable for the isolation of a diverse range
of antibody fragments capable of binding to components similar to those utilised for
selecting them. However it was also apparent from the screening performed that
very few, if any, clones amongst the selected populations had the desired property of
being specific to ICAM-3 despite using cells over-expressing the molecule during
the selection stage.
This section documents an attempt to increase the concentration of ICAM-3 present
during the panning steps by using purified recombinant forms of the molecule as a
selection tool. It was proposed that by separating ICAM-3 from other cellular
antigens in this way, phage antibodies specific to the molecule would rapidly be
recovered. Indeed a phage antibody specific to ICAM-1 was obtained from this
library following three rounds of selection on solid-phase bound ICAM-l-Fc fusion
protein (Dekruif, Boel et al. 1995; Pierce 2000).
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4.1.2 Objectives
As part of a step-wise approach, the initial aim was to demonstrate selection of phage
antibodies to purified ICAM-3 derived from viable cells which could also lead to the
identification of ICAM-3 antibody capable of blocking apoptotic-cell recognition by
macrophages in a similar way to those used initially by Moffatt et al. before
transferring the system to selections on ICAM-3 purified from apoptotic cells.
4.1.3 Results
The ICAM-3 fusion proteins used in the studies described below were constructed
from the two most membrane distal Ig-like domains of the molecule. These domains
were fused to either a human IgGl Fc fragment (ICAM-3-Fc) or to a peptide
containing a polyhistidine and V5 tag (see appendix 4-1).
4.1.3.1 Selection of phage antibodies using ICAM-3-Fc passively
adsorbed to immunotubes.
Initial selections were performed using recombinant lCAM-3-Fc fusion protein
coated directly to immunotubes (a gamma-irradiated polystyrene tube of similar
composition to standard microtitre plates used for protein ELISAs (see materials and
methods section 2.12.3.2). Following three rounds, polyclonal preparations of phage
from each selection were analysed for specific binding to ICAM-3 in an ELISA. An
increase in signal was seen for a polyclonal preparation of phage from the second
round of panning compared to the first round, with a comparable ~5-foId increase in
the number of clones returning (Figure 4-1 panel A). A further ~10-fold increase in
phage number following the third round without an increase in signal for binding to
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ICAM-3-Fc by ELISA, suggested that duplication of clones was occurring without
further enrichment of target binders (Figure 4-1 panel A). However, subsequent
screening and analysis of individual clones revealed that phages bound equally well
to the control fusion protein, CD14-Fc (Figure 4-1 panel B). Thus, it appeared that
the selection of phages had been directed towards the non-desired Fc portion of the
fusion molecule. The trend of increased binding of polyclonal phage preparations to
mouse IgGl as well as ICAM-3-Fc (albeit lower amounts) that was observed with
sequential rounds of selection (Figure 4-1 panel A) may also reflect Fc reactivity.
One explanation for this result is an unfavourable orientation of the fusion protein
during adsorption to the plastic. It was thought that this might have led to the Fc
region becoming the dominant epitope during selection. With this in mind an
attempt was made to orientate the fusion protein such that the desired portion
appeared most distal to the support by capturing the Fc region using protein A coated
beads.
After three rounds of selection in this format no characteristic increase in numbers of
phage returning from selection was observed and polyclonal analysis by ELISA
failed to detect enrichment of target antigen binders (data not shown). A more
detailed search of the literature revealed the little-known fact that protein A can bind
to an epitope exposed on the heavy chain variable region of single chain antibody
fragments (Vidal and Conde 1985; Akerstrom, Nilson et al. 1994). Thus, during the
selection protein-A would have been binding to phage antibodies rather than phage




















































Figure 4-1 Analysis of phage antibodies returning from selections
using ICAM-3-Fc adsorbed to immunotubes as determined by ELISA.
A Polyclonal preparations of phage prepared from the clones returning
from each round of selection were analysed for binding to ICAM-3-Fc
(green) and mouse IgGI (purple) as a control. After the second round
of selection, preferential binding to ICAM-3-Fc was observed. Results
shown are the mean +/- S.D. of triplicate wells. Values in brackets
above bars for rounds 1-3 represent the number of phage (c.f.u./ml)
returning from each selection. B Individual phage clones from round
three of selection for binding to either ICAM-3-Fc (blue) or CD14-Fc
(yellow).
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4.1.3.2 Selection of phage antibodies using polyhistidine-tagged-
ICAM-3 captured on nickel-charged magnetic beads.
Bearing in mind the apparent tendency to select for Fc-binding phage, an alternative
ICAM-3 fusion protein that contains a polyhistidine tag (referred to from hereon as
His-I3) was employed as the selection agent. It was hoped that this construct would
increase the efficacy of obtaining binders to the target in several ways. Firstly, it
provides an increase in the proportion of target within the fusion protein as the
peptide tag only adds 3kDa to the target as compared to approximately 25kDa
provided by the Fc partner.
In addition the polyhistidine moiety provides advantages relevant to selection
protocols. At the immobilisation stage it would allow correct orientation to a nickel-
charged solid phase. Furthermore, following selection it would allow removal of the
protein with bound phage from the support by competitive elution from the nickel
using imidazole, leaving behind phage bound to the support (figure 4-2).
4.1.3.2.1 Optimising the coating ofHis-I3 to nickel-charged beads
Following the production and purification of His-I3, three rounds of selection were
performed using beads coated with the fusion protein. Criteria such as binding
capacity and incubation conditions recommended by the manufacturers were
followed to coat beads. However, this resulted in an enrichment of phage that bound
to the surface of nickel-charged beads (figure 4-3) but failed to bind to ICAM-3-
coated microtitre plates by ELISA (data not shown). This suggested that the beads
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Figure 4-2. Selection strategy using His-13 immobilised on nickels-
charged paramagnetic beads, (a) Domain 1+2 of ICAM-3 fused to a
polyhistidine (H) tag (His-13) is captured on Ni2+ charged paramagnetic
beads, (b) His-13 coated beads are incubated with the phage library
allowing phage to bind to both His-13 and the bead surface, (c) Following
wash steps to remove unbound phage, His-13 with attached phage is
selectively eluted from the bead surface using imidazole. Beads are
separated from the eluted material by virtue of their paramagnetism.
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charged sites on the surface. Thus it was necessary to optimise bead coating. Figure
4-4 panel B shows an example of a bead-based ELISA using binding of an antibody
to ICAM-3 (Bu65) as the readout for monitoring the coating of individual batches of
fusion protein.
As the fusion protein with phage bound was going to be eluted following selections
on the basis of its nickel binding, it was necessary to confirm that the beads were
coated exclusively in this way and that the His-I3 had not passively adsorbed to the
surface. To demonstrate this an ELISA was carried out on beads coated with the
fusion protein and then subjected to elution with imidazole or left untreated. Figure
4-4 panel D shows that no ICAM-3 could be detected on the beads following
incubation with the fusion protein preparation at concentrations required for use
within a selection.
Prior to use in phage selection, suitable conditions for bead coating were established
for each batch of recombinant protein. As relatively high protein concentrations
were required for bead coating, the number of beads used for selections was kept to a
minimum to ensure a single batch of fusion protein could be used for all of the
necessary rounds of selection and screening.
Following one round of selection relatively few phage (~3200 clones) were
recovered. This may have been due to the small quantity of beads and thus antigen
present during the selection. With the knowledge that enrichment can be seen
following a single round of selection if highly purified antigen has been used
(personal communication, Jane Wilton, Cambridge antibody technology), a decision
was made not to continue with further rounds of selection but instead proceed to












































Figure 4-3. Suboptimal coating of beads leads to selection of phage
capable of binding to free nickel-charged sites on the bead surface
A Polyclonal preparations of phage prepared from the clones returning
from each round of selection (purple bars) were analysed for binding to
uncoated nickel-charged magnetic beads. The binding of polyclonal
preparation of phage from a cell-based selection (isotype prep) and
anti-M13 antibody was assessed to determine the level of background
binding (yellow bars). Data in A is representative of two independent
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Figure 4-4. Optimisation of bead coating with His-13 as assessed by
binding of antibody to ICAM-3 in a bead ELISA.
A Schematic representation of the bead-based ELISA used to assess the
level of ICAM-3 associated with beads. Following bead-coating with His-
13, mouse monoclonal antibody BU65 (a-ICAM-3) was used to detect
ICAM-3. HRP; horseradish peroxidase. B Various volumes of a purified
preparation of His-13 were to coat a fixed volume of nickel-charged
beads before assessing bead-associated ICAM-3 by ELISA. D To
determine whether all detectable His-13 was bound to the bead surface
specifically via the nickel-charged sites (as in E) as opposed to being
passively adsorbed (as in F), beads were coated with various volumes of
purified His-13 (150^.1 or 25^1), then either treated with imidazole or left
untreated before making an assessment of bead-associated ICAM-3.
Data in B and D are representative of three and two independent assays
respectively.
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Considering that M500 copies of each clone in the library were present during the
selection it was reasoned that screening of ~600 of the individual clones should
provide a representative indication of the total population of clones selected.
Approximately 75 clones from 600 tested bound to ICAM-3-Fc by ELISA.
k
However, subsequent analysis revealed that they also were able to bind to
preparations of CD14-Fc. Considering both His-I3 and I3-Fc were produced using
the same expression system (transiently transfected HEK 293T cells) and that both
preparations contained significant levels of other proteins, as determined by viewing
of Coomassie blue-stained SDS-polyacrylamide gels (most notably a band at 20-25
kDa of unknown identity. See also section 4.1.3.2.2 and appendix 4-2), it is
conceivable that phage were being selected through a common contaminant present
in both the Fc- and His-tagged fusion protein preparations.
4.1.3.22 Optimising antigen purity
k
Initially the amount of His-I3 purified preparations had been estimated by measuring
total protein concentration in a Bradford dye-based assay. However, subsequent
analysis revealed His-I3 to be only a minor component of the samples obtained from
the purification step (< 1% of total protein in a standardised ICAM-3 ELISA). It was
suspected that these contaminating components were also chelating the nickel on the
column used to purify the fusion protein. The same may also have been true for
ICAM-3-Fc purification. An alternative explanation is that soluble proteins that
associate directly with ICAM-3 could have been co-purified with the fusion protein.
These could have originated either from serum in the culture medium or have been
secreted from cells during growth.
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To circumvent the problem of contaminating serum proteins providing a selection
impediment, fusion proteins were produced in serum-free medium. A number of
commercially available products were assessed for maximum fusion protein
productivity, and one was chosen, which only contained recombinant human insulin
as a source of protein.
Following the purification of proteins produced under these conditions, protein bands
in addition to those of ICAM-3 (and not the size expected for recombinant insulin)
were still observed (appendix 4-2), suggesting contamination by cell-derived
A
molecules in the conditioned medium.
4.1.3.2.3 Screening and characterisation of clones returning from selections
on His-I3 produced in serum free conditions.
Given that the technical requirements for further purification were beyond those
readily available, the decision was made to continue with the selection of phage
using the His-I3 preparation derived from serum free cell culture despite the
persistent presence of contaminating proteins.
Following one round of selection ~600 clones were screened (approximately 15% of
the total number returning from the selection). Nearly 80 of these clones showed a
A
clear signal in an ELISA directed against ICAM-3-Fc. However, subsequent
analysis revealed that these could also bind CD14-Fc. The phage did not show a
high affinity towards uncoated ELISA wells demonstrating that they were not merely
binding to plastic.
As no Fc portion should have been present during the selection, phage must have
been selected through epitopes present in all of the fusion protein preparations.
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One explanation is that phage were being selected through regions in His-I3
conserved amongst other Ig domains allowing them to cross-react with similar
epitopes found on the Ig-domain-containing proteins in the screening assays.
Such specificity may be of diagnostic/therapeutic use, perhaps in discriminating Ig-
domain expressing cells from non-Ig domain expressors or for masking all Ig
A
domains. To address this hypothesis, a panel of phages giving the highest signal in
the initial ELSIA screen were tested for their reactivity to a panel of Ig and non-Ig
domain-containing antigens.
A weak preference towards Ig domain-containing antigens as compared to antigens
not containing an Ig-domain was seen for several clones (figure 4-5). However, the
background signal observed for non-Ig containing antigens was higher than for the
control phage clones Ce3 (anti-CD 14) (figure 4-6) suggesting the clones have a low
affinity for these antigens too.
When tested for the ability to bind to Ig domain-expressing cells, no clones showed
reactivity by flow cytometry or microscopy (data not shown). *
Explanations for this observation include the possibility that the clones only bind
antigen when they are immobilised or that the read-out from the ELISA is more

















Figure 4-5. Some clones selected using His-13 preferentially bind to Ig-
containing protein preparations in a direct ELISA.
Wells were coated with solutions (lO^g/ml) of either Ig-containing
antigens (CD14-Fc and mouse IgG) or non-lg-containing antigens
(bactotryptone and LPS). Phage clones were analysed for the ability to
bind antigen coated wells in an ELISA. Results represent the combined
mean +/- S.D. for each class of antigen (duplicate well for individual























ICAM-3-Fc CD-I 4-Fc Bactotryptone
Antigen
Figure 4-6. Clones with preference for binding Ig-containing proteins
show a higher affinity for non-lg containing preparations than control
clones.
Wells were coated with solutions (10pg/ml) of either Ig containing
antigens (CD14-Fc or ICAM-3-Fc) or the non Ig containing antigen,
bactotryptone. Phage clones were analysed for the ability to bind
antigen coated wells in an ELISA. Clone Ce3 is specific for CD14. Results
shown are the mean +/- S.D. Of duplicate wells.
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The results of this section can be summarised as follows,
• Following the selection of phage antibodies with purified preparations of
recombinant ICAM-3, enrichment of clones capable of binding to
components of the purified preparation was observed.
• Phage antibodies selected using purified preparations of recombinant ICAM-
3 also displayed an equal affinity for similar, non-ICAM-3-containing
preparations of proteins.
• The binding properties of clones obtained from selections performed on His-
tagged ICAM-3 suggested that antibody fragments were being selected
through conserved epitopes on Ig-domains
• Clones binding to immobilised protein preparations did not display cell
binding.
Thus, targeting of selections towards domains 1 and 2 of ICAM-3 using purified
preparations of this protein in recombinant form was not successful. In order to
demonstrate that purified antigens can be used to isolate cell-binding antibody
fragments from the phage library used in this work, selections were performed on an
alternative apoptotic-cell-specific marker, namely phosphatidylserine. The results of
K
these selections are presented in the following section.
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4.2 Selection of Phage Antibodies Specific to
Phosphatidylserine
4.2.1 Introduction
Currently, the most definitive means of detecting surface changes associated with
apoptosis is the persistent exposure of phosphatidylserine (PS). Despite the large
number of receptors and bridging molecules of the innate immune system that have
been suggested to bind PS (Savill, Hogg et al. 1992; Hanayama, Tanaka et al. 2002;
Anderson, Maylock et al. 2003), until very recently, no good-quality monoclonal
antibodies to this phospholipid have been developed (Mandinov, Mandinova et al.
2003).
A
The binding of Annexin V, the fifth member of a structurally related family of
proteins (Reutelingsperger, Kop et al. 1988; Tait, Gibson et al. 1989; Crumpton and
Dedman 1990), by apoptotic cells has been employed as a trusty marker of
programmed cell death for almost a decade (Vermes, Haanen et al. 1995). However
the requirement for calcium to be present at relatively high concentrations for this
binding to occur hampers its use in many systems.
An anti-PS antibody or, in particular, antibodies against specific portions of the
molecule would allow more detailed studies into the structure-function relationship
of the changes to PS, such as alterations in its oxidation state that are known to occur
during apoptosis (Kagan, Borisenko et al. 2003). Moreover, identification of a
neutralizing antibody specific to "apoptotic PS" would allow in vivo discrimination
of effete cells from viable cells that may have external PS as a result of other
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physiological phenomena, such as during the activation of B cells (Dillon, Mancini et
al. 2000).
The presence of naturally-occurring PS-autoantibodies has been linked to many
autoimmune disease states, notably systemic lupus erythematosus (SLE) (Toschi,
A,
Motta et al. 1993). In such situations "antiphospholipid syndrome" can lead to a
number of disorders such as end stage renal disease (Vaidya, Daller et al. 2002).
These antibodies often display heterogeneity in binding specificities, varying in their
dependency on oxidation states and the presence of protein cofactors. The antigenic
epitopes for the autoantibodies appear mainly to be the polar head groups of the
phospholipids suggesting a structural basis by which they can cross-react with DNA
(Cocca, Seal et al. 2001).
Under normal circumstances, lipids are considered to be very poor immunogens
when administered by conventional means (Boullerne, Petry et al. 1996), presumably
due to the requirements for antigen processing during an immune response. Phage
antibodies provide an alternative approach for isolating such specificities. Recently,
a phage-displayed semi-synthetic human antibody library was used successfully to
isolate antibodies specific to methyl palmitate, a major component of bacterial
glycolipids and lipoproteins in animal cells. The selected single-chain variable
fragments were able to prevent micelle formation of lipoteichoic acid from Gram-
positive bacteria, inhibit lipopolysaccharide-induced tumor necrosis factor alpha
release in mononuclear cells and bind to hydrophobic bacterial surfaces (Gargir,
Ofek et al. 2002). These precedent results illustrate the potential of using phage to
produce novel anti-PS antibodies. The work detailed in this section therefore aimed
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to apply phage antibody technology in a similar way to obtain anti-PS antibody
fragments with potential diagnostic or therapeutic applications relevant to apoptosis.
To this end, a suitable means for immobilising PS was sought prior to using solid-
phase-bound PS as a selection agent. PS-binding phage were screened for their
ability to bind apoptotic cells. ,
4.2.2 Results
Functional studies involving purified phosphatidylserine generally involve the
production of liposomes. As it is accepted that liposomes made purely from PS are
unstable in solution, PS usually represents a minor component of these small lipid
vesicles (~30%) compared to other phospholipids (typically phosphatidylserine PC)
which act as PS carriers (Fadok, Voelker et al. 1992). Preliminary selection of PS-
specific liposomes was carried out using PS/PC liposomes in solution. Due to the
low sedimentation coefficient of these small particles long high-speed centrifugation
was required to pellet the liposomes during the washing stages. Minimal success
was achieved in obtaining phospholipid-specific phage, and of the few identified,
none were specific to PS (data not shown). It was reasoned that PC was dominating
the selections. The work described below attempted to circumvent these obstacles
by performing selections using immobilised PS alone.
4.2.2.1 Immobilisation of PS directly to gamma-irradiated
polystyrene and subsequent binding of Annexin V
Immobilisation of lipids for ELISAs usually involves either the addition of the lipid
in ethanol followed by air-drying or their coupling to protein molecules.
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The solvent used for immobilisation can affect the orientation and spatial packing of
lipids to plastic and covalent coupling to protein decreases the relative amount of the
target-lipid to support. As the end use of immobilised PS in these studies was to
select for phage capable of binding apoptotic cells the capacity of phospholipids to
coat plastic in an aqueous phase (in the absence of organic solvent) was tested.
The ELISA results shown in figure 4-7 reveal that PS can bind directly to gamma-
irradiated polystyrene microtitre plates for the specific detection by Annexin V. A
simple short incubation of the lipid dissolved in an aqueous serum-free solution
A
(Hank's Balanced Salt Solution, HBSS) as a buffer at 37°C, resulted in a stable
coating that was suited for use in ELISA. Furthermore, Annexin V binding capacity
was maintained following 20 washing steps with PBS as an imitation of the rigorous
procedure required to remove non-specifically bound phage following a selection.
BSA in HBSS was the chosen blocking solution for both the unoccupied sites on the
solid support and for the phage library in subsequent selections. This was used in
preference to the popular blocking agent, dried milk powder, as although being
marketed as "non-fat", phospholipids could still be present in low amounts.
4.2.2.2 Enrichment of phospholipid-specific phage
A
Following the ELISA result confirming firm immobilisation of phospholipids,
selection of phage particles displaying phospholipids-reactive antibody fragments
was conducted by panning against PS-coated immunotubes. Immunotubes were
coated with PS and blocked using the concentrations and conditions used to establish


























Figure 4-7. Preservation of the Annexin V binding epitope of
phosphatidylserine in an ELISA format. Phospholipids were resuspended
in serum-free HBSS and used to coat gamma-irradiated polystyrene
microtiter ELISA plates prior to analysis using biotinylated Annexin V
and detection with streptavidin HRP. Wells were coated using solutions
of phosphatidylserine (PS), phosphatidylcholine (PC) or a 30:70 mixture
of PS:PC. Results shown are the mean +/- S.D. of duplicate wells.























































Figure 4-8. Binding of polyclonal phage to phospholipids as determined
by ELISA. Bacterial culture supernatants containing phage were
prepared from the first and second round (R1 and R2 respectively) of
selections on PS-coated immunotubes, and analysed for binding to PS,
PC as a control phospholipid or the irrelevant antigen, BSA. After the
second round of selection, preferential binding to PS was assessed for
phage populations eluted using PS in solution (ePS) or apoptotic cells in
suspension (eAC). Ce3 phage antibody supernatant (a-CD14)




A range of elution strategies was employed during the various rounds of panning.
Following the first round of selection, bound phage were eluted by direct disruption
of all ionic interactions in a low pH (2.2) buffer to maximise retrieval (and
neutralised with 1 M Tris, pH 7.4). For subsequent rounds, an attempt was made to
elute just those phage bound to phospholipids by competing phage from solid-phase-
supported PS with PS at high concentration in solution. A similar strategy has been
successfully used to generate anti-idiotypic antibody fragments capable of
mimicking conformational epitopes of tumor-associated antigens (Goletz,
Christensen et al. 2002).
For these studies the competitive elutants used were: -
(a) A high concentration of PS in solution prepared in an identical way to that used
to coat immunotubes (methods section 2.12.3.2). This was followed by incubation
with PC-coated immunotubes to select negatively for broad-spectrum phospholipid
binders.
(b) A suspension of apoptotic Mutu I cells with PS exposed on the outer-leaflet of
the plasma membrane. The rationale for this was to elute just those phages capable
of binding phospholipid in the context of the cell membrane. Cell-bound phage
were pelleted and washed before infection into TGls.
Figure 4-8 shows the results of an ELISA used to monitor enrichment of
phospholipid-binding phage after the various selections.
Polyclonal preparations of phage showed a considerable increase in binding to PS-
coated wells following the second round. In addition, a stronger signal was seen for
PS as compared to PC and there was no significant enrichment of phage capable of
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binding BSA-coated wells. These results show that selection of phage on
immobilised phospholipid followed by a specific elution strategy can afford a rapid
enrichment of target-specific binders.
4.2222 Binding characteristics of the selected phage clones
4.2.2.2.2.1 Initial screening and analysis by ELISA
Following the various rounds of panning, selected monoclonal phages were screened
in an ELISA for PS. A number of clones reactive to microtitre plates coated with PS
were isolated. For clones eluted using a solution of purified PS, 70 of 880 screened
(8%) were positive, whilst from the clones eluted using whole apoptotic cells, 14 of
400 screened (3.5%) were positive (table 4-1). The relative proportion of binders
between elution methods is consistent with the polyclonal phage ELISA analysis.
In order to evaluate whether a significant portion of ELISA-positive phage had scFv
specific for PS, a panel of phage clones giving the highest ELISA levels were tested
on plates coated with either the irrelevant antigen, BSA or PC as phospholipid
control in addition to PS. When tested in an ELISA format, some phage bound only
to PS coated wells (e.g. A3) and some bound to both PS and PC (e.g. B9). Others
bound to similar levels to all antigens tested (e.g. HI l)(figure 4-9). Thus, multiple
clones with contrasting binding specificities had been selected.
K
4.2.2.2.2.2 Binding of anti-phospholipid phage to Mutu I cells
Based on the ELISA data indicating the presence of immobilised-PS-specific phage
antibodies amongst the selected population, individual ELISA-positive clones were
further analysed for their ability to bind native PS as it exists on apoptotic Mutu I
cells. For clones eluted using a solution of purified PS 2 of 880 screened (0.23% of
142
PS-eluted AC-eluted
Figure. 4-9. Anti-phospholipid binding characterisation of selected
phage clones. Individual scFv clones identified as positive from primary
screening were analysed for binding to PS, PC as a phospholipd control or
the irrelevant antigen, BSA in an ELISA. Examples of clones from
selections where either purified PS in solution (PS-eluted), or apopotic
cells exposing PS (AC-eluted) were used during the elution step are
shown. Representative of two similar assays.
PS Solution Eluted Apoptotic Cell Eluted
Total screened ELISA +ve Cell+ve Total screened ELISA +ve Cell+ve
No. of clones 880 70 2 400 14 5
Xi of total screened 8% 0.23% 3.50% 1.25%
% of ELISA +ve 2.86% 36%
Table 4-1. The effect of different elution strategies on the reactivity
of PS-selected phage populations towards PS in an ELISA or on
apoptotic cells.
Summarised results of screening individual phage clones for the ability
to bind purified PS in an ELISA (ELISA +ve) or apoptosis-induced Mutu I
cells by flow cytometry (Cell +ve). A higher percentage of phage
clones identified as positive for binding PS by ELISA were also positive
for binding ACs when eluted from immobilised purified PS using ACs
than when eluted using purified PS in solution (P = 0.0011, Fischer's
exact test).
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total, 2.86% of ELISA-+ve) bound the population of Mutu I cells which display a
high level of level of AxV binding, whilst from the clones eluted using whole
apoptotic cells 5 of 400 screened (1.25% of total, 36% of ELISA-+ve) bound (table
4-1 and figure 4-10). Five clones failed to bind cells following regrowth on a larger
scale despite maintaining ELISA reactivity. It is unlikely that these were false
positives because original batches showed the same binding pattern when used for
staining on separate occasions.
The loss of cell reactivity could have been a result of mutation within variable
regions that provided a growth advantage to the bacteria. This is known to occur in
non-recombinant deficient strains such as TGls (personal communication, John
Dekruif, see also section 5.5). Perhaps antibody fragments with too strong a
specificity for native PS would bind to the phospholipids, which have been shown to
be present for several seconds as a synthetic intermediate of PE at cytoplasmic
membranes. Considering that this is also the site of phage particle assembly, one
could imagine binding to PS here could interfere with normal cellular function. Loss
of cell reactivity was not due to decreased sensitivity following a reduction in phage
particle production as the total phage content remained the same or even increased
after regrowth (see figure 4-11). However, this method only measures total coat
A
protein and is not a measure of phage particles bearing antibody fragments.
Alternatively, this could have been due to a reduced level of antibody fragment
expression per phage particle resulting in lower avidity effects. Furthermore, failure
to regrow specifically-binding clones was not due to outgrowth of another clone


























Figure 4-10. Binding of monoclonal phage antibodies to
apoptosis induced Mutu I cells. ELISA-positive phage were
prepared from individual clones after the second round of
selection and analysed for their ability to bind Mutu I cells by
flow cytometry. Blue histograms represent staining with clone
that produced a strong signal in an ELISA for PS that failed to
bind cells. Clones 4.D10 and 5.G7 bound late apoptotic
Mutul cells. Staining with the a-CD14 phage clone, Ce3 is also
included as a negative control. Representative of staining









Figure 4-11. Determination of Ml 3 coat-protein
concentration by dot-blot analysis. Supernatants of
bacterial cultures containing phage particles were serially
diluted and aliquots allowed to adsorb to PVDF membrane.
The amount of Ml 3-coat-protein present on membranes
was visualised using a peroxidase conjugated antibody to
the protein. A preparation of the phage clone, Ce3 was
included as a positive control to gauge the amount of
Ml 3-coat-protein required within a sample in order to see
cell binding. Representative of three separate
experiments.
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grown up and tested for binding) all tested positive by ELISA but were still negative
on cells. Nevertheless, clones 12.D12 and 13.F2 maintained cell reactivity upon re-
growth, albeit with low signals (figure 4-12). Low-affinity antibodies are a feature
of naive phage libraries, and this problem could have been compounded by the
elution strategy employed during these selections. These clones were analysed by
A
ELISA for phospholipid specificity. Although clone I2.D12 showed specificity
towards PS, surprisingly, clone 13.F2 bound equally as well to PS as to PC (figure 4-
13).
This raises the question of why clone 13.F2 only bound to apoptotic cells and not the
PC in the outer leaflet of viable cell plasma membranes. There are several possible
explanations for this observation. It could be that due to changes in membrane
fluidity, lipid packing or oxidation, the exposed phospholipid epitopes on apoptotic
cells are more similar to those exposed on plastic-immobilised phospholipids as
detected by ELISA than on "unstressed", viable cells. Alternatively, phage particles
could have been entering cells and cross-reacting with other sites bearing similar
A
epitopes to phospholipids such as the phosphate groups of DNA. Or perhaps clone
13.F2 simply doesn't bind to PC in the conformation found on the viable cell surface.
Whatever the mechanisms, these studies have demonstrated that cell-binding















Figure 4-12. Binding of "re-grown" monoclonal phage
antibodies to apoptosis-induced Mutu I cells. The binding
capacity of original and "re-grown" monoclonal phage
preparations was compared by flow cytometry. Clones 12.D12
and 13.F2 reproducibly bound to late apoptotic cells (when
produced on three independent occasions). Clone 1 2.H3 is an
example of a clone which displayed loss of cell binding capacity
following re-growth. Clones 1 2.D1 2 and 1 3.F2 bound equally well
to ionomycin and UV induced Mutu I cells. Staining with the a-
CD14 phage clone, Ce3 is also included as a negative control
(Red histograms). Representative of cell-staining performed
using phage prepared on three independent occasions.
Representative of staining performed on two separate occasions






Ce3 ACH11 12.D12 13.F2
Phage Antibody Clone
Figure 4-13. Anti-phospholipid binding characterisation of cell-binding
phage clones. Cell-reactive scFv clones were analysed for binding to PS,
PC as a phospholipid control or the irrelevant antigen, BSA in an ELISA.
ACH11 represents a clone that showed phospholipid binding capability
in an ELISA but not to cell membranes. Results shown are the mean +/-
S.D. of duplicate wells. Representative of two similar experiments.
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4.2.3 Selection on lipid symmetric erythrocytes
Although it is possible that further screening of clones from the sub-library collected
after two rounds of selection on immobilised PS could have led to the identification
of a high affinity PS-specific cell-binding antibody fragment, it was decided to use
an alternative source of membrane-bound PS for further selections. Erythrocytes
from normal human peripheral blood lose their membrane asymmetry following
osmotic treatment in the presence of calcium. This results in exposure of PS on the
outer leaflet of the cells without the gross changes in the cytoskeletal network
associated with apoptosis (Schlegel, McEvoy et al. 1985). In addition, these cells
lack a nucleus and are much smaller than lymphocytes, so have a higher ratio of cell-
surface membrane to cytoplasm. For these reasons they were chosen as a tool for
further selection of PS-specific antibodies.
Figure 4-14 shows analysis of the PS-binding capacity of polyclonal phage
preparations from a round of selection on lipid-symmetric erythrocytes using sub-
libraries derived from the earlier phage selections on immobilised PS. No increase in
binding to purified PS by ELISA was observed. The slight decrease could be
explained by the loss of phages that preferentially bind to PS, as it exists
immobilised on plastic, whilst enriching for cell-binding phage.
No reactivity of polyclonal preparations to apoptotic cells was observed, (data not
shown). However, experiments demonstrated that up to 1 in 16 cell-binding phage
are required in a standard phage preparation to see a signal by flow cytometry (data
not shown). Therefore, in the event that the number of cell binding phages within
the polyclonal population was just below detection limits, individual cones were
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Figure 4-14. Comparison of the binding of polyclonal phage from
selections on lipid-symmetric red blood cells (RBCs) and purified PS
in an ELISA for PS. Bacterial culture supernatants containing phage
were prepared from the first and second round of selections on
purified PS (R1 and R2 respectively) and lipid symmetric red blood
cells (RBCs - R3) that had been eluted with either PS in solution (PSE
yellow bars) or apoptotic cells in solution (ACE red bars).
Supernatants were analysed for binding to PS by ELISA. A decrease
in binding was seen following selection on lipid symmetric red blood
cells. The isotype supernatant represents background binding. Results
shown are the mean +/- S.D. of duplicate wells.
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phage was seen (from ~300 screened) compared to those selected from the first two
rounds on immobilised PS.
The findings of this section can be summarised as follows,
• Phosphatidylserine can be directly bound to gamma-irradiated polystyrene
microtitre plates for the specific detection by Annexin V. »
• Phosphatidylserine in this format is a suitable tool for selecting phage
antibodies capable of specifically recognising the phospholipid in an ELISA.
• Specific elution of phage following a selection provides a means to rapidly
amplify phage that bind to the target.
• Immobilised purified phosphatidylserine does not appear to target the
selection of phage antibodies towards phospholipids in the way they are
found on the cell surface.
Similar to the work described in section 4.2, it seems that purified antigens do not
A
yield high affinity cell-binding phage antibodies for the target molecules of interest
to this thesis. Given that purified forms of these targets were employed for selections
following the difficulties encountered when using whole apoptotic-cells, the decision
was made to explore the use of purified preparations of membrane fractions from
apoptotic cells as a selection tool.
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4.3 Selection Using Liposomes Prepared from the Membrane
Fraction ofApoptotic Cells
4.3.1 Introduction
The results from sections 3.1.4 and 3.1.5 highlighted two of the main problems
associated with using whole apoptotic cells for selection. These were (1) loss of
k
apoptotic-cell surface epitopes during the washing process and (2) loss of membrane
integrity during the selection incubation period and washing steps allowing phage to
bind abundant epitopes found intracellularly. The results from sections 4.1 and 4.2
showed the importance of conformation, context and purity when using immobilised
molecules to select for antibodies capable of binding cell-associated epitopes. In
addition it is not known whether an ICAM-3 fusion protein, even if produced in cells
undergoing apoptosis, could ever model the "apoptotic ICAM-3" found in the
context of an apoptotic-cell membrane or whether the purification process itself may
affect antibody binding properties.
The results in this section document an attempt to overcome these problems by using
liposomes prepared from the membrane fraction of apoptotic cells as a device for
selection. Such preparations (also known as proteoliposomes) were employed by
Brown et al. for investigating membrane changes occurring during apoptosis. In
their system, proteoliposomes derived from primary human neutrophils
(polymorphonuclear leukocytes, PMNs) were used as a tool to probe for the
constitutive cleavage of membrane-associated actin during spontaneous apoptosis
(Brown, Bailey et al. 1997).
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For the studies described herein, Mutu I and primary PMNs were used as the source
of apoptotic-cell membrane as their recognition by HMDM has been well
characterized in vitro (Flora and Gregory 1994). Thus, it was possible to isolate
monoclonal phage antibodies capable of binding to proteoliposomes in an ELISA
format. These clones were analysed for their ability to bind intact apoptotic cells. t
4.3.2 Results
4.3.2.1 Immobilisation of proteoliposomes on gamma-irradiated
polystyrene.
Proteoliposomes were prepared from the cell lysates of apoptotic Mutu I cells and
PMNs by sequential centrifugation to isolate the membrane-containing fraction.
Competence to bind Annexin V in an ELISA format was used to demonstrate that the
proteoliposome solutions could be passively adsorbed to polystyrene. Wells of
microtitre plates containing proteoliposomes prepared from both Mutu I cells and
PMNs showed comparable Annexin V binding to wells containing PS liposomes
figure 4-15.
As proteoliposomes were prepared in the absence of detergent (i.e. membrane lipids
would not be partitioned from other membrane components) the presence of PS
indicated that such a cellular fraction immobilised in this way would provide a





















Figure 4-15. Adsorption of liposomes prepared from apoptotic-cell
membranes to polystyrene as detected by Annexin V ELISA. Plates were
coated with proteoliposome preparations derived from apoptotic primary
human neutrophils (PMN) or the B-cell lymphoma cell line (Mutu I),
phosphatidylserine (PS) or phosphatidylcholine (PC) by incubation for
45min at 37°C. Solutions were prepared and diluted in serum-free HBSS .
Absorbance492 nm represents optical density values corresponding to
proteoliposome adsorption after detection with Annexin V. Results shown
are the mean +/- S.D. of duplicate wells. Representative of
proteoliposomes prepared on three separate occasions.
155
4.3.2.2 Selection of immobilised proteoliposomes derived from
apoptotic-cell membranes
Initially, panning was performed using proteoliposomes from apoptotic Mutu I cells.
Following two rounds, the enrichment of phages specific to components of the
selection material was assessed by ELISA (Figure 4-16 panel A). Polyclonal
preparations were tested for their ability to bind PS and PC (representing common
membrane components) in addition to Mutu and PMN proteoliposomes. BSA was
included as a negative control. The general trend was an increase in binding
A
following the second round of selection. A modest signal for both PS- and PC-
coated wells indicated that a subpopulation of clones were able to bind lipids. An
equi-molar concentration of solutions was used to coat the plastic (although this may
not reflect the absolute level of lipid that remains bound). Despite the inclusion of
steps to pre-deplete eluted phage on PC coated tubes, a similar-strength signal was
observed for both PC and PS.
A signal was observed for both proteoliposomes prepared from PMNs as well as
Mutu I cells (Figure 4-16 panel A). This suggests selection toward antigens common
to both cell types. Even though proteoliposomes for each cell type were prepared
using the same number of cells, a slightly higher signal was observed for
proteoliposomes prepared from PMNs compared to Mutu I cells (Figure 4-16 panel
A). This may represent either a higher concentration of total antigen in the PMN
preparation (because of their inherent ability to maintain membrane integrity during
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Figure 4-16. Following 2-3 rounds of panning on apoptotic-Mutu
derived proteoliposomes, enrichment of phages specific to
components of the selection material was observed.
A Bacterial culture supernatants containing phage were prepared from
various rounds (RO to R3 respectively) of selection on proteoliposome-
coated immunotubes, and analysed for binding to PS liposomes, PC
liposomes, proteoliposmones derived from PMNs (PMN) or Mutu I cells
(Mutu I), or BSA as an irrelevant antigen. Ce3 phage antibody
supernatant (a-CD14) represents background binding. Results shown
are the mean +/- S.D. of duplicate wells. B Adsorption of
proteoliposomes to wells was quantified using Annexin V.
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the selected phages. A slightly stronger signal for Annexin V binding to the PMN
preparation (Figure 4-16 panel B) supported the former suggestion.
In an attempt to enrich further for antigen-binding clones, a third round of selection
was performed using PMN proteoliposomes. The rationale for changing cell types.as
an antigen source was to try and lose common B-cell specificities whilst still
providing common apoptotic-leucocyte epitopes. After the third round, no
significant increase in binding to any of the antigens tested was seen. (Figure 4-16
panel A) Consequently the decision was made to screen individual clones from the
second and third rounds for their ability to bind proteoliposomes by ELISA.
4.3.2.3 Screening of monoclonal phage
~80 clones from a total of ~1500 tested bound to apoptotic-Mutu I derived
proteoliposomes in ELISA format. Of the ELISA-positive clones, 6 preferentially
bound to the "late apoptotic" sub-population of an ionomycin-treated Mutu culture;.
However, as was previously encountered for cell-binding phage from selections on
immobilised PS, these clones failed to bind cells following regrowth on a larger scale
despite maintaining phage concentration and ELISA reactivity (figure 4-17).
Explanations for the loss of cell binding capacity, such as differences in avidity of
phage clones between batches (i.e. batches of lower avidity which maintain an
affinity suitable for ELISA but insufficient for flow cytometry), will be discussed in
more detail in section 5.
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Figure 4-17. Analysis of regrown phage antibodies from selections on
apoptotic-Mutu derived proteoliposomes as determined by flow cytometry
and ELISA. Individual phage clones were prepared from culture stocks
originally identified as positive (e.g. clone 4.C4) for reactivity towards
apoptotic cells. Original (d,e) and regrown (g,h) batches of clone 4.C4 were
analysed for the ability to bind apoptotic cells by flow cytometry. Clone 4.C4
lost the ability to bind cells following regrowth. Clone Ce3 (anti-CD 14)
included as a control during production of all batches maintained binding to
CD14 expressing cells (f,i). K, regrown monoclonal preparations were also
analysed for binding to proteoliposomes or BSA as a control. Clone 4.C4
maintained ELISA reactivity following regrowth. Results shown are the mean
+/- S.D. of duplicate wells. Data is representative of two independent
analyses.
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The work described in this section can be summarised as follows;
• Proteoliposomes derived from the membrane fraction of apoptotic cells were
prepared and their passive adsorption to a polystyrene support established.
• Proteoliposomes immobilised in this manner can be used to select a
population of antibody fragments with affinity for immobilized PC, PS and
proteoliposomes in an ELISA format.
• A small number of antibody fragments from these selections that bound
A
antigens in an ELISA also bound preferentially to a sub-population of late
apoptotic cells within an induced culture.
• None of the monoclonal phage retained cell-binding capacity following
regrowth. Loss of reactivity towards cells was not due to a decrease in total
phage concentration.
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5 Discussion - bacteriophage display work
The aim of the work documented in results chapters 1 and 2 was to select antibody
k
fragments with specificity for apoptotic cell-associated epitopes from a
bacteriophage antibody library. Selections were targeted towards whole cells
overexpressing ICAM-3, purified preparations of recombinant ICAM-3, purified
phosphatidylserine (PS) and the purified membrane fraction of apoptotic cells.
Several methods were employed in an attempt to separate clones that bind from those
that do not. Novel protocols for selections were designed and optimised by
modification of previous methods performed using this library and successful
published examples.
5.1 Summary of findings
k
Results chapter l began by describing the development of techniques aimed at
obtaining antibody fragments to the form of ICAM-3 found on apoptotic-cells
("apoptotic ICAM-3") by selecting and screening on whole cells, exogenously
overexpressing ICAM-3. Following optimisation of phage antibody selection using
viable K562 cells in suspension (section 3.1.3), a repertoire of many different cell-
binding phages was isolated using apoptotic K562 cells overexpressing ICAM-3,
demonstrating functionality of both the phage antibody library and the basic
techniques for its' manipulation.
However, none of the identified cell-binders proved to be specific for ICAM-3 or
apoptotic cells. What is more, the clones selected for all seemed to bind epitopes
expressed at higher levels on viable cells (section 3.1.4).
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As a result, an alternative approach to reduce the selection of phage that bind to
unwanted targets was sought. Negative cell-selections have proven an inefficient
means to remove unwanted phage (Van Ewijk, de Kruif et al. 1997; Topping, Hough
et al. 2000) and introduce the risk of losing phage of interest through non-specific
binding to the "negative" antigen. Therefore, the decision was made to try dual
k
positive and negative selection where a small number of ICAM-3-positive apoptotic
cells were mixed with a larger number ICAM-3-negative viable cells. However
these more sophisticated selections, aimed at homing in on "apoptotic ICAM-3" in a
single selection procedure were also unsuccessful (section 3.1.5). This was reflected
by the lower number of clones returning from sequential rounds of selection than had
been observed for K562 selections (section 3.1.3 and 3.1.4), suggesting that there
may have been a fundamental flaw in this procedure (although it is difficult to assess
the value of separate methods without comparing directly to positive cell selections
using the same cell type performed in parallel). Thus, the results presented in results
chapter 1 suggested that the use of whole apoptotic cells for selection would pot
provide a simple means to achieve the aims of this thesis. This may in part have
been due to the availability on whole cells of a wealth of alternative antigens
(carbohydrates, lipids and proteins) in addition to the sought targets. These
molecules will be common to other cells, therefore during selection the type of
antigens expressed on the cell surface are likely to bias the type of antibodies
selected from the phage library (discussed in more detail in section 5.3).
In appreciation that many successful results of phage display have been achieved
using selections carried out on purified antigens (Dekruif, Boel et al. 1995; Hodits,
Nimpf et al. 1995; Pierce 2000; Horn, Nielsen et al. 2003), the work described in
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results chapter 2 attempted to overcome the problems mentioned above by using
purified forms of apoptotic-cell-associated targets, namely, ICAM-3,
phosphatidylserine and membranes prepared from apoptotic cells. Targeting
selection to ICAM-3 in the way it is found on cell-surfaces using immobilised
recombinant ICAM-3 proved difficult as epitopes present in purified preparations of
the protein, other than those specific to ICAM-3, dominated selections (section 4.1).
However, selections on purified PS demonstrated the functionality of the phage
k
library with regards to the ability to select for immobilised-lipid-specific phage
(section 4.2), and that the specific elution approach taken to achieve this can work as
a quick way to amplify phage that bind to the desired target. However, relatively
few of these clones bound to apoptotic cells, and of those that did, their affinity for
cells was relatively low (a general feature of phage antibodies selected from unbiased
libraries, see section 5.2).
Given that immobilisation of antigens to a particular surface might favour exposure
of only certain parts of the antigen, there was never any guarantee that the epitope(s)
on ICAM-3 or PS associated with their function in the lipid bilayer of apoptotic cells
would be represented in a purified, immobilised form (c.f. introduction section
A
1.2.5.2.1.1). For these reasons the decision was made to use liposomes prepared
from the membrane fraction of apoptotic cells as a device for selection. However
none of the minority of proteoliposome positive clones reproducibly bound to
apoptotic cells following growth on a larger scale.
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The issues encountered in trying to realise the aims of this work using phage display
can be summarised as;
• Technical difficulties associated with the use of bacteriophage antibody
libraries (especially of naive origin).
• Difficulties of using whole cells as a selection agent for phage display, a
problem that is confounded by the fragility of apoptotic cells.
• Unfavourable properties of immobilised antigen as a target for selection.
The discussion will now focus on what these findings mean, how they compare to
published/previous phage work and the direction which future work with these
techniques could be taken.
5,2 General difficulties of working with naive bacteriophage
antibody libraries
Phage-display technology offers the potential to generate antibodies specific for any
epitope. Statistically speaking, the higher the complexity of the library, the greater
the chance is that it will contain antibodies of the desired specificity. However,
high-complexity libraries have their downside for in vitro use. For example, in the
A
case of the library used for this work, which has an estimated complexity of 3.8xl08
specificities, each clone would only have been represented ~1500 times during a
selection (i.e. ~5xl0" input particles per selection -s- 3.8x10s ). Furthermore, as a
result of the phagemid selection system, the antibody coat protein fusion construct
competes with the coat protein from the helper phage for incorporation into phage
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particles. As a result only some particles display antibody fragments, which reduces
the number of functional phages 10 fold or more (Breitling and Deubel 1999).
K
During selection, few specific phage particles exist bound to their antigen (i.e. some
exist freely in solution), lowering even further the probability that clones survive the
first round of selection. Thus, one reason for explaining the consistent inability to
isolate an ICAM-3 antibody is to hypothesise that there are very few ICAM-3
specific antibodies within the phage library that was used, which in combination with
the small likelihood of binding during the first round of selection, resulted in their
loss from subsequent sub-libraries. This is, however, unlikely considering the
successes with this library for similar targets (Dekruif, Boel et al. 1995; Pierce 2000).
Alternative explanations will be discussed in sections 5.5 and 5.6 below.
Phage antibody technology using naive libraries does not have the advantage of the
body's natural affinity maturation process whereby antibodies mutate over relatively
short periods generating higher affinity for their targets. This drawback may explain
why only low-affinity antibodies to phosphatidylserine were obtained following the
specific elution approach employed for selections against this phospholipid (section
4.2). One way to obtain antibodies of higher affinity by this approach could be to
use longer incubation during the elution step to remove antibody fragments with
longer "on rates" or to use a more severe elution step (low pH). Alternatively, the
affinity of the selected antibodies could be improved by mutation in vitro (Gram,
Marconi et al. 1992).
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Despite the shortcomings mentioned above, the quality of the antibody library was
assessed in the very first section and was shown to contain cell-binding phage of
relatively high affinity (section 3.1.3). Direct selection from the library using
apoptotic cells led to the selection of irrelevant cell-binding antibodies indicating the
requirement for extensive depletion (section 3.1.4). However, dual positive and
negative selections failed to enrich even for common cell-binding phage (section
3.1.5). Another option to prevent enrichment of undesirable clones would be-to
switch cell lines during the panning procedure or to use purified proteins in between
selections on cells.
5.3 Additional problems imposed by apoptotic cells
All cell-binding monoclonal phage antibodies that were identified from screening of
the selections carried out on apoptotic K562/ICAM-3 cells showed a much lower
signal on apoptosis-induced populations than viable on populations (section 3.1.4).
This suggests that the antigens selected for were present at lower levels on cells as a
result of programmed cell death. Indeed, a number of macromolecules (including
ICAM-3)(Moffatt 1999) are known to be lost from the surface during apoptoSis
(Brown, Kluck et al. 1996; Hart, Ross et al. 2000). Additionally, even in cell
cultures provided with a uniform dose of apoptotic stimuli, heterogeneity with
respect to the stage of apoptosis is often observed amongst a population, such that
cells with a compromised plasma membrane could have been amongst the selection
mixture, or have arisen during the washing procedure. The release of degradative
enzymes from such "leaky cells" could cleave antibody fragments from phage
particles or could have modified the target (ICAM-3) making further propagation
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impossible. The addition of protease inhibitors to apoptosis-induced cultures could
potentially limit such harmful effects. Loss of "apoptotic-target" specific phage
could also have occurred through loss of cellular material (presumably with phage
bound to them) in the wash supernatants, as for the selections on apoptotic K562
cells during these selections. A substantial decrease in cell-pellet size during the
washing process was observed, a phenomenon that was not seen during viable cell
selections (section 3.1.3). Furthermore, as permeabilised cells display a generalised
increased "background" binding of antibodies (phage or otherwise), this could have
led to the propagation of unwanted clones. A more detailed assessment of cell
viability following selection would be worthwhile in the future.
With these drawbacks in mind, attempts were made to select for apoptotic-cell
markers using purified preparations of antigens. However, this approach also proved
to have significant shortcomings.
5.3.1 Problems associated with the use of purified antigens for
selection.
5.3.1.1 Quality of antigen
It is well known that the quality and quantity of the target antigen are important
parameters when selecting from highly complex antibody libraries (Breitling and
Deubel 1999). Thus, the quality of the selecting antigen determines the properties of
the selected antibodies. Section 4.1.3.2 showed the difficulties encountered
obtaining a uniform preparation of ICAM-3. Such "purified preparations" were
shown to contain large amounts of protein in addition to the target antigen, despite
measures such as growth under serum-free conditions (section 4.1.3.2.2), indicating a
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possible preferential enrichment of phage that bind to contaminating components of
the ICAM-3 preparations. Possible ways to overcome this would be to include an
isotype fusion protein in the selection mixture or to use more extensive purification
procedures (e.g. liquid chromatography) during the preparation of the antigen.
However purification procedures could very well, and may indeed have had effect on
the antigens binding properties by altering their conformation.
5.3.1.2 Epitope dominance and immunogenicity of ICAM-3
Due to the requirement for multiple rounds of selection to enrich and isolate specific
antibody fragments, phage display selections will generate clones with specificity for
a dominant epitope either on the target molecule itself or within the antigen mixture.
Repeatedly choosing clones with the highest binding affinity or which have a growth
advantage in this way can lead to loss of diversity amongst potential binders. This
may explain the apparent impediment for selection of phage against ICAM-3, that is,
if the available ICAM-3-specific antibodies within the library are of relatively low
affinity or if (as was realised in section 4.1.3.2) ICAM-3 represents a minor
component of purified preparations/cell-surface.
It is also possible that ICAM-3 offers only "weak epitopes" for in vitro selections.
Experts in the phage display field have published evidence that the type of epitopes
on a target antigen can have profound effects on the success of isolating phage
antibodies. For example, using the same methodology and starting with the same
library, Hoogenboom et al. were able to select an exceptionally high frequency of
antigen-specific phage antibodies to CD36. However, none were obtained to a
A
somatostatin receptor (sst), even though both targets were overexpressed to the same
level on the same cell type. Even following attempts to extensively pre-adsorb the
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library with sst-negative cells or specific elution with somatostatin, no success was
achieved (Hoogenboom, Lutgerink et al. 1999). The authors of this work concluded
that glycosylation of the cell-surface-exposed portion of sst prevented enrichment of
specific phage. Comparable difficulties were encountered in trying to isolate phage
antibodies specific for the glycoprotein, Mucin-1 (Muc-1). Following numerous
selection approaches and the screening of thousands of clones by ELISA, only one
binder was identified which upon subsequent analysis failed to bind cells expressing
Muc-1 (personal communication, Mark de Souza, Dyax Corp). In a similar way to
Muc-1, ICAM-3 is the most heavily glycosylated member of its protein family.
Therefore, quite feasibly, the glycosylation on domains 1 and 2 of ICAM-3 could
K
prevent phage from accessing the peptide stalk of the molecule. Whilst appreciating
that the phage library used in these studies is not peptide specific, masking of
peptides would mean the only available ICAM-3-specific sites would have been the
carbohydrate chains. Although phage display has been used to isolate carbohydrate-
binding antibodies (Mao, Gao et al. 1999), glycoconjugates are conformationally
very dynamic, a property which reduces the effective concentration of target antigen
at any one time and yields only low-affinity antibodies which could easily have be
overlooked during primary screening. Therefore, any selection procedure using
glycosylated domains 1 and 2 of ICAM-3 could be problematic for this reason. To
test the hypothesis that ICAM-3 provides only "weak epitopes" for use in phage-
display one could compare selections carried out in parallel on deglycosylated
ICAM-3 and the fully glycosylated protein.
Numerous other approaches aimed at maximising the targeting of selections towards
ICAM-3 were considered, but due to time restraints, not attempted during this work.
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For example, an immune phage antibody library focused on ICAM-3 could be
constructed (produced from an IgG library from animals immunised with ICAM-3).
An interesting approach, named "ProxiMol®technologies", developed by
"Cambridge Antibody Technology group", allows focusing of selections to minor
components of an antigenic mixture (http://www.biotechsforum.com/cat.htm). The
strategy taken is to biotinylate only the phage bound to the target by peroxidase
catalysis of the biotinylation reaction with a pre-existing HRP-conjugated antibody
that binds to a nearby site on the antigen. Streptavidin can then be used to separate
target-specific phage from phage bound to other antigens. This technique would be
A
feasible for domain 1 ICAM-3 (the site recognised by antibodies which lock
apoptotic cell recognition), as a number of epitope mapped antibodies to this
molecule exist (Moffatt 1999).
5.4 Many clones which screened positive by ELISA failed to
bind cells
For selections carried out on His-tagged ICAM-3 (section 4.1.3.2), none of the phage
clones that screened positive by ELISA demonstrated cell binding. For these
selections magnetic separation was used to isolate phage that bind to the immobilised
antigen during the wash steps. This avoided the strong shear-forces either associated
A
with other washing techniques or what would be experienced during flow cytometry.
This may have selected phage clones which, although able to express antigen-
specific fragments, may have off-rates that are higher than the threshold set by the
cell-screening but lower than set by the ELISA. One way to increase the overall
avidity of weak affinity phage preparations is by increasing the number of antibody
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fragments presented on phage particles by using a helper phage named "hyperphage"
A
(Rondot, Koch et al. 2001). Hyperphage have been shown to increase the antigen-
binding activity of phage preparations by ~400 fold.
In addition to selections carried out on His-tagged ICAM-3, numerous ELISA-
positive-PS-specific phages from selections on the purified phospholipids also failed
to bind apoptotic cells (section 4.2.2.2.2). Strong shear forces were used for
washing antigen-bound immunotubes following these selections, arguing against
selection of very low-affinity clones. Therefore, it is conceivable that
immobilisation of the target antigens to a hydrophobic surface may have exposed
hydiophilic aieas to the phage, or may even have denatuied the targets such that they
no longer resembled the cell-associated counterparts. To prevent this phenomenon,
selections could be carried out with tagged antigens in solution followed by capture
of the antigen-phage complex prior to washing (Goletz, Christensen et al. 2002).
5.5 Lack of reproducibility in cell-binding following regrowth
of phage clones
Many of the apoptotic cell-positive phage obtained following selections carried out
on phosphatidylserine and proteoliposomes, (sections 4.2.2.2.2 and 4.3.2.3
respectively) failed to bind cells following regrowth on a larger scale. Considering
that the original batches of these clones were observed to bind cells when staining
was carried out on different occasions it is unlikely that these were false positives.
Although it is possible that the true positives were outgrown by antigen-negative
phage contaminating the "monoclonal" cultures, it could also be that subtle
mutations to the genes encoding antibody fragments occurred. Bacteriophage
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genomes exhibit a high degree of dynamic instability (Palevitz 2003). It is also
possible that selection of phage specific for molecular patterns on apoptotic cells
could have provided a driving force for selection of low affinity phage or
spontaneously arising mutants during re-growth. The rationale for this is discussed
A
in depth in the following section.
5.6 Depletion of high affinity apoptotic-cell-associated-
pattern-specific antibodies from the phage library by
pa thogen-associa ted-molecular patterns.
Many of the receptors used by phagocytes to interact with apoptotic cells are known
to recognise microbial components (see introduction section 1.2.6) eluding to the
likelihood that the molecular patterns associated with apoptotic cells (ACAMPs)
resemble those found on microbes (PAMPs). One might even propose that the
glycoconjugates of ICAM-3, or more specifically "apoptotic ICAM-3", bear
resemblance to microbial moieties. The fact that the pattern-recognition-receptor
(PRR), dendritic-cell-specific ICAM-3-grabbing non-integrin (DC-SIGN) a receptor
for ICAM-3, also binds many pathogen-associated structures (Maeda, Nigou et al.
2003) would support this. Given that bacteriophage libraries are propagated in
bacterial cultures, clones displaying antibody fragments with high affinity for
epitopes resembling PAMPs or ACAMPs could provide a growth impediment to
bacterial hosts or even be absorbed out of solution. If this were the case, clones
specific for bacterial components that resemble ACAMPs may have been under-
represented in the initial phage library, or subtle mutations to regions of a phage
genome encoding antigen-binding sites that result in a lower affinity for bacterial
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host components and a consequent growth advantage to the phage would dominate.
Mutations of this kind resulting in subtle differences to the antigen binding properties
of the antibodies may explain why some clones lost cell-reactivity but retained
binding of immobilised antigen. Consistent with the hypothesis that ACAMPs
resemble PAMPs in three-dimensional space, the very antibody used for detecting
bacteriophage throughout this work was shown to bind a proportion of apoptotic
eukaryotic cells in preference to viable cells (figure 5-1).
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Figure 5-1. Preferential binding of anti-Mi 3 bacteriophage antibody to
apoptotic cells as assessed by flow cytometry. Mutu I cells were induced
to undergo apoptosis by treatment with ionomycin for 16 hours. The
ability of an antibody to the major coat protein of Ml 3 bacteriophage
(blue histograms) to bind cells was compared to binding of isotype-
matched antibody (red histograms) by flow cytometry. Cells at a density
of 2.5x106/ml were incubated with antibodies at a concentration of
25ng/ml. After washing, bound antibody was detected with FITC labeled
goat anti-mouse secondary antibody. Within the population cells were
defined as either apoptotic or viable on the basis of light scatter
properties (see methods section 2.3.3.3)
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5.7 Conclusion to phage-displayed antibody studies
a
From the position reached in this work, there remains potential for using phage
antibody approaches to isolate antibody fragments with specificity for apoptotic-cell-
associated targets. Several possible areas for improving on the limited success seen
in these studies include;
• Sub-cloning of the DNA encoding the antibody-binding site from phage into
a non-bacterial expression system immediately subsequent to identification of
apoptotic-cell reactivity and prior to loss of cell-binding capacity.
• Improved purification of target antigens (for example by chromatographical
methods) to reduce levels of unwanted epitopes in selections.
A
• In vitro affinity maturation of low-affinity target-binding clones.
• Creating a library of patient-derived repertoires from individuals with
autoimmune diseases linked to the presence of persistent apoptotic-cells (or
from a similar mouse model) to increase the frequency of target-specific
clones in a phage library.
However, in light of the apparent impediment for isolating desired antibodies from
phage propagated in bacterial species the decision was made to investigate further
whether apoptotic-cell-associated molecular patterns indeed resemble pathogen-
associated-molecular patterns.
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6 Results Chapter 3: Probing Apoptotic Cells for
Ligands of Pattern Recognition Receptors using
anti-Microbial Antibodies.
6.1 Introduction
Results chapters l and 2 document attempts made to isolate phage antibodies specific
for apoptotic cells. With the knowledge that many pattern recognition receptors of
the innate immune system recognise both apoptotic cell and microbial structures
A
(ACAMPs and PAMPs), it was hypothesised that the limited success seen with the
phage approach may in part have been due to the fact that a bacterial system was
used to propagate phage antibody library. That is, high affinity antibodies to
ACAMPs may have been "negatively selected" from the library by virtue of their
similarity to PAMPs. Thus, the work presented in this chapter aimed to test the
hypothesis that antibodies which react with PAMPs can cross-react with ACAMPs.
This was tested by screening a panel of mAbs raised against microbial-associated
CD 14 ligands for reactivity towards apoptotic cells with the intention of
characterising the epitopes bound by any antibodies filling this criterion and testing





6.2.1 Some antibodies previously characterised as having
specificity towards lipopolysaccharide also bind to
apoptotic cells.
Initial results obtained from screening a panel of antibodies raised against pathogen-
associated epitopes for their ability to bind apoptotic Mutu I cells are summarised in
table 6-1. Apoptotic cells were stained by 3 of 13 mAbs tested. Figure 6-1 displays
example flow cytometric histograms of such staining. Reactivity with mAb WN1
222-5 was the most marked. This antibody has been characterised as having broad
cross-reactivity towards numerous forms of rough and smooth LPS (Di Padoya,
Brade et al. 1993). Recent studies demonstrated that mAb WN1 222-5 binds to the
inner core region of LPS at a position most distal to Lipid A and have defined the
structural element required for its recognition (Muller-Loennies, Brade et al. 2003).
6.2.1.1 Staining of apoptotic cells with anti-LPS mAbs is not cell-
surface restricted.
Confocal microscopic analysis was used to examine the distribution of
immunofluorescence staining with the apoptotic-cell-reactive a-LPS mAbs. This
revealed staining throughout the cytoplasm of apoptotic Mutu I cells suggesting
recognition of intracellular epitope(s) made accessible following the loss "of
membrane integrity as a result of apoptosis. All three apoptotic-cell-positive mAbs
exhibited a similar staining pattern of the cytoplasm. Figure 6-2 shows staining with
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Ab Name Pathoqen Specificity species AC reactive Supplier
wnl 222-5 LPS mouse + EU
R1 R1 LPS mouse - EU
R2 R2 LPS mouse - EU
R3 R3 LPS mouse weak + EU
F6 446-24 LPS mouse - EU
F6 504-11 LPS mouse + EU
F6 514-12 LPS mouse - EU
FK4 224.10 10 LPS mouse - EU
FK4 224-14 LPS mouse - EU
FK4 224-1 7 LPS mouse - EU
FK4 224-24 LPS mouse - EU
UT LPS mouse - EU
AD 1 Chlamydial LPS mouse - BU
MOMP no 1 Chlamydial MOMP goat - EU
MOMP no 2 Chlamydial MOMP mouse - BU
Ad x coat protein Ad5 mouse - EU
Ad 45 coat protein Ad5 mouse - EU
Table 6-1. Panel of antibodies with specificity for pathogen associated
epitopes included in a preliminary screen for the ability to bind to
apoptotic cells. Antibodies with a known specificity for pathogens were
tested for the ability to bind apoptotic Mutu I cells by
immunofluorescence and flow cytometry. Antibodies were incubated
with apoptotic cells at concentrations previously established for labeling
of their pathogen-associated epitope. Of 1 3 antibodies to LPS tested, 3
(indicated by + as AC reactive) produced a significant signal. Neither of
the 2 antibodies to viral coat proteins or 2 antibodies to bacterial major
outer membrane protein (MOMP) produced a signal. EU; Edinburgh
University, BU; Birmingham University, LPS; lipopolysaccharide.
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monoclonal antibody WN1 222-5 as an example. In contrast, no staining was seen
with control mAbs (Fig 6-2 panels D, E).
Having established that some antibodies to LPS display binding to apoptotic cells,
the decision was made to locate a source of a-LPS mAbs with similar AC cross-
reactivity in order for these studies to be extended further as those obtained from
Edinburgh University were in limited supply. Antibodies were selected on the basis
A
of their previously characterised ability to cross-react with the broadest range of LPS
species. Such antibodies are often obtained by immunisation with rough mutants of
bacteria which expose conserved inner-core LPS determinants. Indeed antibodies
raised against the rough mutant, Escherichia coli OHLB4 (strain J5) and affinity
purified against LPS derived from Salmonella were shown to react with a series of
unrelated Gram-negative bacteria (Tyler, Spears et al. 1991). The same E. coli
strain, in addition to other species lacking the hypervariable O-antigen of LPS such
as Chlamydia trachomatis, were used by the antibody manufacturers at QED
Biosciences Inc for an immunisation. The resultant commercially available panel of
mAbs are marketed as having broad cross-reactivity to LPS. *
Table 6-2 lists the antibodies chosen from those supplied by QED Biosciences Inc
along with their reported LPS reactivities. Specificity of these antibodies to LPS was
later confirmed by ELISA (see appendix A6-1). Staining of apoptotic Mutu I cells
with the three chosen antibodies by concentration-dependent titration was assessed
by flow cytometry (Figure 6-3) All three antibodies preferentially stained apoptotic
cells compared to control Abs and no staining was observed for viable cells (top
three panels, green histograms). The strongest signal was seen with mAb 15308,
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Figure 6-1. Some antibodies previously characterised as having a
specificity for lipopolysaccharide also bind to apoptotic cells. Antibodies
with a known specificity for LPS were tested for their ability to bind
apoptotic Mutu I cells by flow cytometry. Mutu I cells were treated with
ionomycin for 16h before incubation with primary antibodies. Bound
antibody was detected with FITC labeled goat anti-mouse secondary
antibody (GAM-FITC) and cell-associated fluorescence was quantified by
flow Cytometry.
Upper panel; viable and apoptotic cells were discriminated on the basis of
light scattering properties as described in Materials and Methods (section
2.3.3.3). Lower panel; a-LPS antibodies WN1 222-5 and F6.11 (blue
histograms) showed a clear signal on apoptotic cells where as other a-LPS
antibodies such as F6.12 (red histograms) exhibited no staining compared
to secondary antibody alone (black histogram). Green histograms
represent staining with Bu65 (a-ICAM-3).
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Figure 6-2. Binding of anti-LPS mAbs to apoptotic Mutu I cells is not
restricted to the plasma membrane as determined by confocal
microscopy. Mutu I cells were treated with ionomycin for 16h before
incubation with primary antibodies. Binding of the a-LPS antibody, WN1
222-5 (B,C) or isotype-matched control, y2a (D,E) was detected with
goat anti-mouse secondary antibody labeled with alexaFluor-488 (green).
Cell-associated fluorescence was visualised using a laser-scanning
microscope. The images represent individual cross-sections taken from
three-dimensional serial sections of cells. Staining was observed
throughout the cytoplasm but was not apparent in nuclear regions (seen
most clearly with the cell to the lower right of panels B and C (arrow)). A
& D; bright field images, B and E; fluorescence, C; merge.
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15174 Chlamydia trachomatis mouse lgG2a
Table 6-2. Reported reactivities of commercially available cross-
reactive anti-LPS mAbs used in these studies. Antibodies were assessed
for binding to purified preparations of LPS in an ELISA.
LPS of Chlamydia trachomatis lacks the O-polysaccharide region most
distal to Lipid A. Thus, although being marketed as anti-Chlamydia
antibody (the most oooular from several suoolied bv OED Biosciences).
mAb 15174 was chosen for its potential reactivity towards conserved







293T Primary human embryonal kidney cells adherent GI¬LL<
MCF-7
Adenocarcinoma of human mammary
qland epithelial cells
adherent Al
HeLa Human cervical carcinoma adherent FP
A549 Lunq carcinomatous tissue adherent Al , FP
BJAB Epstein-Barr virus-negative Burkitt's
lymphoma suspension
Al
Mutu I Epstein-Barr virus-positive Burkitt's
lymphoma B-cell (clone 179) suspension
Al , FP
K-562 Multipotential, malignant hematopoietic
cells suspension
Al , FP
NsO Mouse myeloma suspension Al
Al .1 Mouse thymoma suspension Al
PMN Blood of a healthy human donor primary Al
COS-1 Kidney cells of a monkey adherent Al , FP
Table 6-3. Cell types with which mAb 15308 has tested positive for binding.
All cells either induced into apoptosis (Al) or fixed and permeabilised (FP) have
shown to bind mAb 1 5308 as assessed by flow cytometry and/or microscopy.
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Figure 6-3. Sensitivity of anti-LPS Antibodies for Binding to Epitopes on
Apoptotic Cells. Mutu I cells were induced to undergo apoptosis by
treatment with ionomycin for 1 6h. The ability of anti-LPS Abs to bind
cells was analysed by flow cytometry. Cells at a density of 2.5x106/ml
were incubated with antibodies at the concentrations indicated to the top
right of each histogram (^ig/ml). After washing, bound antibody was
detected with FITC labeled goat anti-mouse secondary antibody. Negative
control staining with isotype-matched antibodies (y2a for 15174 and
15306, y3 for 15308) was performed at the same concentrations (Red
histograms).
Within the population cells were defined as either apoptotic (~80%) (blue
histograms) or viable (green histograms) on the basis of light scatter
properties (see methods section 2.3.3.3).
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62.1.1.1 The epitope(s) defined by mAb 15308 can be detected in
permeabilised viable cells
Epitopes to which apoptotic cell-cross-reactive anti-LPS mAbs bind may be
generated as a result of apoptosis or may be present, but inaccessible within viable
cells due to an intact plasma membrane. Tests were therefore carried out that
included a membrane permeabilisation step. Strong, uniform binding was observed
A
when permeabilisation was performed before the addition of mAb 15308 (Figure 6-
4). Binding was lost with mAbs 15306 and 15174 on apoptotic and viable cells
following permeabilisation, indicating that the epitope(s) recognised are either
removed or sensitive to the fixation or permeabilisation reagents used for the studies
(see also section 6.2.1.3). The staining of both the apoptotic and permeabilised
viable cells by mAb 15308 was further examined by confocal microscopy. Figure 6-
5 shows that this antibody stains cytoplasmic regions of permeabilised viable Mutu
cells and apoptotic cells. In view of the fact that mAb 15308 displayed the strongest
signal when used to stain cells (figure 6-3) and that its epitope is resistant to the
fixation and permeabilisation regents used for the study mentioned above, focus was
A
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Figure 6-4. Equivalent levels of the epitope recognised by mAb 15308
can be found in both permeabilised apoptotic and viable lymphoma cells.
Mutu I were treated with ionomycin for 16 hours (induced) or left
untreated (Viable). Cells were then either fixed and permeabilised (using
Intrastain™, DAKO) or left intact. The ability of antibody 15308 to bind
cells was analysed by flow cytometry. Staining with an isotype-matched
mouse monoclonal antibody (y3) was performed as a negative control.
Within the population cells were defined as either viable or apoptotic on
the basis of light scatter properties (dot-plot shown for apoptosis induced
population, prior to permeabilisation).
A decrease in fluorescence was observed for both 15308 and isotype-














Figure 6-5. MAb15308 antibody binds an intracellular-epitope found
within both viable and apoptotic cells, as determined by confocal
microscopy.
Mutu I cells were treated with ionomycin for 16 hours to induce
apoptosis (A-G). Binding of the anti-LPS antibody, 15308 was detected
with goat anti-mouse secondary antibody labeled with alexaFluor-488
(green, B and D).
Ceils were counterstained with the cell-impermeant dye, TO-PRO-3, for
visualisation of nucleic acid and as a measure the integrity of the
membrane (blue, B, C, F and PI).
Unfixed, non-permeablised viable cells were not stained at all (lower cell,
A); the isotype-matched control antibody (y3) exhibited no staining (F
and G).
When fixed and permeabilised (Intrastain ™, DAKO), Mutu I cells also
exhibit cytoplasmic staining with mAb 1 5308 (PI). Viable cells display a
large rounded nucleus (open arrow head) where nuclei of apoptotic cells
are condensed (closed arrow head).
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6.2.1.1.2 The epitope(s) defined by mAb 15308 can be found within
numerous cell types.
It was of interest to know whether the molecule(s) bearing epitopes recognised by
mAb 15308 can be found in cells originating from other species and tissues, as a
wide pattern of expression would be an expected feature of true apoptotic cell-
associated ligands for CD 14 or other pattern recognition receptors (Devitt, Pierce et
al. 2003). Figure 6-6 shows examples of flow cytometry histograms assessing
staining performed on primary cells (PMNs) and mouse thymoma cells (A 1.1)
k
demonstrating reactivity to cell types other than the human tumour cell line Mutu I.
Indeed expression has been detected for all cell types and lineages examined (listed
in table 6-3).
6.2.1.2 Localisation of epitopes defined by anti-LPS mAbs within
viable adherent cells.
6.2.1.2.1 The epitope defined by mAb 15308 co-localises with microtubules
To gain further insight into the nature of the molecule(s) holding the epitope(s)
recognised by mAb 15308 subcellular localisation was investigated further.
Attempts to look for colocalisation with markers of known cytoplasmic organelles
and cytoskeletal markers in apoptotic Mutu I cells were inconclusive due to the
breakdown of cellular structures during cell death (data not shown). Given that this
antibody was also seen to bind permeabilised Mutu I cells, (c.f. figure 6-4) the
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Figure 6-6. The epitope recognised by anti-LPS antibody 15308 can be
found associated with apoptotic cells originating from different species
and tissue lineage.
Expression of the epitope recognised by mAb 1 5308 was analysed by flow
cytometry for populations of both primary human cells (PMN) and a mouse
thymoma (A1.1) cell line. Cells were allowed to undergo spontaneous
apoptosis (see methods section 2.3.3). Staining with an isotype control
mouse monoclonal antibody was performed at the same concentrations as
a negative control (red histograms). Bound antibody was detected with
FITC labeled goat anti-mouse secondary antibody.
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are more abundant in cytoplasm. Figure 6-7 shows the adherent cell line A549
prepared and stained in this way.
The "filamentous" appearance of the epitopes recognised by mAb 15308 prompted
investigation of colocalisation with components of the cytoskeleton. To this end,
A549 cells were double-stained using anti-cytokeratin-20, anti-|3-tubulin antibodies
and phalloidin in addition to mAb 15308. Figure 6-7 demonstrates mAb 15308
staining appeared to colocalise with microtubules but displayed a distinct pattern of
staining to cytokeratin-20 and did not colocalise with actin stress fibres. The same
pattern of distribution was observed in all adherent cell lines (Figure 6-8).
6.2.1.3 Different mAbs to LPS display distinct patterns of staining
within viable adherent cells.
Contrary to the observed loss of binding to Mutu I cells by mAbs 15306 and 15174
following use of the permeabilisation and fixation reagents used for this suspension
cell line, staining with mAb 15174 was observed when using the most optimal
permeabilisation and fixation reagents and protocol for adherent cells. A diffuse
staining of cytoplasmic regions was observed with mAb 15174 (figure 6-9 panel A)
compared to the filamentous localisation seen with mAb 15308 (figure 6-9 panel B)
suggesting that these two a-LPS antibodies recognise different epitopes within
eukaryotic cells.
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Figure 6-7. The binding of anti-LPS antibody, 15308 localises specifically
with microtubules in adherent cell lines.
The human lung-epithelial cell line, A549 was grown on coverslips, fixed
with 3% paraformaldehyde and permeabilised with 0.2% Triton X-100 in
preparation for intracellular immunofluorescence. A-D; Cells were double-
labeled with 15308 antibody and tubulin antibody. Microtubule distribution
was detected by anti-p-tubulin antibody followed by alexaFluor-568 labeled
secondary antibody (red, A). The distribution of 15308 antibody was
visualised by secondary staining with AlexaFluor-488 labeled secondary
antibody (green, B). The microtublue and 15308 images were
superimposed for assessment of colocalisation (C and close up D).
On separate occasions, cells were either double-labeled with mAb15308
antibody (green) and phalloidin conjugated to AlexaFluor-568 (red) to show
a distinct localisation from actin filaments (E) or single/double labeled with
phalloidin conjugated to AlexaFluor-568 (red) and/or anti-cytokeratin-20




Figure 6-8. A filamentous pattern of staining with mAb 15308 is seen in
numerous adherent cell lines.
The monkey kidney cell line (COS-1) and human breast adenocarcinoma cell
line (MCF-7) were grown on coverslips fixed with 3% paraformaldehyde and
permeabilised with 0.2% Triton X-100 in preparation for intracellular
immunofluorescence. The distribution of 15308 antibody was visualised by











Figure 6-9. Anti-LPS mAbs 15308 and 15174 display a distinct
distribution of cytoplasmic staining in adherent cell lines.
293T were grown on coverslips fixed with 3% paraformaldehyde and
permeabilised with 0.2% Triton X-100 in preparation for intracellular
immunofluorescence. Cells were stained with mAb 15174 (A) and mAb
1 5308 (B) and the distribution of bound antibody visualised by secondary
staining with AlexaFluor-488 (green) conjugated secondary antibody.
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6.2.2 Investigating the involvement of intracellular epitopes in the
recognition of apoptotic cells by macrophages
It has been shown that for assays performed in vitro, features in addition to those
responsible for the morphology of apoptosis (e.g. PS exposure and nuclear
K
condensation) are required for the effective clearance of cell corpses (Devitt, Pierce
et al. 2003). Furthermore, these studies suggested that apoptotic cells are most
efficiently recognised at stages during programmed cell death that coincide with loss
of membrane integrity.
As can be seen in figure 6-10, assessment of membrane integrity (by the exclusion of
DAPI) revealed that only the feed cells with compromised membranes demonstrably
bound to the surface of macrophages during a standard interaction assay.
Considering that the epitopes recognised by anti-LPS mAbs (and hence potential
apoptotic-cell-associated ligands of 'pattern-recognition-receptors' such as CD 14)
appear to be intracellular-derived epitopes, the possibility that internal structures can
be recognised and accessed by macrophages was explored.
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Figure 6-10. Analysis of apoptotic-feed cell membrane integrity
following a macrophage interaction assay as determined by
microscopy.
Mutu I cells were treated with ionomycin for 16 hours to undergo
apoptosis then subjected to an interaction assay as described in section
2.10. Subsequent to co-incubation, cells were washed and membrane
integrity assessed by adding the membrane impermeant dye, DAPI
(blue) for 10 seconds before washing and viewing immediately by
microscopy. Only those cells with comprised membrane remained firmly
bound to THP-1 -derived macrophages following co-incubation.
Representative of three independent assays.
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6.2.2.1 The recognition of apoptotic Mutu I cells by stimulated THP-
1 macrophages correlates with the loss of membrane
integrity.
To investigate whether ostensibly internal epitopes of apoptotic cells can serve as
ligands for binding or phagocytosis, experiments were performed using Mutu I cells
at a fixed period following UV-B irradiation that had been subjected to varying
amounts of mechanical stress (by pipetting) to provoke accessibility of internal
antigens through loss of membrane integrity. These were used in a phagocyte
interaction assay with stimulated THP-1 cells representing macrophages.
(Figure 6-11 panel A). A level of pipetting sufficient to cause a loss in membrane
integrity increased interaction. A good correlation between interaction of apoptotic
cells and leakiness (as assessed by the uptake of PI) was seen when using feed cells
at a fixed time following induction into apoptosis on several different occasions (n =
10, P value 0.0014 figure 6-11 panel B). At this point it is worth noting that
permeability of cell membranes to PI may not reflect permeability to larger
A
macromolecules. Nevertheless, increased interaction was not due to the stimulation
of macrophages by a soluble factor released from the mechanically stressed cells as
the incubation of non-stressed apoptotic cells and macrophages with the supernatant
obtained from stressed cells did not lead to a level of interaction seen with stressed




















Figure 6-11. Recognition of apoptotic Mutu I cells by THP-1
macrophages correlates positively with loss of membrane integrity.
Mutu I cells were exposed tol 00mJ/cm2 UV-B and left to incubate for
16 hours before use in a standard interaction assay as described
section 2.10.
(A) Aliquots of resuspended cells were subjected to mechanical stress
by pipetting 5 or 10 times (5 pip or 10 pip) or left untreated (0 pip).
(B) Interaction of apoptotic Mutu cells with stimulated THP-1 as a
function of membrane permeability as assessed by uptake of propidium
iodide (PI) ,each point represents the mean of duplicate wells.
(C) On this occasion the supernatant from cells pipetted 15 times (15
pip) was used for incubating a sample of untreated apoptotic cells
during the course of the assay (0 pip 15 res). Each data point
represents the mean of duplicate wells. Error bars are ± S.D. the mean
values. Figures A and C are representative of 3 independent assays.
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6.2.2.2 The forces required to prepare apoptotic cells for
macrophage interaction assays can result in an increased rate
of membrane deterioration compared to resting apoptotic
A
cells.
Contrary to the findings of Devitt, Pierce et al. 2003, the results of some in vitro
studies have led to the proposal that even cell populations containing very early
apoptotic cells are phagocytosed by macrophages (Kurosaka, Takahashi et al. 2003).
However such studies often allow long incubation periods for interaction (e.g. 4
hours) and a large excess of feed cells (which may contain a small fraction of cells at
relatively late stages of death). To investigate whether these observations can be
explained in other terms the rate of membrane decomposition was monitored
following treatments akin to those used for preparing cell cultures for interaction
assays. Figure 6-12 displays the percentage of leaky cells within apoptosis-induc'ed
cultures over a period of 4 hours that had either been left undisturbed, gently
centrifuged (to simulate preparation for an interaction assay), or gently centrifuged
and subjected to varying degrees of mechanical stress. A more rapid rate of
membrane weakening was seen even after gentle centrifugation compared to resting
apoptotic cells whereas populations subjected to vigorous pipetting in addition to
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Figure 6-12. Analysis of apoptotic Mutu I cell viability in populations
subjected to different mechanical treatments.
Mutu I cells were exposed to 100mJ/cm2 UV-B and left to incubate for
16 hours before either gentle centrifugation (225g, 4 min),
centrifugation plus pipetting 5 or 1 5 times (5 pip or 1 5 pip), or leaving
untreated (incubator) and assessing viability by measurement of uptake
of propidium iodide (PI) at hourly intervals following incubation at 37°C.
On average the fluorescence of 5,000 cells was assessed by flow
cytometry for each data point. Representative of 3 similar assays.
198
6.2.3 Involvement of epitopes recognised by anti-LPS mAbs in
the recognition of apoptotic Mutu I cells by HMDM
Given that macrophage interaction appears to correlate with leakiness (or other
temporally associated events) of the feed cells, and that membrane decay may occur
during the course of an assay involving apoptotic cells, the possibility that
recognition of apoptotic Mutu I cells by macrophages can occur through the epitopes
recognised by a-LPS Abs was tested in a system that shows some CD 14-
dependence. Recognition was not seen to be inhibited by the presence of a-LPS Abs
during the assay compared to control IgGs (Figure 6-13) despite the marked
inhibitory activity of the CD 14 antibody, 61D3. The same was true for assays
performed using stimulated THP-1 cells (data not shown). However, given the
possibility that CD 14 (and other pattern-recognition receptors) can recognise many
different patterns within or on an apoptotic cell, blocking a minority low-affinity
ligands may be compensated by the large polyvalency of other ligands within the
confined space of a phagocytic synapse. Also, it could be that the epitopes of
molecules recognised by the antibodies are not the same molecular regions bound by
CD 14. Nevertheless, the appearance of the epitope(s) recognised by mAb 15308 and
























Figure 6-13. mAb blocking studies fail to provide evidence for
involvement of "LPS-like" epitopes in the interaction of apoptotic Mutu
cells with HMDM's. Mutu I cells were induced into apoptosis by
treatment with ionomycin for 1 6 hours. After ionomycin treatment, Mutu
cells were incubated with or without 50 /jg/ml of a-LPS mouse
monoclonal antibody (15306, 15174, 15308) or control antibodies
(mouse lgG2a or lgG3) in assay medium (RPMI 1 640-HEPES containing
0.2% BSA) at 0 °C for 30 min, washed, and subjected to the binding
assay. All the data are the means ± S.E.M. of triplicate experiments using
macrophages derived from different donors.
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6.2.4 MAb 15308 binds to a Western blot of Mutu I cell lysates
separated by SDS-PAGE
Having found that anti-LPS antibodies can associate with apoptotic cells, it was of
interest to investigate the structural basis of this interaction in terms of the molecular
species that form these "LPS-like epitopes". Whilst many methodologies could be
applied in an attempt to gain such insights (see general discussion section 8), the
initial approach taken towards identification of the species recognised by these
antibodies was to assess preferential binding of a-LPS Abs towards Mutu I cell
lysates separated by SDS-PAGE by Western blot analysis (Figure 6-14). Notably,
one band with an approximate molecular mass of ~40 kDa present in the lysates of
cells was detected by mAb 15308. No band with this mobility was seen for the other
anti-LPS mAbs or control antibodies.
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Figure 6-14. Screening of Mutu I cell lysates with anti-LPS
antibodies.
A lysate of Mutu I cells was prepared and separated by
electrophoresis through a 10% polyacrylamide SDS gel before
transferring to PVDF membrane. The resultant membrane was cut
into strips and probed with the antibodies indicated above the blot.




The antibody staining studies described in this chapter suggest that: -
• Viable eukaryotic cells hold intracellular epitopes that are also associated
with microbial organisms.
• These epitopes can become exposed during apoptosis.
In addition, through assessing the ability of apoptosis-induced cells, destined for
use in macrophage interaction assays, to take up vital dyes, it was possible to
demonstrate that: -
A
• Following a standard macrophage interaction assay the only apoptotic Mutu I
feed cells that remain firmly bound to macrophages are those with a
compromised membrane integrity.
• Increasing the permeability of apoptotic cells by mechanical disruption leads
to an increase in the ability of macrophages to interact with apoptotic cells.
• The preparation of cells that have been induced into apoptosis for
macrophage interaction assays by standard procedures leads to an increased
rate of membrane breakdown.
Thus, in this system, the onset of engulfment appears to correlate with the loss of
A
membrane integrity. These findings advocate the possibility that apoptotic cells
present internal epitopes to macrophages engaging in apoptotic-cell clearance.
Considering that the appearance of epitopes recognised by antibodies to LPS display
similar kinetics, there is an opportunity for these molecules to participate in
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engulfment. However, blocking of apoptotic-cell recognition by HMDM or
stimulated THP-1 by these antibodies was not observed.
Finally, anti-LPS mAb 15308 showed activity towards an ~40 kDa molecule from
Mutu I whole cell lysates by Western blot analysis. To ascertain whether this
molecule participates in apoptotic-cell recognition, focus was placed on its
identification and characterisation, the results of which are presented in the following
Results chapter.
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7 Results Chapter 4: Characterisation of the
Apoptotic-Cell-Associated Epitope Recognised by
anti-LPS Monoclonal Antibody 15308.
A
7.1 Introduction
The data presented in chapter 3 established that antibodies previously defined as
being specific for LPS can be observed to bind to late apoptotic cells. One of the
cross-reactive mAbs, 15308, bound to a ~40 kDa band from lysates of Mutu I BL
cells on a denaturing gel.
The work described in this chapter identifies the ~40kDa molecule which bears an
epitope recognised by mAb 15308 as the 37/67kDa Laminin Receptor (laminin
binding protein, (LBP/p40). Confirmation of binding to LBP/p40 exogenously
expressed in both mammalian and bacterial systems will be explored and attempts
Amade to purify recombinant LBP/p40 for functional studies with relevance to CD 14-
dependent apoptotic cell clearance by macrophages. In addition, evidence for the
appearance of the epitope defined by mAb 15308 on the surface of apoptotic cells
prior to loss of membrane integrity will be presented.
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7.2 Results
7.2.1 Identification of mAb 15308-reactive species present in Mutu
I cells
7.2.1.1 15308 binding to sub-cellular fractions
In section 6.2.4, mAb 15308 was seen to bind to a species present in lysates of Mytu
I BL cells on a denaturing gel that resolves at ~40kDa. Within cell lysates, many
molecules are likely to resolve at a similar position to this, making identification of
the target species difficult. Considering that mAb 15308 has been shown to locate to
definite regions within cells (for example microtubules - section 6.2.1.2.), attempts
were made to reduce the level of non-reactive background molecules in the cell
lysates being studied by exploring reactivity of the antibody towards various sub¬
cellular fractions, with the intention of using mAb 15308-reactive fractions for
identification of the target species by matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF-MS).
Figure 7-1 illustrates the relative reactivity of mAb 15308 associated with cellular
fractions isolated from Mutu I cells by differential centrifugation. SDS/PAGE and
western blot analysis of 15308 reactivity revealed major differences amongst the four
fractions, with the majority of the reactivity (~40kDa) found within fraction PI
(which corresponds to large organelles and protein complexes). Less was observed
in fraction P2 (which corresponds to insoluble membrane fraction). A faint
reactivity of higher molecular weight (~65kDa) was seen in the final soluble fraction.











Figure 7-1. SDS-PAGE and Western Blot analysis of Mutu I cell
lysate fractions.
A lysate of Mutu I cells was prepared and fractionated by sequential
centrifugation into a 1,000g pellet (N), 27,000g pellet (PI)
100,000g pellet (P2) and remaining supernatant (S). Pellets were
resuspended in a volume of lysis buffer equal to that remaining in
the final supernatant. Equal volumes of the fractions were
electrophoresed in the positions as indicated above the lanes
through a 10% polyacrylamide SDS gel and transferred to PVDF
membrane before blotting with antibodies indicated below the
blots.
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7.2.1.2 Protein identification by matrix-assisted laser
desorption-ionization/ time-of-flight-mass spectrometry
(MALDI-TOF-MS) analysis
Genome sequence information in combination with data produced by matrix-assisted
laser desorption/ionization time-of-flight (MALDI/TOF) mass spectrometers has
provided a convenient and powerful resource for protein identification. Database
searching allows identification of proteins using the data produced by MALDI/TOF
spectrometry.
These approaches were applied to the identification of the mAb 15308-reactive band
present in the electrophoretically-separated protein mixtures of Mutu I cells. Thus,
A
larger scale Mutu I cell lysates were prepared and fractionated (see methods section
2.2.3) and two identical gels were used to separate fraction PI of lysed cells.
Following separation, one gel was stained for total protein content and the other
Western blotted and probed with mAb 15308. Comparison of blot and gel suggested
that the mAb 15308 reactive band might be associated with any of three discrete
bands of similar size.
The three bands were excised and peptides contained within tryptic digests of them
analysed by MALDI-TOF-mass-spectrometry. The suggested identities of the three
species were: |3-Actin, Laminin binding protein (LBP/p40) and a Septin named
NEDD5 (neuronaly expressed, developmentally downregulated-5).
(3-Actin was not considered a candidate mAb 15308-reactive protein as distinct
patterns of localisation were seen when co-staining with phalloidin (see section
6.2.1.2). Moreover, Western-blot analysis of fractionated cell lysates had shown
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actin to be present in different relative proportions to the molecule bearing the 15308
epitope (figure 7-1).
At this point it is worth noting that in addition to identifying the mAb 15308-reactive
species by direct analysis of cell lysate fractions, immuno-precipitations with mAb
15308 were attempted. However in gel visualisation of SDS-PAGE-separated
protein bands obtained from the precipitation revealed the presence of only a ~25
kDa species when compared to the control immuno-precipitation with an isotype-
matched antibody. MALDI-TOF-MS analysis identified this band as 40S ribosomal
protein, S3A. This protein is of lower molecular weight than that recognised by
A
mAb 15308 so was not considered as a candidate for direct recognition by the
antibody. However, the possibility that it co-immunoprecipitates with the true mAb
15308 reactive species is discussed in section 7.2.1.3. Table 7-1 and figure 7-2 show










Figure 7-2. Matrix-assisted Laser Desorption and lonization-Time of
Flight (MALDI-TOF) Mass Spectrometry Analysis of the putative
protein recognised by mAb 15308.
Polypeptide bands of interest were excised from a 10%
polyacrylamide SDS gel and digested in trypsin. Tryptic peptides
were extracted from the gel prior to MALDI-TOF mass spectrometric
analysis. Resultant peptide masses were used to search the
SwissProt and MASCOT databases. A: the MALDI-TOF mass spectrum
for the tryptic digest of the peptide band identified as Laminin-
Binding Protein. B: summary of the output from the database query.
The matched peptides covered 58% of the total protein as indicated







Beta-actin 40.2 48 AAH08633
Laminin-binding
protein
31.8 58 X61 156.1




Table 7-1. Summary of matrix-assisted laser desorption-
ionization/time-of flight (MALDI-TOF) mass spectrometry analysis
of peptide mixtures resulting from the tryptic digestion of
candidate proteins. Predicted mass; molecular weights calculated
from primary amino-acid sequences. % Coverage; percentage of
total protein which matched peptides covered. Accession No.;
gene identity.
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7.2.1.3 Consideration of LBP/p40 as a candidate molecule bearing
an epitope recognised by mAb 15308.
The 37kDa precursor of laminin-binding protein (LBP/p40) also known as 32/67-kD
laminin receptor (LR) (Clement, Segui-Real et al. 1990) or 37/67-kD LR
(Castronovo, Claysmith et al. 1991) is an evolutionarily conserved, multifunctional
protein which can be found distributed on the cell surface associated with a6(34
integrin as laminin-binding protein in its 67kDa form (Ardini, Tagliabue et al. 1997),
on 40S ribosomes as a component of the translational machinery (Rosenthal and
Wordeman 1995; Ardini, Pesole et al. 1998), and to a lesser extent bound to histones
in the nucleus (Sato, Kinoshita et al. 1996). «
The terminology used by previous investigators of this protein often relates to the
particular biological function or sub-cellular localisation studied. Discrepancies arise
from the fact that cDNA clones of the 67 kDa laminin receptor only contain coding
potential for a 32 kDa polypeptide (Clement, Segui-Real et al. 1990), while the
translation product of the corresponding mRNA has a molecular mass of 37-40 kDa
and acts as a precursor of the 67 kDa LR (discussed in more detail section 8).
LBP/p40 has been described as an abundant cytoplasmic protein expressed in
numerous cell types and at elevated levels in malignancies including breast, colon,
prostate, lung, liver, ovary cancer, and lymphoma (Yow, Wong et al. 1988; Rescan,
K
Clement et al. 1991; al-Saleh, Delvenne et al. 1997; Fontanini, Vignati et al. 1997;
Menard, Tagliabue et al. 1998).
Through study of tumour samples the oncogenic potential of LBP/p40 has been
realised, and functional studies suggest it is involved in interactions between cancer
cells and laminin during tumour invasion and metastasis (Yow, Wong et al. 1988;
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Certain information presented in the literature regarding this protein is in keeping
with the following features of the mAb 15308 reactivity: -
(1) Recognition of an epitope present in the cytoplasm of numerous cell types
(described in results chapter 3).
(2) Distribution of reactivity towards fractionated cell lysates (fraction corresponding
to sub-cellular organelles and large protein complexes section 7.2.1.1).
(3) Immuno-precipitation of components of the translational machinery (Ribosomal
subunit S3a section 7.2.1.2).
Consideration of this evidence led to focusing on the possibility that LBP/p40
contains the epitope to which 15308 binds.
7.2.2 PCR amplification and molecular cloning of LBP/p40 cDNA
To generate a cDNA fragment of LBP/p40 from Mutu I total mRNA, a PCR was
carried out using primers based on the complete coding sequence of the gene
(accession X61 156.1 ) cited in the records obtained from the primary result of
MALDI-TOF-MS analysis (Yow, Wong et al. 1988). The same approach was also
employed for NEDD-5, in the event that this candidate from MALDI-MS analysis
held the epitope recognised by mAb 15308. As shown in figure 7-3, the reactions
yielded single cDNA fragments of approximately 890 bp for LBP/p40, 1050 bp for
NEDD5 (accession BCO 14455.1) (Strausberg, Feingold et al. 2002), and 528 bp for




































Figure 7-3. Detection of laminin-binding protein (LBP/p40) and NEDD5
in Mutu I cDNA by PCR. Primer sets pCDNA3.1 D/LBP/p40-V5-His and
pCDNA3.1 D/NEDD5-V5-His resulted in PCR product sizes, approximately
890 and 1050bp for LBP/p40 and NEDD5 respectively. Primer sets for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as a
quality control for cDNA production (528 bp). Kbp; kilo-base pair.
214
7.2.3 Expression and detection of LBP/p40 in 293T cells and
detection of by immunoblotting with mAb 15308
To determine the ability of mAb 15308 to bind exogenously expressed LBP/p40,
HEK293T cells were transfected with pCDNA3.1D/LBP/p40-V5-His (see section
2.1.4 for plasmid construction). Control cells were either mock transfected without
plasmid DNA or transfected with pCDNA3.1D/NEDD5-V5-His. Cell lysates were
run on SDS-PAGE gels and detected by subsequent Western blotting both with an
antibody to the V5 epitope (encoded by the expression vector) and with mAb 15308.
Exogenously expressed LBP/p40 was observed as two species of approximately 40
kDa and 50-70 kDa when using the a-V5 antibody for detection (figure 7-4). This is
consistent with both the faint band seen in fraction S of Mutu I lysate (figure 7-1)
and the 67kDa form of this protein. Exogenously expressed cloned NEDD-5 was
detected at ~42 kDa when using the a-V5 antibody for detection. No bands were
found with this antibody in the lysates of mock-transfected cells.
MAb 15308 was seen to react with the corresponding exogenously expressed cloned
LBP/p40 species but neither NEDD5 nor any bands in addition to the endogenous
reactivity found in lysates of mock-transfected cells. No reactivity corresponding to
A
cloned LBP/p40 was seen when probed with y3 isotype-matched antibody to 15308
or an cx-|3-actin antibody. The differences in signal intensity between detection using
a-V5 and mAb 15308 for the exogenously expressed LBP/p40 can be explained by
the high affinity of a-V5 to its epitope with detection of as little as 2pg of a 50 kDa























Figure 7-4. Binding of anti-LPS mAb 15308 to LBP/p40 exogenously
expressed in HEK293T cells as shown by immunoblotting. HEK293T
cells were transiently transfected with pCDNA3.1 D/LBP/p40-V5-His or
pCDNA3.1 D/NEDD5-V5-His encoding the V5-tagged products LBP/p40
(p40) and NEDD5 respectively, or mock transfected (M). Cell lysates
were separated by electrophoresis through a 10% polyacrylamide SDS
gel and transferred to PVDF membrane before blotting with the
antibodies indicated below the blots. A: Detection of the transiently
expressed LBP/p40 using an antibody to the V5 tag reveals two species
of approximate molecular weight 40kDa and 50-70kDa. B: Transiently
expressed LBP/p40 can be detected with mAb 15308 but not with an
isotype control antibody (y3). Probing with an antibody to actin indicates
the amount of whole cell-lysate loaded in each sample. C: Transiently
expressed NEDD5 can be detected with a-V5 mAb but not mAb 15308
(which detects only endogenous LBP/p40).
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SDS-PAGE geis (personal communication - Invitrogen Technical support). These
results confirm the presence of an epitope recognised by the a-LPS 15308 in cloned
LBP/p40 exogenously expressed in mammalian cells.
7.2.3.1 Expression of polyhistidine-tagged-LBP/p40 and purification
by nickel metal-affinity.
In order to study further the role of LBP/p40, notably in the context of apoptotic-cell
clearance and interaction of its "LPS-like" epitope (as defined by mAb 15308) with
LPS-binding PRRs, specifically CD 14, attempts were made to purify recombinant
forms of the protein for use in functional studies. Initially, recombinant poly-
histidine tagged LBP/p40 (rLBP/p40) was expressed and purified using three
systems; (1) as a secreted protein from the culture supernatants of stably transfected
K562 cells, (2) from lysates of E. coli or (3) from lysates of stably-transfected MCF-
7 cells (refer to methods sections 2.1.4 to 2.1.6 for plasmid construction).
In all cases, nickel metal-affinity resin columns were used for one-step purifications
of His-tagged rLBP/p40 constructs. The resultant protein-containing fractions were
dialysed against PBS to remove imidazole and the purity of the protein was
examined by comparing total-protein-stained SDS-polyacrylamide gels to Western
blots probed with a-V5 Ab, mAb 15308 or a commercially available antibody to
LBP/p40 (Lam-R) which became available for later experiments.
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With these tools the intention was to test;
A
The ability of LBP/p40 to bind CD14-expressing cells.
I
Recombinant LBP/p40 preparations for the ability to block CD14-dependent
apoptotic-cell interactions
The relationship of the laminin-binding site of LBP/p40 to the epitope
recognised by mAb 15308.
7.2.3.2 Expression of LBP/p40 in E. coli
DNA encoding LBP/p40 was sub-cloned from pCDNA3.1D/LBP/p40-V5-His into
pTrcHis2C (see section 2.1.6.2 for plasmid construction) for expression in E. coli.
Expression in E.coli was confirmed by probing Western blots of pTrcHis2C-
LBP/p40pm transformed and non-transformed cell culture lysates with an antibody
to the V5 tag of the recombinant protein and mAb 15308 (figure 7-5 panel A). High-
level expression of rLBP/p40 was induced with the addition of ImM IPTG to cell
cultures prior to purification from cell lysates following sonication. As was seen
with 293T cells transiently-transfected with LBP/p40 (section 7.2.3, figure 7-4), the
molecular sizes observed for the bands of the bacterially expressed rLBP/p40 species
by Western blot using a-V5 were approximately 40 kDa and 50-70 kDa for figure 7-
6 panel C. MAb 15308 and Lam-R antibody also detected the recombinant protein
(figure 7-6, panels A and B).
Examination of total-protein-stained SDS-polyacrylamide gels (figure 7-5 panel B),
revealed the presence of protein bands in addition to those of LBP/p40 species
observed by probing Western blots of the recombinant protein with either a-V5,






Figure 7-5. Expression of the recombinant LBP/p40 (rLBP/p40) in
E. coli.
A; The presence of recombinant protein in rLBP/p40 (p40)-
transformed or non-transformed (NT) E. coli cell lysates was
detected by probing Western blots of total protein with mAb
1 5308. Equal amounts of total protein were loaded to lanes of SDS-
page gels for each cell type.
B; The presence of proteins other than LBP/p40 in nickel-metal
affinity-purified rLBP/p40 preparations was assessed by examination
of 10% SDS-polyacrylamide gels stained for total protein.
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15308 Lam-R a-V5
Figure 7-6. Assessment of Nickel-metal Affinity-Purified
Recombinant LBP/p40 Derived From Different Expression Systems.
LBP/p40 was expressed as an intracellular protein in E. coli and MCF-
7 cells or as a secreted protein in K562 cells. Western blots of
purified LBP/p40 preparations were analysed by probing with mAb
1 5308 (A), Lam-R Ab (B, a commercially available anti-LBP/p40 Ab)
or anti-V5 (C). Equal amounts of total protein were loaded to lanes
of SDS-page gels for each rLBP/p40 preparation.
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high purity, the presence of these contaminating proteins in greater amounts than
recombinant LBP/p40 confirms the specificity of mAb 15308 to this protein.
Furthermore, reactivity towards the protein expressed in a bacterial system provides
information that eukaryote-specific processing is not required for binding to
LBP/p40 by mAb 15308.
7.2.3.3 Stable expression of LBP/p40 in MCF-7 cells and purification
from cell-lysates.
For purification of LBP/p40 from an endotoxin-free mammalian system, MCF-7
cells were transfected with pCDNA3.1D/LBP/p40-V5-His by electroporation and
selected for stable expression rLBP/p40 by resistance to neomycin. Expression was
confirmed by probing Western blots from cell lysates of transfected and non-
transfected cells and by probing permeabilised transfected cells with a-V5 mAb by
indirect immunofluorescence (figure 7-7 panels A and B) prior to purification of the
histidine-tagged recombinant protein from cell lysates. The presence of recombinant
protein in purified preparations was assessed by western blot using a-V5 and mAb
15308 and mAb Lam-R (figure 7-6). As was seen for 293T cells transiently-
transfected with this construct and bacterially-expressed LBP/p40 (sections 7.2.3 to
7.2.3.2), the molecular sizes observed for the bands were approximately 40 kDa and
50-70 kDa for the purified rLBP/p40 species.
Again, examination of total-protein-stained SDS-polyacrylamide gels revealed the
presence of protein bands in addition to those of LBP/p40 species observed by










Figure 7-7. Expression of the recombinant LBP/p40 (rLBP/p40) in
MCF-7 cells and K562 cells.
The presence of rLBP/p40 in MCF-7 cells was detected by probing
Western blots of total protein with a-V5 mAb (panel A) or by
indirect immunofluorescence using a-V5 antibody followed by
AlexaFluor-568 labeled secondary antibody (red, panel B). The
presence of proteins other than LBP/p40 was assessed by
examination of 10% SDS-polyacrylamide gels stained for total
protein (C)(a preparation obtained from expression in K562 cells is







7.2.3.4 Expression of secreted LBP/p40 in K562 cells.
DNA encoding LBP/p40 was sub-cloned from pCDNA3.1 D/LBP/p40-V5-His into
pSecTag2/HygroA (see methods section 2.6.1.3 for plasmid construction) to allow
transport of the translated protein into the secretory pathway for release from cells.
K562 cells were transfected with pSecTag2/HygroA-LBP/p40 by electroporation and
a Hygromycin-resistant clone, expressing high levels of recombinant protein (Clone
A2) identified by screening of culture supernatants by ELISA (figure 7-8 panel A).
K
Cultures of Clone A2 were grown in serum-free growth medium (Sigma hybridoma
medium, animal component-free) to saturation prior to purification of the histidine-
tagged recombinant protein from cell-free supernatants. The presence of
recombinant protein in purified preparations was assessed by Western blot using a-
V5 and mAb 15308 and mAb Lam-R (Figure 7-6). Contrary to the observed
molecular sizes for the V5-containing bands present in preparations derived from
MCF-7 cells or E. coli (-40 kDa and 50-70 kDa) (sections 7.2.3.2 and 7.2.3.3),
recombinant LBP/p40 as a secreted protein in K562 cells was found to be expressed
as three main species of molecular weight ~50 kDa, ~75 kDa (approximately 10 kDa
greater than in MCF-7 and E. coli seen more clearly in figure 7-8 panel B) and
~80kDa. Significantly, neither mAb 15308 nor Lam-R antibody were able to detect
the recombinant LBP/p40 expressed in this way.
Comparison of the relative amounts of recombinant protein in this preparation with
the MCF-7-derived preparation by ELISA, detecting the presence of a V5 epitope,





Figure 7-8. Expression of the recombinant LBP/p40 (rLBP/p40) in
K562 cells.
A; Recombinant protein in supernatants of rl_BP/p40 transfected
K562 cells was detected in an ELISA for the V5 epitope. Poly-CM:
polyclonal culture of rLBP/p40-transfected K562 cells expressing
varying levels of rLBP/p40. CIA2-CM: a rl_BP/p40-transfected K562
cell clone expressing high levels of recombinant protein grown in
complete culture medium. CIA2-SF: a rl_BP/p40-transfected K562
cell clone expressing high levels of recombinant protein grown in
serum-free culture medium. The absence of serum proteins (which
compete for binding sites on plastic wells) in this sample allowed for
a stronger ELISA signal than for the CIA2-CM sample.
B; size difference between intracellular bacterial and secreted form
of eukaryotic of rLBP/p40 as assessed by the presence of V5
epitope on a Western blot. Equal amounts of total protein were












Figure 7-9. Comparison of Purified Preparations of Recombinant
LBP/p40 (rLBP/p40) Expressed as Intracellular or Secreted Proteins
by ELISA. rLBP/p40 was expressed as a polyhistidine and V5 tagged
fusion protein either intracellular^ in MCF-7 cells or in a secreted form
in K562 cells and purified by nickel-metal affinity. Binding of either an
anti-V5 antibody (top) or mAb 1 5308 (bottom) was tested on the
purified preparations by ELISA. 2% milk powder in PBS (MPBS) was
used as a control to assess the level of background binding for each
antibody. Bound antibodies were detected via a goat anti-mouse
peroxidase-conjugate as described in materials and methods. Data
points are means +/- SD of duplicate wells in one ELISA.
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Consideration of this along with examination of SDS-polyacrylamide gels stained
for total protein (figure 7-7 panel C), showing strong bands at the corresponding
molecular weights (~75 kDa and ~80 kDa) to the recombinant protein for K562
derived preparation and few contaminating proteins, it seems unlikely that the lack of
reactivity by mAbl5308 and mAb Lam-R was due to a lack of recombinant protein.
Bearing in mind also, the observed increase in molecular weight for this preparation,
one explanation is that additional modifications imparted by processing through the
secretory pathway resulted in loss or masking of the epitope recognised by these
antibodies.
7.2.4 Intracellular localisation of exogenous LBP/p40.
Two different constructs were used to analyse the localisation of exogenously
expressed LBP/p40 within transfected mammalian cells; (1) LBP/p40 fused to a V5
epitope (see methods section 2.1.4) allowing detection with an anti-V5 antibody, and
(2) LBP/p40 fused to green-fluorescent-protein (EGFP) (see methods section
2.1.6.1).
When detecting V5-tagged LBP/p40 using an antibody to the V5 epitope, diffuse
staining was seen throughout the cytoplasm (figure 7-10 panel A-D). LBP/p40
expressed as an N-terminal EGFP fusion protein localised mainly to the perinuclear
region, nucleus and, to a lesser extent in the cytoplasm (Figure 7-11).
For both the EGFP- and V5-tagged constructs, fluorescence-associated with the
exogenously expressed LBP/p40 was not found to mirror endogenous 15308
labelling (i.e. filamentous, microtubule association), with colocalisation occasionally
found restricted to the perinuclear region. Furthermore, transfection with exogenous
A
FBP/p40 failed to generate a detectable increase in mAbl5308 binding.
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MCF-7
Figure 7-10. Intracellular localisation of recombinant LBP/p40
expressed as a C-terminal-V5-tagged fusion protein.
MCF-7 cells transiently transfected with pCDNA3.1 D/LBP/p40-V5-Flis
and double stained with mAb 15308 followed by AlexaFluor-568
labeled secondary antibody (red) and anti-V5 followed by AlexaFluor-
488 labeled secondary antibody (green).
B-D Expanded view of image contained within the white box in A;













Figure 7-11. Intracellular localisation of recombinant LBP/p40
expressed as an N-terminal-EGFP fusion protein.
293T cells transiently transfected with pEGFP-C3-LBP/p40 (green)
stained with mAb 15308 followed by AlexaFluor-568-labeled
secondary antibody (red). Fluorescence was assessed by confocal
microscopy. Preservation of the epitope recognised by mAb 1 5308 in
this construct was confirmed by Western blot analysis. The increase in
molecular weight of reactive bands in GFP-LBP/p40 compared to
endogenous LBP/p40 (seen clearly in Mutu PI fraction included as a
positive control for mAb 15308 reactivity, c.f. section 7.2.1.1) being
due to the EGFP tag.
228
There are a number of possible explanations for these observations. It could be that
the epitope recognised by mAb 15308 in LBP/p40 on a denaturing gel by Western
blot is hidden in LBP/p40 in its native, folded form within intact cells. This would
require there to be a different epitope for recognition by the antibody as seen by
microscopy. Alternatively, exogenously expressed LBP/p40 may not always ,be
processed in the same way as the endogenously expressed protein resulting in the
inability of mAb 15308 to bind the protein. In addition, there is the possibility that
the tags provided by the expression vectors could interfere with sequence-specific
localisation signals for LBP/p40. Evidence that mAb 15308 can indeed recognise
LBP/p40 in its native form (as opposed to the denaturing conditions used for
Western blot analysis) will be presented in section 7.2.7.1.2.
7.2.5MAb 15308 does not bind to the 67kDa cell-surface
expressed form of LBP/p40
A 67kDa form of LBP/p40 is expressed on the surface of a number of healthy ceflls
and elevated levels on tumour cells (Menard, Tagliabue et al. 1998; Canfield and
Khakoo 1999; Montuori, Selleri et al. 1999). MLuc5 is a monoclonal antibody
produced by immunisation with a human small cell lung carcinoma cell line,
originally characterised by its ability to immunoprecipitate a 67 kDa molecule from
the membrane of the laminin-binding target cells (Martignone, Pellegrini et al. 1992).
This antibody specifically recognises the 67 kDa, but not the 37 kDa form of
LBP/p40. Surface staining of viable MCF-7 cells with MLuc5 confirmed expression
of the 67kDa form in this cell line (figure 7-12).
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However, no surface staining of viable MCF-7 cells was seen with mAb 15308
suggesting that the epitope recognised by this antibody on the 67 kDa surface form
on viable cells is either on an intracellular portion of the molecule, hidden on an
extracellular portion of the molecule due to the additional modifications required to
process the 37 kDa form to the 67 kDa form, or totally absent from this isoform.
In addition, a commercially available antibody to LBP/p40 (Lam-R) that recognises
the same proteins as 15308 by Western blot (figure 7-6) also failed to detect the
epitope seen by Mluc5. Mutu I, BJAB, K562, 293T and A549 cells were all negative







Figure 7-12. Surface expression of the 67kDa form of LBP/p40 on
viable MCF-7 cells as assessed by standard fluorescence microscopy.
A; Viable MCF-7 cells were probed with mAb MLuc5 (anti-67kDa
LBP/p40) followed by FITC-labeled secondary antibody. B; No staining
was observed with isotype matched antibody to MLuc5 (IgM)
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7.2.6 Surface expression of the 15308 epitope during apoptosis.
7.2.6.1 Surface expression on MCF-7 and Mutu I cells
Results chapter 3 presented data showing that the epitope recognised by mAb 15308
can be found associated with cells undergoing apoptosis. During these initial studies
with apoptotic Mutu I cells it became apparent that cells staining positive for mAb
15308 were at a relatively late phase of apoptosis. Thus, due to the preparation
required for immunofluorescence analysis of such fragile suspension cultures, it was
difficult to ascertain whether these cells had lost their membrane integrity. To study
whether the epitope defined by mAb 15308 can be exposed on the surface of
apoptotic cells prior to loss of membrane integrity, a system that imposes lower shear
forces than those applied to flow cytometry preparations was required. To achieve
this, apoptosis was induced in the adherent cell line, MCF-7, with etoposide for 48-
72 hours and immunofluorescent staining by mAb 15308 analysed by confocal laser-
scanning microscopy. As shown in figure 7-13 some cells could be identified
unequivocally as positive for surface staining under these conditions.
Surface 15308 reactivity was mostly localised to areas corresponding to the blebs
and apoptotic bodies. Lack of staining with PI demonstrated that the membrane
covering the main body of these cells was intact (although not necessarily true for
individual blebs), in contrast to Pi-positive "leaky" cells (figure 7-13 panels C-E
arrow). No surface staining was seen with the same population of apoptotic cells




Figure 7-13. The 15308 epitope is exposed on the surface blebs of
apoptotic MCF-7 cells, as determined by microscopy.
MCF-7 cells were treated with etoposide for 48-72 hours to undergo
apoptosis. Binding of the anti-LPS antibody, 1 5308 was detected with
goat anti-mouse secondary antibody labeled with AlexaFluor-488
(green). PI (red) was included in all samples as a measure of plasma
membrane integrity throughout the procedure and to exclude the
possibility that the 1 5308 antibody bound intracellular epitopes instead
of cell surface-exposed molecules. A-E: assessment by standard
microscopy (panels A-B and C-E are from two separate fields of view).
The 15308 antibody stained bleb-like regions on the cell-surface of
some of the apoptotic cells (examples indicated with arrow heads). F-l
Closer inspection of surface blebs of two separate cells by confocal
microscopy.
In order to test cell types and induction agents other than etoposide-treated MCF-7
cells for the capacity to expose this epitope at the cell surface, the decision was made
to return to Mutu I cells induced into apoptosis with ionomycin using a modified
staining protocol involving fewer, gentler wash steps and shorter antibody incubation
times to reduce the overall stress on the fragile plasma membranes of the apoptotic
cells. Flow cytometric analysis of cells stained in this way showed that a
subpopulation of cells defined by light scattering properties (Dive, Gregory et al.
1992) to be at a late phase of apoptosis bound mAb 15308 whilst remaining negative
for the uptake of PI (figure 7-14). As previously established, no staining was
observed with either viable/early apoptotic cells or the population frequently
observed using this modified protocol that appeared in-between the two regions
(figure 7-14 panels labelled R1 and R2). The isotype-matched control antibody y3
displayed no staining.
Confocal microscopic analysis revealed that, consistent with the observations on
MCF-7 cells, staining appeared to be confined to the surface blebs of non-leaky cells
or polarised to one region of the surface (figure 7-15). Staining of surface blebs was
also observed for apoptotic BJAB cells (figure 7-16). The appearance of 15308
epitope was inhibited by caspase inhibitor Z-BOC-fmk (figure 7-17), confirming that
the event was caspase-dependent and therefore likely to be associated with an
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Figure 7-14. The 15308 epitope can be observed associated with
apoptotic cells that are negative for the uptake of vital dyes as
determined by flow cytometry.
Mutu I cells treated with ionomycin for 14 hours to undergo apoptosis
were assessed for binding of the anti-LPS antibody, 1 5308 compared to
isotype-matched control (y3). Bound antibody was detected with goat
anti-mouse secondary antibody labeled with FITC. PI was included as a
measure the membrane integrity. Within the population, cells displayed
light scattering properties corresponding to being either viable/early
apoptotic (R1), late apoptotic (R3) or at an in-between phase (R2) (see
methods section 2.3.3.3)
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Figure 7-15. The 15308 epitope is exposed on the surface of
apoptotic human lymphoma cells, as determined by confocal
microscopy.
The human B-cell lymphoma cell line, Mutu I was treated with ionomycin
for 1 6 hours to undergo apoptosis. Binding of the anti-LPS antibody,
15308 was detected with goat anti-mouse secondary antibody labeled
with AlexaFluor-488 (green). PI (red) was included in all samples as a
measure the integrity of the membrane throughout the procedure and
to exclude the possibility that the 15308 antibody bound intracellular
epitopes instead of cell surface-exposed molecules.
As seen in A and B, the 1 5308 antibody stained the cell surface of
some of the apoptotic cells (closed arrow heads), whereas secondarily
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Figure 7-16. The 15308 epitope is also exposed on the surface of
BJAB cells, as determined by confocal microscopy.
The human B-cell lymphoma cell line, BAJB was treated with ionomycin
for 1 6 hours to undergo apoptosis. Binding of the anti-LPS antibody,
1 5308 was detected with goat anti-mouse secondary antibody labeled
with AlexaFluor-568 (red). TO-PRO-3 dye (which would appear blue)
was included in samples as a measure the integrity of the membrane
throughout the procedure and to exclude the possibility that the
1 5308 antibody bound intracellular epitopes instead of cell surface-
exposed molecules. No staining was observed with an isotype-
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Figure 7-17. The appearance of the epitope defined by mAb 1 5308 on
PI negative ionomycin treated cells is caspase dependent as determined
by flow cytometry. Mutu I cells treated with ionomycin in the presence
or absence of the caspase inhibitor Z-BOC-FMK (50|iM) for 14 hours
before being assessed for binding of the anti-LPS antibody, 15308.
Bound antibody was detected with goat anti-mouse secondary antibody
labeled with FITC. PI was included as a measure the membrane integrity.
Within the population, cells displayed light scattering properties
corresponding to being either viable/early apoptotic (R1), late
apoptotic(R3) or at an in-between phase (R2) (see methods section
2.3.3.3).
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7.2.6.2 Co-distribution of the epitope defined by mAb 15308 with
other known apoptotic-cell markers
Numerous molecules have been shown localised to the bleb-like structures that arise
A
at the cell-surface during apoptosis (Cocca, Cline et al. 2002) (Korb and Ahearn
1997). To further investigate whether the cell-surface appearance of the epitope
recognised by mAb 15308 is in agreement with such markers, co-distribution was
explored with two indicators of apoptotic-cell blebs, Annexin V and Clq.
Confocal analysis demonstrated co-distribution of mAb 15308 and Annexin V
binding to isolated parts of cell surfaces and blebs of unpermeabilised, etoposide-
treated MCF-7 cells (Figure 7-18). Although both markers seemed to be confined to
the same regions of the cell surface, complete colocalisation (judged by the
appearance of golden fluorescence) was only occasionally observed. Similarly,
when cells were co-incubated with mAb 15308 and biotinylated, purified Clq, then
A
stained with the relevant fluorochrome-conjugated reagents for detection, regions of
cells that stained positive for mAb 15308 also stained positive for Clq (figure 7-19).
As was noted from co-staining with Annexin V, colocalisation was occasionally
observed around blebs and polar-regions on the cell surface. No staining was
observed when biotinylated IgGl was used instead of Clq as an irrelevant protein
control or when cells were stained with an isotype-matched irrelevant antibody for




Figure 7-18. Colocalisation of 15308-reactivity and PS on the
surface of apoptotic human breast carcinoma cells.
MCF-7 cells were treated with etoposide (lOO^M) for 48 hours, and
the colocalisation of the 15308 epitope and PS examined. Shown
are the confocal fluorescence images of 1 5308 epitope visualised
by goat anti-mouse secondary antibody labeled with AlexaFluor-568
(red), biotinylated-annexin V binding to PS visualised by streptavidin
labeled with AlexaFluor^l88 (green). A and B: The epitopes
recognised by mAb 15308 and Annexin V localise to regions
containing bleb like structures. E,F and G: Close up view showing
staining of bleb surface (white square C) with single Z-section
images. B and D: Bright field. A,C and G: Dual excitation for
colocalisation.
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Figure 7-19. Colocalisation of 15308 and Clq reactivity on
apoptotic Mutu I cells as assessed by confocal microscopy.
Mutu I cells were treated with ionomycin for 1 6 hours to undergo
apoptosis, before examining the localisation of the epitopes
recognised by mAb 15308 and biotinylated-CI q. Bound mAb
15308 was visualised using a goat anti-mouse secondary antibody
labeled with AlexaFluor-568 (red), biotinylated CI q was visualised
using streptavidin labeled with AlexaFluor-488 (green). TO-PRO-3
(blue) was included in all samples as a measure of membrane
integrity. A; bright field image overlayed with the fluorescence
associated with a mid-way Z-section (fluorescence alone shown in B)
demonstrating co-distribution of mAb 1 5308 and Clq. C; total cell-
associated fluorescence. D; fluorescence associated with a different
z-section from that displayed in A and B. No staining was observed
with isotype matched antibody to 15308 or an irrelevant
biotinylated protein (appendix 7-3).
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7.2.6.3 Surface expression of exogenously expressed LBP/p40 during
apoptosis.
In an attempt to determine whether LBP/p40 is the (or one of the) molecule(s)
bearing the epitope recognised by mAb 15308 displayed on the cell-surface during
apoptosis, the presence of exogenously-expressed cell-surface LBP/p40 was
examined following apoptosis induction. For these studies, two cell lines stably
expressing the molecule were examined. Firstly, MCF-7 cells expressing V5-tagged
LBP/p40 and secondly BJAB cells stably expressing EGFP-tagged LBP/p40.
Figures 7-20 and 7-21 display example images of each analyses.
As noted for EGFP-tagged LBP/p40 293T transfectants in section 7.2.4, in contrast
to MCF-7 transfectants which exhibited diffuse cytoplasmic staining with an
antibody to V5-tagged LBP/p40, viable BJAB transfectants exhibited a significant
level of nuclear-associated LBP/p40 (figure 7-21). No detectable increase in the
level of surface staining with mAb 15308 was observed with EGFP-tagged LBP/p40-
transfected cells compared to wild-types during apoptosis.
In the case of MCF-7 cells induced into apoptosis with etoposide it was possible to
detect small amounts of the V5 epitope at the surface of non-membrane-
compromised cells. However the appearance of this exogenously expressed
LBP/p40, was a scarce event (figure 7-20, < 2% of total cells). One could interpret
these results in a number of ways. Firstly, it could be that LBP/p40 is not the
molecule recognised by mAb 15308 at the cell-surface during apoptosis. Secondly,
it is possible that LBP/p40-transfectants are unable to translocate exogenous













Figure 7-20. Examining the appearance of exogenously expressed
LBP/p40 on the surface of apoptotic MCF-7 cells by confocal microscopy.
A; The expression of V5-tagged LBP/p40 in transfected cells in comparison
to wild-type non-transfected (wt) was assessed following permeabilisation
of viable cell monolayers by staining with an antibody to the V5 epitope.
Bound antibody was detected with goat anti-mouse secondary antibody
labeled with alexaFluor-488 (green). B-G; MCF-7 cells stably expressing V5-
tagged LBP/p40 were treated with etoposide (1 OOfiM) for 48 hours prior to
staining. PI (red) was included in all samples as a measure the integrity of
the membrane throughout the procedure. On rare occasions (<2% total
cells) examination of individual Z-sections revealed the presence of the V5
epitope on surface blebs of membrane intact cells (closed arrows in B) as
opposed to membrane compromised cells (open arrow B, D) which stained
throughout the cell and were positive for PI (seen more clearly through








Figure 7-21. Examining the appearance of mAb 15308-reactivity
on the surface of EGFP-tagged BJAB transfectants.
BJAB cells were treated with ionomycin for 1 6 hours to undergo
apoptosis before staining with mAb 1 5308. Bound antibody was
visualised using a goat anti-mouse secondary antibody labeled with
AlexaFluor-568 (red). TO-PRO-3 was included in all samples
(although not shown in these images) to allow discrimination
between membrane intact (panel A) and membrane compromised
mAb 15308-positive cells. No detectable increase in surface staining
with mAb 15308 was observed in EGFP-tagged LBP/p40
transfected cells (green A and B) as compared to wild type cells (C
and D).
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Finally, it could be that LBP/p40 is processed in the same way as the molecule(s)
bearing the endogenously expressed epitope(s) recognised by mAb 15308, but at
levels at the lower end of detection limits.
7.2.7 Functional studies involving LBP/p40
7.2.7.1 Binding of recombinant LBP/p40 to CD14
A
7.2.7.1.1 Initial studies utilising mammalian and bacterial cell-derived
recombinant LBP!p40
Initially, purified recombinant LBP/p40 (rLBP/p40) derived from the two previously
described mammalian expression systems (sections 7.2.3.3 and 7.2.3.4) and the
bacterial system (section 7.2.3.2) were assessed for preferential binding to CD14-
transfected K562 cells compared to CD 14 negative cells. The nickel metal-affinity
purified preparations of rLBP/p40 were allowed to incubate with cells and bound
protein subsequently detected with a-V5 antibody by flow cytometry. Whereas
binding of LBP/p40 preparations derived from the culture supernatants of transfected
K562 cells or lysates of transfected MCF-7 cells did not display binding,
preparations from the bacterial expression system bound preferentially to CD 14-
expressing cells compared to CD14-negative cells (figure 7-22). Interpretation of
these findings must be made with caution as subsequent analysis showed LPS to be
present in high amounts in the bacterially derived preparation (>250 endotoxin
units/ml). However, when binding experiments were carried using the preparations
derived from mammalian expression systems in the presence of comparable levels of
purified LPS from Pseudomonas aeruginosa (based on the assumption that 10
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endotoxin units of in a chromogenic Limulus amoebocyte lysate (LAL) assay is
equivalent to lng LPS), binding of these preparations to CD14-expressing K562 cells
was not enhanced (figure 7-23).
Attempts to remove LPS (achieving <0.5 endotoxin units/ml) from the bacterial-
derived preparation also led to a significant loss of protein (10 fold reduction) and
consequently a reduction in binding to CD 14 expressing K562 cells (figure 7-23,
A
bottom panels). Given the hypothesis that LBP/p40 bears an "LPS-like" epitope,
any approach to remove LPS from LBP/p40 using affinity-based endotoxin-specific
decontamination systems might be flawed from the outset.
Given these inconclusive observations, attempts were made to obtain a sufficient
quantity of purified "LPS-free" LBP/P40 in order to confirm or refute the capacity of
the molecule to interact with CD 14. This was achieved by infection of sf9 insect
cells with a LBP/p40-recombinant Baculovirus vector, the results of which are
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Figure 7-22. Purified recombinant LBP/p40 (rLBP/p40) derived from a
bacterial expression system binds preferentially to CD14 expressing
cells.
Purified preparatbns of rLBP/p40 were incubated with either wild type
K562 cells (CD14 -ve) or K562 cells overexpressing CD14 (CD! 4 -i-ve).
Bound recombinant protein was was detected with an antibody to the
V5 tag of rLBP/p40 (a-V5) followed by an anti-mouse secondary
antibody labeled with FITC. The expression of CD14 on cells was
confirmed by staining with mAb 63D3 (anti-CD14).
Representative of 4 staining experiments using preparations of
rLBP/p40 produced on two independent occasions.
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Figure 7-23. Effect of LPS contamination on the ability of recombinant
LBP/p40 (rLBP/p40) to interact preferentially with K562 cells
expressing CD14.
Purified preparations of rLBP/p40 were incubated with either wild type
K562 cells (CD14 -ve) or K562 cells overexpressing CD14 (CD14 +ve).
A-D; The addition of comparable amounts of LPS found to that found in
the bacterial derived preparation of LBP/p40 (green histograms) to
preparations of LBP/p40 derived from endotoxin-free mammalian cell
expression systems (MCF-7 or K562) did not enhance binding to CD14
(blue histograms). E,F; Conversely, depletion of LPS (brown
histograms) from bacterial-cell derived LBP/p40 preparations resulted in
reduced interaction with CD14. However the process of LPS depletion
also led to a reduction in protein concentration within the preparation,
and thus a possible cause for the reduced signal.
Bound recombinant protein was was detected with an antibody to the
V5 tag of rLBP/p40 (a-V5) followed by an anti-mouse secondary
antibody labeled with FITC. The expression of CD14 on cells was
confirmed by staining with mAb 63D3 (anti-CD14).
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7.2.7.1.2 Production and Purification of LBPIp40 in insect cells using a
Baculovirus expression system.
Western blot analysis of Sf9 cells infected with recombinant LBP/p40 baculovirus
revealed the presence of relatively large amounts of mAb 15308-reactive protein
(figure 7-24, panel A). In contrast to the crude cell-lysates obtained from
mammalian and bacterial cells exogenously expressing LBP/p40, a clear band was
visible on a total protein-stained SDS-polyacrylamide gel compared to non-
transfected/transformed cells (figure 7-24 panel B), corroborative of high-level
expression.
The high level of expression of LBP/p40 in sf9 cells was used to confirm that this
protein in its native form can be recognised by mAb 15308 by ELISA (a concept that
was questioned following investigation of the intracellular localisation of
exogenously expressed LBP/p40 in section 7.2.4). Thus, a signal was seen with
A
mAb 15308 when lysates from infected cells were used to coat ELISA plated
compared with lysates from non-infected cells coated with matching concentrations
of total protein (figure 7-25).
A strong signal was also seen by Western blot analysis for nickel-metal purified
LBP/p40 from baculorvirus-infected cells with major and minor bands migrating at
the expected molecular mass (strong band 50-70 kDa and a weaker band ~40 kDa
figure 7-24, lane labelled p40/F). This construct was used in its partially purified
form for binding assays, to CD14-expressing cells K562. As was the case for
LBP/p40 expressed in bacterial and mammalian expression systems, Baculoviral-












Figure 7-24. Expression of the recombinant LBP/p40 (rLBP/p40)
in baculovirus-infected sf9 insect cells.
A; The presence of rLBP/p40 in sf9 insect cells detected by probing
Western blots of total protein from non-infected (Nl) or
recombinant-LBP/p40 (p40) baculovirus-infected cells with mAb
15308.
The level of expression in crude cell-lysates (B) and degree of purity
in nickel metal-affinity purified LBP/p40 (p40/F) (C) was assessed
by examination of 10% SDS-polyacrylamide gels stained for total
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Figure 7-25. Binding of mAb 15308 to LBP/p40 derived from insect
cells.
An ELISA against lysates prepared from sf9 insect cells infected with
LBP/p40-recombinant Baculovirus (red bars) or left uninfected (yellow
bars) was used to confirm the reactivity of mAb 15308 to LBP/p40
under non-denaturing conditions. y3 isotype-matched antibody did not
react with Baculovirus-infected cells. ELISA plates were coated with
equal amounts of total protein from cell lysates.
Results shown are the mean +/- S.D. of duplicate wells.
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technical difficulties and time limitations it was not possible to express and purify a
control construct (i.e. NEDD5) in Sf9 cells. As a substitute negative control, nickel-
k
metal purified soluble-LBP/p40 from K562 cells (which was shown not to contain
the epitope recognised by mAb 15308, c.f. figure 7-6) was used for these studies at
an equal concentration of a-V5 reactivity, as detected in a direct ELISA (Although it
is appreciated that this is not an ideal control as it was expressed in a different
system). The insect-cell-purified LBP/p40 construct clearly bound equally well to
both CD 14 positive and negative K562 cells (figure 7-26). This observation raises
two issues; (1) the means by which LBP/p40 binds to K562 CD 14 negative cells, and
(2) the absence of preferential binding to CD14 positive cells.
Addressing the former question first; as mentioned in section 7.2.1.3 LBP/p40 is
known to associate with a6 integrins (Ardini, Tagliabue et al. 1997). This could
explain binding to CD 14 negative K562 cells as the expression of some integrin
chains by these cells has been documented (Denda, Reichardt et al. 1998). An
alternative explanation is that K562 cells, being of myeloid origin are positive for a
PRR other than CD 14 that is capable of interacting with LBP/p40. However, this
would not explain the ability of bacterial-cell derived LBP/p40 to bind preferentially
to CD 14 positive K562 cells.
In addressing the second issue, several explanations are possible for the absence of
preferential binding by the insect-cell derived protein. One possibility is that
preferential binding of the bacterial-derived protein was solely due to LPS
contamination. This would require LBP/p40 to bind, either directly or indirectly'to
LPS, and for this complex to bind either directly or indirectly to CD 14.
252
CD14 +ve CD14 -ve
10-4 0° 101 102103
70







10-4 0° 101 TO2103
17.5
10-4 0° 10' 102103
Log FL FITC —
□ GAM-FITC
■ 63D3
10-4 0° 101 102103
A
10-4 0° 10' 102103




10-4 0° 10'102 103 J
Figure 7-26. Purified recombinant LBP/p40 (rLBP/p40) derived from a
recombinant-Baculovirus insect expression system does not bind
preferentially to CD14-expressing cells.
Purified preparations of rLBP/p40 were incubated with either wild type
K562 cells (CD14 -ve) or K562 cells overexpressing CD14 (CD14 +ve).
Numbers at the top right hand corner of each histogram represent the
total protein concentration (i.e. including contaminants) of rLBP/p40
incubated with cells ([xg/ml).
Bound recombinant protein was detected with an antibody to the V5
tag of rLBP/p40 (a-V5) followed by an anti-mouse secondary antibody
labeled with FITC. The expression of CD14 on cells was confirmed by
staining with mAb 63D3 (anti-CD14).
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An alternative explanation (which assumes that LBP/p40 contains a functional "LPS-
like" pattern), is that binding of bacterial-cell derived LBP/p40 was facilitated by an
LPS-binding protein present in the bacterial preparation not found in the sf9 cell-
derived preparation. This proposition is based on the knowledge that LPS itself is
k
rarely ever found in isolation, but is usually associated with a binding partner (Chaby
2004).
Studies intended to explore these issues included: -
• The addition of LPS to insect-cell derived LBP/p40 to test for enhancement
of its binding to CD14-expressing K562 cells.
• Testing the ability of insect-cell derived LBP/p40 to interact preferentially
with CD14 expressing cells of non-myeloid origin.
• Measuring the potential for preferential interaction between LBP/p40 to
CD 14 or other LPS-binding proteins by ELISA.
However, due to the instability of purified LBP/p40 preparations following freeze-
thawing or prolonged storage at 4°C, and a tendency to precipitate from solution
these tests were not completed at the time of documenting this thesis.
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7.2.7.1.3 Point of contact between surface 15308 epitope and phagocyte
membrane
As a starting point to investigate the role of LBP/p40 as a possible apoptotic-cell-
associated ligand for macrophage recognition the relative coincidence of 15308-
reactivity at the point of phagocyte interaction was examined. Confocal analysis of
macrophage-apoptotic cell interaction with respect to mAb 15308 staining following
a binding assay carried out at room temperature showed that the epitope recognised
on the Mutu I cell-surface was occasionally localised at the sites where the cells
attached to the mouse peritoneal-derived macrophages (summarised in figure 7-27).
Interaction with membrane intact feed cells was only observed following very gentle
washing, in contrast to thorough washing commonly used following interaction
assays (c.f. section 6.2.2). Furthermore, even with such mild washing these were rare
events (<5% of total mAb 15308-positive cells were non-leaky), and mAb 15308 un-
reactive feed cells were also observed (figure 7-27, panel B, open arrows).
Preliminary attempts to recreate these findings with HMDM looking for point of
contact between CD 14 indicated a requirement for further optimisation as only leaky
cells were observed bound to the phagocytes. However, these observations indicate
the possibility lhat apoptolic cells can be recognised by macrophages through regions
positive for "LPS-like" epitopes.
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Figure 7-27. Localisation of mAb 15308 positive regions on
apoptotic Mutu I cells at the point of contact with macrophages.
After coincubation of apoptotic Mutu I cells with mouse peritoneal-
derived macrophages at room temperature (as described in methods
section 2.10) and following removal of unbound cells by either
gentle or regular washing the cells were stained with mAb 1 5308
followed by secondary antibody labeled with alexaFluor-350 (blue),
and AlexaFluor-488-conjugated mouse-F4/80 antibody. PI (red)
was included in all samples as a measure membrane integrity.
Whilst A and C display total cell-associated fluorescence, scanning
through sequential Z-sections revealed the appearance of the mAb
15308 positive regions (arrow in A) at the point of contact with the
mouse macrophage membrane. Open arrows in B indicate mAb
1 5308-non-reactive feed cells. When regular, thorough wash steps
were employed prior to staining, only membrane-compromised
apoptotic feed cells were observed bound to macrophages (C).
256
The results described in this chapter can be summarised as follow: -
• MALDI/TOF spectrometrical analysis allowed identification of three
candidate proteins with similar mobility to the mAb 15308-reactive band
present in the electrophoretically-separated protein mixtures of Mutu I cells
as:- (1) (3-Actin, (2) Laminin binding protein (LBP/p40) and (3) NEDD5
• The ability of mAb 15308 to bind LBP/p40 exogenously expressed in
HEK293T cells confirmed the observed cross-reactivity of this anti-LPS
antibody.
• LBP/p40 was seen to exist in two main forms with molecular sizes of
~40 kDa and ~50-70 kDa when overexpressed as an intracellular protein in
mammalian, bacterial and insect expression systems. In contrast, when
expressed via the secretory pathway as a secreted protein in mammalian cells,
LBP/p40 was found to be expressed as three main species of molecular
weight ~50 kDa, ~75 kDa and ~80kDa.
• Whilst both mAb 15308 and Lam-R antibody were able to detect
recombinant LBP/p40 expressed as an intracellular protein they did not
recognise the secreted form.
• It was not possible to detect the exact co-distribution of mAbl5308-reactivity
with the localisation of exogenously expressed LBP/p40 within transfected
mammalian cells by microscopy.
• As a result of apoptosis the epitope recognised by mAb 15308 can be
detected at the cell-surface prior to loss of membrane integrity. Cell-surface
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mAb 15308-reactivity was detected in the same localised regions bound by
Annexin V and Clq. However, relatively lower amounts of exogenously
expressed LBP/p40 were detected under the same conditions.
• Whilst partially-purified recombinant LBP/p40 derived from bacterial cells
was observed to bind preferentially to CD14-expressing K562 cells compared
to CD 14 negative K562 cells, LBP/p40 derived from insect cells bound
equally well to both cell types.
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8 General Discussion
8.1 A Means to Define ACAMPs
The ability of anti-LPS antibodies to recognise structures associated with dying-self
as demonstrated in this thesis increases the number of known classes of markers for
apoptotic cells. Although it had been postulated previously that akin to the PAMPs
of micro-organisms recognised by PRRs, apoptotic cells expose ACAMPs, and that
the functioning of such phagocytic receptors in microbial recognition might have
evolved secondarily to their function in the recognition of dying self (Franc, White et
al. 1999) the criteria for defining ACAMPs have not been set. Thus far, all
molecules on the surface of dying cells implicated in their clearance have been
referred to as ACAMPs, including for example, markers such as CD31, which bear
no obvious relationship to PAMPs.
While examples of individual innate PRRs interacting with both pathogens and
apoptotic-cell-associated ligands including CD14, Clq and Pentraxin-3 (Devitt,
Moffatt et al. 1998; Ogden, deCathelineau et al. 2001; Garlanda, Hirsch et al. 2002),
have been described, the ACAMPs with which they interact have not. The results of
the work described herein allow a clearer classification of ACAMPs in terms of
molecular motifs shared between microbes and apoptotic cells (albeit in the absence
of a functional definition at the time of writing).
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8.2 New findings of "LPS-iike" structures within and on
A
apoptotic cells
The data presented in results chapter 3 established that viable eukaryotic cells hold
epitopes that can be recognised by some antibodies previously characterised as
having specificity towards lipopolysaccharide. In addition to this, the data in section
7.2.6 of results chapter 4 showed that these epitopes can be found on the surface of
apoptotic cells prior to the loss of membrane integrity in the same localised regions
to which Annexin V and Clq bind. Consistent with the majority of apoptotic-cell-
surface markers defined previously, the "LPS-like" epitopes observed in these
studies do not appear to have been generated as a result of the apoptosis process, as
they were detected intracellularly in permeabilised viable cells of numerous types
(section 6.2). Characterisation of previously defined apoptotic-cell-surface markers
has revealed them to appear as a result of either changes to cell-surface resident
molecules such as CD43 (Eda, Yamanaka et al. 2004), or from a redistribution of
intracellular molecules to the cell surface such as Annexin 1 (Arur, Uche et al. 2003).
The distribution of staining seen with mAb 15308 falls into the latter of these classes.
The possible implications of these findings are discussed in section 8.4.
8.2.1 Identification of mAb 15308-reactive species present in Mutu
I cells
MALDI/TOF mass spectrometry analysis of three candidate proteins for the species
recognised by mAb 15308 within lysates of Mutu I cells revealed their identity as: -
(1) |3-Actin, (2) Laminin binding protein (LBP/p40), and (3) a Septin named
NEDD5 (neuronally expressed, developmentaly downregulated-5). In section 7.2.2
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the presence of cDNA encoding LBP/p40 and NEDD5 was detected from Mutu I
mRNA by reverse transcriptase PCR. Following transfection of cDNA for LBP/p40
and NEDD5 into 293T cells, anti-LPS mAb 15308 was seen to bind exogenously
expressed LBP/p40 but not NEDD5 suggesting that LBP/p40 bears an "LPS-like"
epitope. Whilst investigating a potential for LBP/p40 to function in apoptotic-cell
clearance, a number features characteristic to this molecule were noticed. The
discussion will focus on these issues before considering possible future studies
leading on from these findings.
8.2.1.1 Exogenously expressed, cloned LBP/p40 can be seen to exist
as two major species on a denaturing gel
With the exception of expression as a secreted protein in K562 cells, exogenous
expression of LBP/p40 resulted in the presence of two species of approximate
molecular weight 40 kDa and 67 kDa (section 7.2.3). Studies aimed at elucidating
the means by which the 67 kDa form of LBP/p40 is produced from its 37 kDa
precursor suggest that it consists of homodimers of the lower molecular weight
polypeptide (Landowski, Dratz et al. 1995). The 37 kDa polypeptide has been
studied as a molecule restricted to the cytoplasm whereas the 67 kDa cell-surface
expressed molecule, found on a limited number of healthy cells, is overexpressed on
a number of malignancies (Yow, Wong et al. 1988; Rescan, Clement et al. 1991; al-
Saleh, Delvenne et al. 1997; Menard, Tagliabue et al. 1998). The 37 kDa LBP/p40 is
encoded by a single active gene (Jackers, Clausse et al. 1996; Jackers, Minoletti et al.
1996), the cDNA of which encodes a polypeptide precursor of ~300 amino acids,
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which is post-translationally modified to the 67 kDa form (Castronovo, Claysmith et
al. 1991). The complete process of this modification is not entirely clear but
evidence suggests it requires cytoplasmic factors (Landowski, Dratz et al. 1995)
(Buto, Tagliabue et al. 1998) (Castronovo, Claysmith et al. 1991). The ability of the
dimer to withstand denaturing conditions such as those used for analysis in an SDS-
polyacrylamide gel may be explained by the presence of a conserved lock-and-key
structure/function domain at the carboxyterminal end of the protein (Clausse, Jackers
et al. 1996). The fact that both forms of this protein were also observed when
expressed in a bacterial system (section 7.2.3) provides information that eukaryote-
specific processing is not required for this process.
Despite detecting the presence of a ~67 kDa protein by Western blot analysis of
mammalian cell-lysates following transfection with LBP/p40 (section 7.2.3), surface
expression with either Mluc5, a-LBP/p40, a-V5 or mAb 15308 was not detected on
viable cells. Several studies investigating the requirements for surface expression
have been published. To be expressed on the outer membrane, the 67 kDa form of
the protein seems to require interaction with the a6 integrin chain (Ardini, Tagliabue
et al. 1997). This is supported by the observed coexpression and
coimmunoprecipitation of the 67kDa LBP/p40 and a6 in tumour cells (Romanov,
Sobel et al. 1994; Ardini, Tagliabue et al. 1997). In another study, transfection of 37
kDa LBP/p40 cDNA conferred 67 kDa LBP/p40 surface expression in a Jurkat clone
that is usually negative for the 67 kDa protein. The authors suggested that this may
be due to the fact that all these clones express some surface a6 (Canfield and Khakoo
1999). However, in CHO cells, attempts to confer p67 kDa LBP/p40 surface
expression by transfection of the 37 kDa LBP/p40 cDNA resulted in the
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accumulation of cytoplasmic polypeptide (Castronovo, Claysmith et al. 1991).
During the studies carried out for this thesis, transfection of the 37 kDa LBP/p40
cDNA into a cell line (MCF-7) capable of expressing the 67 kDa form endogenously,
failed to detect an increase specifically in surface expression (section 7.2). If an
accessory molecule (such as a6 integrin) is required to achieve this, one could argue
that failure in increased surface expression may be due to a limitation in amounts of
endogenous accessory molecule available.
Thus far, two forms of naturally occurring LBP/p40 have been mentioned, that is a
37 kDa intracellular form and a 67 kDa cell-surface form. However, the existence of
an additional differentially processed form of this protein has been suggested by
studies investigating a 37 kDa T-and B-lymphocyte-stimulating, tumor-specific
rejection antigen, expressed on "the surface" of carcinomas, sarcomas and
lymphomas/leukemias of rodents and humans which converged with studies of
LBP/p40 (Coggin, Barsoum et al. 1999). The authors of this work reinforce that the
molecule they refer to is not the 67 kDa form of LBP/p40 (Coggin, Rohrer et al.
2004) and have shown with both in vitro and in vivo studies that a monoclonal
antibody specific for this 37 kDa "Oncofetal antigen (OFA)" detects the protein on
various malignancies and in embryos/early fetuses but not in term fetus, neonate, or
adult differentiated tissues (Coggin, Barsoum et al. 1998). OFA protein and 37kDa
are > 99% identical proteins based on amino acid and cDNA sequencing (Coggin,
Barsoum et al. 1999). OFA expression in the early foetus is in keeping with studies
investigating a role for LBP/p40 in the developing limb bud (Hara, Satoh et al. 1997;
Ruyani, Sudarwati et al. 2003). So it appears that the cell-surface expression of the
67 kDa form of LBP/p40 enables malignant tumour cells to penetrate laminin tissue
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and vessel barriers, whereas the 37 kDa form of OFA-LBP/p40 activates anti-OFA-
LBP/p40 specific cytotoxic T cells which can kill tumour targets. The relevance of
differentially processed forms of LBP/p40 to the studies described in this thesis will
be considered in the following section.
8.2.2 Intracellular localisation of exogenously-expressed
LBP/p40.
Whilst demonstrating unambiguously the ability of mAb 15308 to bind LBP/p40 by
Western blot analysis (section 7.2.3) and by ELISA (section 7.2.7), fluorescence
microscopical comparison of exogenously expressed LBP/p40 and mAb 15308
reactivity detected differing distributions within cells (section 7.2.4). For both the
EGFP- and V5- tagged LBP/p40 constructs, fluorescence associated with the
exogenously expressed LBP/p40 was not found to mirror endogenous labelling with
mAb 15308. Furthermore, transfection with exogenous LBP/p40 failed to cause a
significant detectable increase in 15308 binding.
These discrepancies could be due to differential processing of the protein akin to
those mentioned in the previous section. As mentioned in section 7.2.4, there are
several other possible explanations for these observations. One explanation is that
differing sensitivity of mAb 15308 and anti-V5 (for exogenous LBP/p40) make
comparison of the different forms difficult. Thus, if the antibody to the V5 tag
produces a much higher signal (as demonstrated by Western blot analysis) then
perhaps an increase in signal would not be seen with mAb 15308 (or would not be
within the detection limits of microscopy with this antibody).
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Alternatively, it is possible that the tags provided by the expression vectors could
interfere with sequence-specific localisation signals for LBP/p40. Initially a role for
cell cycle dependent factors in the ability of exogenous LBP/p40 to match mAb
15308 binding was questioned as preliminary staining attempts were performed soon
after transient transfection. Whilst staining of stable transfectants at a later date
argued against this, it is possible that expression of endogenous LBP/p40 is only
switched on and processed transiently during the cell-cycle, whereas only a fraction
of the exogenous protein, through being expressed continuously, receives the
processing required for recognition by mAb 15308.
Uncertainty regarding the staining patterns of LBP/p40 can also be found in
published literature regarding this protein. Although perfomed on tissue sections,
observations that "Different antibodies (to LBP/p40) produce different staining
patterns"have been made (Prof. S. Ghosh, personal communication) (Shmakov, Bode
et al. 2000). Whereas the localisation has been stated as diffuse or vesicular, reports
of cytoskeletal association (Keppel and Schaller 1991) are in keeping with the
observed pattern of staining with mAb 15308 in these studies. The possible
relationship between documented LBP/p40 biology and the epitope recognised by
mAb 15308 is summarised schematically in figure 8-1.
When detecting LBP/p40 in pCDNA3.1 D/V5-His-TOPO© using an antibody to the
V5 tag, diffuse staining throughout the cytoplasm was seen. Conversely, LBP/p40
expressed as an EGFP fusion protein to the N-Terminus, localised mainly to the
perinuclear region, nucleus and to a lesser amount in the cytoplasm. Again, these
discrepancies could be due to either differing sensitivity of detection of the two tags
or differing effects on intracellular localisation (C-terminal V5 vs N-terminal EGFP).
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In any case, the inconsistency in location with these two forms of LBP/p40
highlights the fact that exogenous expression may not always provide a faithful
reflection of a protein's physiological behaviour within a cell. Finally, it remains
possible that the tags are cleaved at different stages during the processing of the
protein resulting in a loss in detection of LBP/p40.
The finding that exogenously-expressed LBP/p40 as an EGFP fusion protein
localised mainly to the nucleus and peri-plasmic regions (section 7.2.4) is also in
keeping with some published reports (Sato, Kinoshita et al. 1996). The studies
conducted by this group using epitope-tagged LBP/p40 led to the finding that the
nuclear localisation of LBP/p40 was found to be mediated through binding to
histones H2A, H2B, and H4 but not H3 (Sato, Kinoshita et al. 1996; Kinoshita,
Kaneda et al. 1998). Future work aimed at clarifying the issues raised following
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Figure8-1.Possiblrelationshipbetwee documentedLaminin-BindingProt i (LBP/p40)biologyandtheepit pe recognisedbymAb15308. LBP/p40canexistanintr cellularprotein (-37-40kDa)abundantlyexpressedinth cytoplasm(Landowski,Dratze.1995)(A) andtolesserext ntinhnucl us(Sato, Kinoshitaeal.1996)(B),rs-67kDa surface-expressedlamininrec ptor (Castronovo,Cl ysmithel.1991)(C). Anti-LPSmAb15308recognisesaepitop foundoLBP/p40.Thisepitopeis withinviablecellsandnbe omssociated withcell-surfaceduringapoptosis. TheepitopeonLBP/p40r cog isedbymAb 15308isnotaccessiblewhenexpressedt thesurfaceofviablcells(C),rwh n exogenouslyxpressedasolublec ted protein(D).
8.2.3 Functional studies involving LBP/p40
Based on the potential role for an apoptotic-cell associated molecule bearing an
"LPS-like" epitope in recognition by phagocytes several studies involving LBP/p40
were intended. However, due to time limitations and technical difficulties
encountered whilst obtaining a stable endotoxin-free purified preparation of this
protein at the time of writing this thesis, these studies were not completed. Thus, the
following discussion summarises the results obtained at the time of documenting this
work, whereas proposed further studies will be mentioned in later sections.
To ascertain whether LBP/p40 can interact directly with CD14, binding studies were
performed using purified preparations of LBP/p40 and CD14-expressing cells. The
nickel-metal affinity-purified preparations of rLBP/p40 derived from a bacterial
expression system bound preferentially to CD14-expressing K562 cells compared to
CD14-negative K562 cells (section 7.2.7). Given that this preparation contained
endotoxin it is possible that LPS is responsible for this result. The removal of LPS
from this preparation also resulted in loss of protein, making the concomitant loss in
binding to CD14-expressing cells difficult to interpret (section 7.2.7).
The nickel-mctal affinity-purified preparations derived from culture supernatants of
transfected K562 cells did not retain the epitope recognised by mAb 15308, and
adequate yields were not obtained from lysates of LBP/p40 transfected MCF-7 cells.
Nevertheless, when binding experiments were carried using the K562-derived
preparation in the presence of purified LPS, binding of these preparations to CD 14
expressing cells was not observed (section 7.2.7), suggesting that a simple mixture of
LBP/p40 and LPS is not sufficient to produce the result seen with the bacterial-cell
derived preparation.
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Production of sufficient quantities of functional LBP/p40 using an endotoxin-free
insect system attempted to answer these issues conclusively. Preliminary tests using
this preparation of LBP/p40 failed to demonstrate a preferential affinity for CD14-
expressing K562 cells compared to CD14-negative K562 cells.
Nevertheless, as it is known that binding of LPS to CD 14 is facilitated by LPS-
binding proteins (Tobias, Mathison et al. 1988), and that bacteria themselves possess
LPS-binding proteins (Hirschfeld, Ma et al. 2000), there is a possibility that the result
obtained with the bacterial-derived preparation could be recreated through the
addition of such transfer molecules to the LPS-free insect cell-derived preparation.
However, time limitations prevented performance of an in-depth investigation of the
role for LPS-binding proteins in enhancing interaction between LBP/p40 and CD 14
or other PRRs.
8.2.4 Consolidating the findings described in this thesis
The results documented in this thesis provide scope for broadening studies in the
area of markers associated with apoptotic cells. However, there are a number of
important issues surrounding the foundational work performed thus far which require
further investigation. These are summarised below: -
(1) Do "LPS-like" molecules on apoptotic cells play a role in their phagocytosis by
macrophages? Answering this question would require a more rigorous testing of
anti-LPS antibodies in recognition assays than those performed in section 6.2.3,
perhaps testing cocktails of cell-reactive antibodies to investigate the possible
confounding factor of multiple ligands for individual PRRs, or using Fab fragments
to prevent the possible contribution of Fc-mediated phagocytosis.
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(2) Of priority with respect to the reactivity of mAb 15308 will be to determine
whether this antibody binds solely to LBP/p40 in its native form within cells, and if
so, is specific posttranslational modification required? This could be addressed in a
number of ways: -
• Immuno-depletion of endogenous LBP/p40 under native conditions within
cell-lysates using the commercially-available antibody to LBP/p40 (Lam-R)
followed by probing of the Lam-R negative (and hence LBP/p40 negative)
lysates with mAb 15308.
• An alternative and perhaps more conclusive way to remove LBP/p40 would
be to silence it's expression by RNA interference. This would allow a simple
test for ablation of mAb 15308-reactivity to be assessed by
immunofluorescence. Preliminary attempts to this effect have been made and
the results are shown in appendix A8-1. However, Western blot analysis with
Lam-R demonstrated only a modest reduction in protein levels following
transfection with LBP/p40 siRNA suggesting a requirement for
methodological optimisation. In the event that stable knock-down of
LBP/p40 expression proves troublesome focus could be placed on sourcing or
engineering LBP/p40 knock-out mice.
• Carrying out a more extensive testing of different cells lines stably expressing
LBP/p40, or by microscopic analysis of LBP/p40 infected insect cells, as
these expressed high levels of mAb 15308-reactive protein.
• In vitro translation of LBP/p40 could be used to determine the need for such
posttranslational modification.
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Answering these questions would also help clarify whether LBP/p40 is the molecule
recognised by mAb 15308 at the surface of apoptotic cells prior to loss of membrane
integrity.
In the following sections the discussion will focus on the structural basis for cross-
reactivity between anti-LPS antibodies and apoptotic cells, centring on the existing
molecular knowledge of LPS. Some suggestions for such investigations will be
discussed with specifically with respect to LPS, but the same lines of investigation
could also be applied to other ligands for PRRs such as peptidoglycan, lipoproteins
and lipoteichoic acids.
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8.3 Structural basis for interactions between anti-LPS
antibodies and apoptotic-cell-associated epitopes
Much could be gained from understanding the observed capacity of anti-LPS
antibodies to recognise apoptotic-cell-associated epitopes in terms of the exact
molecules (or three-dimensional patterns of charge) conserved between the foreign
and self structures which are directly involved in contacts with the immunoglobulin's
binding-site. Knowledge of the precise epitope to which antibodies bind on ligands
of PRRs such as CD 14 could potentially be used to develop compounds capable of
blocking LPS responsiveness by masking CD14 or could lead to a fuller
understanding of how apoptotic cells exert their non-inflammatory/anti-inflammatory
effects. However, at present it is unknown whether LPS binds directly to CD 14 or if
a bridging molecule is required (da Silva Correia, Soldau et al. 2001). Why
apoptotic cells do not signal through TLRs despite being recognised by the same
phagocytic PRRs associated with TLR-activity in response to microbes is unknown
(Blander and Medzhitov 2004). Nevertheless, one can make two broad proposals to
explain the cross-reactivity observed during this work:- (1) either matching chemical
structures to parts of LPS exist on molecules inside eukaryotic cells, or (2) the
molecules inside eukaryotic cells simply bear a similar pattern of electrostatic
charge/hydrophobicity to LPS enabling their recognition by anti-LPS Abs. In the
former scenario the shared structures may be of carbohydrate, lipid or phosphate
origin. One can suggest conditions for each based on what is known about CD14
ligands and cross-reactivity of LPS Abs. These are discussed below.
The precise chemical groups on LPS to which the broadly cross-reactive antibodies
used in this work bind have not been determined. Common core carbohydrate
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determinants are assumed to be the targets as the O-antigen of LPS is structurally
hypervariable. Evidence supporting this presumption is supplied by a study into the
isotypes of a panel of cross-reactive mAbs performed by Pollack et al. They found
all IgGs (16 of 29) recognising core sugars were of the 2a or 3 isotype with no type
1, whereas those to lipid A (13 of 29) were all of IgM class (Pollack, Chia et al.
1989). Alternatively, one can draw structural similarities between the repeating units
of hexoses or N-acetyl linked hexoses found in O-antigens and mammalian
glycoconjugates. Epitope mapping would provide conclusive insight into the
structural requirement for the binding of these antibodies to LPS and crystallographic
data could be utilised to reveal structural similarity between the LPS and the
proposed ACAMP.
To investigate whether conserved carbohydrate structures are indeed responsible for
the antibody cross-reactivity described in this thesis one may refer to the techniques
employed by their manufacturers to characterise their microbial specificity. Thus, in
addition to carrying out ELISAs on purified LPS, the suppliers of the anti-LPS Abs
used in this work characterised their LPS specificity by testing binding to whole
bacterial cells that had been treated with Proteinase K to strip the cell surfaces of
protein moieties, and periodate to oxidise carbohydrate moieties (such as those of
LPS). Reactivity of all anti-LPS antibodies was unaffected by proteinase K, yet
periodate treatment resulted in loss of reactivity with whole cells (Personal
communication, Tom Glickman, QED Biosciences). Repeating these studies using
apoptotic cells may provide an insight into the nature of the epitope recognised,
although it must be appreciated that not all protein epitopes are sensitive to
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Proteinase K and that periodate can oxidise many more structures than
carbohydrates.
Many reliable techniques exist to study carbohydrate-containing molecules. Lectins
can be used specifically to probe for the presence of mono- and oligosaccharides.
Indeed, preliminary studies using a panel of 14 lectins, screened for differential
binding to apoptotic or viable Mutu I cells, identified Dolichos biflorus (DBA), a
lectin that binds specifically to N-Acetyl-galactosamine, as having a preference for
dead cells (Ceri Oldreive - personal communication). Subsequent studies revealed
that this lectin, as was observed for the anti-LPS antibodies, bound to late apoptotic
cells and permeabilised viable cells. Also of interest is the fact that N-Acetyl-
galactosamine residues can also be found in the core regions of some LPSs (Yokota,
Ohtsuka et al. 1996; Vinogradov and Sidorczyk 2001) and that N-Acetyl-linked
sugar residues are a form of post-translational modification for nuclear and
cytoplasmic proteins found in mammals (Zachara, Cheung et al. 2004). In
considering these facts, it would be of interest to establish whether the observed
apoptotic-cell-reactivity is due to the presence of N-Acetyl-galactosamine groups on
apoptotic-cell-associated epitopes by looking for competition for staining between
antibodies and DBA. Another possibility would be to examine the effects of treating
cells with panels of glycosidases or inhibitors of glycoprotein processing, on
antibody binding.
It is also possible to draw structural similarities between ceramide (Joseph, Wright et
al. 1994) or phosphatidyl inositides and lipid A of LPS (all three being CD14
ligands) (Wang, Kitchens et al. 1998). For example, the long fatty acid carbon
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chains of ceramide and LPS show identical conformational placement on the
backbones of each molecule (Joseph, Wright et al. 1994).
To investigate whether conserved lipid structures are required for the recognition of
ACAMPs by the anti-LPS mAbs one could apply simple lipid overlay tests using
lysates of mammalian cells and compare probed samples to purified preparations of
known lipids (Cowart, Szulc et al. 2002). This approach could also be used to
examine the requirements for apoptotic-cell-binding by mAbs 15306, 15174 (and
other potential apoptotic-cell binding anti-LPS mAbs) in addition to testing the
effects of various fixation and permeabilisation methods, to investigate the observed
basis for sensitivity of mAb 15174 to IntraStain (DAKO) (c.f. section 6.2).
The involvement of structural mimicry in dual recognition has previously been
examined following the detection of antibodies to lipid-A in the synovial fluid and
serum from children with oligoarticular arthritis. Reactivity of these antibodies
towards lipid-A can be inhibited by collagen types I and II, cardiolipin, and
denatured DNA (Miller, Zhu et al. 1996). In this instance, antibody recognition was
found to be dependent on contacts with diphosphate groups of lipid A. Thus,
phosphorylated protein moieties could well be responsible for apoptotic-cell binding.
Figure 8-2 summarises potential structures associated with intracellular eukaryotic
molecules which anti-LPS antibodies could recognise.
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O-polysaccharide
Figure 8-2. Potential structures associated with intracellular eukaryotic
molecules which anti-LPS antibodies could recognise. Several possibilities
exist for matching chemical structures found on molecules inside eukaryotic
cells to parts of LPS. The shared structures may be of carbohydrate, lipid or
phosphate origin. However it is also appreciated that cross-reactivity of anti-
LPS antibodies might be mediated via a similar patterns of ionic charge or
hydrophobicity rather than matching chemical groups.
apoptosis
Figure 8-3. Possible routes by which ACAMPs might become exposed
during apoptosis. ACAMPs appear on the surface of dying-self as a result
of losing membrane asymmetry (Fadok, Voelker et al. 1992)(A),
translocation of cytoplasmic compartments (Arur, Uche et al. 2003)(B), or
the premature exposure of endoplasmic reticulum/ Golgi components at
the cell-surface (Morris, Hargreaves et al. 1984; Lane, Lucocq et al. 2002)
(C).
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8.3.1 Structural basis for recognition of LBP/p40 by mAb 15308
The increase in molecular weight resulting from expression of LBP/p40 following
transport through the secretory pathway in K562 cells (section 7.2.3.4) may in part
have been due to glycosylation as LBP/p40 has a number of potential sites for O-
linked glycosylation (although none for N-linked glycosylation). Endogenous
LBP/p40 does not possess a classical leader sequence for transport through the
secretory pathway (Yow, Wong et al. 1988). Recognition of LBP/p40 by mAb
15308 and a commercial anti-LBP/p40 antibody was lost following expression via
this route, which suggests that the modifications imparted by processing through the
secretory pathway resulted in loss of (or masking of) the epitope required. This
could also be interpreted as evidence that O-linked sugar chains do not provide the
means by which anti-LPS mAb 15308 can bind LBP/p40. This does not exclude the
possibility that other less well-known forms of cytoplasmic glycosylation, such as
the addition of N-Acetyl-linked sugar residues to serine and threonines (Zachara,
Cheung et al. 2004) could provide suitable carbohydrate residues for recognition by
an anti-LPS antibody. However, the reagents required to examine such
modifications are not widely available.
In considering other forms of post-translational modification which could provide
chemical groups for recognition by an anti-LPS mAb, reports that LBP/p40 can act
as a substrate for the cell-cycle-specific kinase CDC2 (Keppel, Lenger et al. 1997)
and that the protein is acylated (Landowski, Dratz et al. 1995) would suggest
phosphate groups or lipids as a possible basis for recognition. Whilst structural
predictions could be made based upon the reported reactivity of mAb 15308 towards
LPSs from different strains of E. coli, cross-reactivity could simply be due to a
277
certain configuration of amino-acid residues on LBP/p40 that resembles LPSs
through a similar three-dimensional pattern of ionic charge.
The biological implications of epitope conservation are discussed in the following
sections.
8.4 Implications for LPS-like molecular structure for the
biology of apoptosis, inflammation and immunity
8.4.1 Involvement of epitopes recognised by anti-LPS mAbs in
the recognition of apoptotic cells
The observation that "LPS-like" epitopes are displayed on the surface of apoptotic
cells raises the question of whether they may function in the recognition and
clearance of apoptotic remains. Although initial studies have failed to demonstrate
blocking of apoptotic-cell interaction using the apoptotic-cell cross-reactive anti-LPS
Abs (section 6.2.3) it is possible that blocking a single "LPS-like" pattern amongst
the many different patterns within or on an apoptotic cell that PRRs such as CD14
can recognise, may be insufficient to compromise apoptotic-cell clearance. The
possibility of multiple distinct pathogen-like epitopes mediating interaction within an
apoptotic-cell phagocyte synapse could be investigated by testing a cocktail of
similar antibodies that demonstrate reactivity towards apoptotic cells. Such a panel
could be formed from antibodies to pathogen-associated ligands in addition to LPS
and of PRRs other than CD14.
Besides CD 14, the apoptotic-cell opsonins, SP-A, SP-D, MBL and Clq, have also
been shown to bind core regions of LPS (Zohair, Chesne et al. 1989; Van Iwaarden,
Pikaar et al. 1994; Devyatyarova-Johnson, Rees et al. 2000). The findings of this
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thesis provide fuel for the hypothesis that apoptotic-cell-associated "LPS-like"
epitopes form the ligands that allow these innate receptors to participate in the
engulfment of dying self. To investigate whether PRRs such as SP-A, SP-D, and
Clq use the same contact surfaces to bind apoptotic cells as they do to bind LPS, the
ability of LPS and anti-LPS Abs to compete with these opsonins for binding to
apoptotic cells could be assessed. It would also be of interest to know whether the
epitopes recognised by each of these receptors are exposed in unison or if there is a
hierarchy in their appearance. Regardless of the timing, once at the surface, these
LPS-like epitopes also have implications for understanding tolerance and
autoimmunity and the normal response to apoptotic cells.
8.4.2 Implications for immune responses
8.4.2.1 Immune response to apoptotic cells
It is tempting to speculate how the property of dual recognition of apoptotic cells and
pathogens by PRRs like CD14 might reflect general features of autoimmunity. The
ability of pathogen-specific T or B cells to interact with similar structures found on
dying self increases the probability of raising an autoimmune response in situations
where dying cells and pathogens are encountered in close proximity. In other words
this could explain how immune effector cells designed to see pathogen-derived
epitopes could cross-react with self-antigens displayed on dying cells to drive
autoreactivity by molecular mimicry.
Finally, as mentioned previously, TLRs, although not implicated in apoptotic-cell
clearance can be stimulated by endogenous ligands. For example, whilst normally
inactive or inhibitory to TLR9 signalling, mammalian DNA can stimulate this
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receptor when present in immune complexes (Leadbetter, Rifkin et al. 2002).
Therefore it is not unreasonable to imagine the potential for immune complexes of
"LPS-like" structures similarly to trigger TLR dependent signalling pathways.
8.4.2.2 Immune response to pathogens
In considering the findings of this thesis one may also expect that an excess of
apoptotic cells could lead to an impaired ability to fight infection. Incidents of this
kind have been observed in other disease settings as it has been shown that dextran-
binding antibodies from plasma of human donors bind to glycoconjugates from yeast
and to lipopolysaccharides from Klebsiella and group A Streptococci. Inhibition by
galactose and glucose as well as certain disaccharides was obtained at concentrations
below those reached in diabetic sera suggesting a reason for the increased
susceptibility of diabetics to infection (Chacko and Appukuttan 2003).
Taking a step further back, cross-reactivity of this kind raises the question of how B
cells specific for these molecules escape from negative selection, as these structures
could well be presented on the surface of dying cells in the germinal centres. Thus,
the exposure of "LPS-like" structures on the surface of apoptotic blebs would
suggest tolerance to LPS in the periphery as interactions between immature and B
cells and surface-exposed LPS-like structures on a neighbouring apoptotic cell could
trigger strong stimuli toward central deletion. However, the moieties expressed by
apoptotic cells are unlikely to represent entire LPS molecules allowing those B-cells
specific for the remaining portions of LPS to mount an immune response. On the
other hand, as the surface exposure was seen to be a late phenomenon, clearance
mechanisms may exist in areas of B-cell development which remove the dying cells
before the exposure of such epitopes at these sites, leaving the exposure of these
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patterns to occur on "late" apoptotic cells under other circumstances in the periphery
where different recognition systems may operate.
8.4.2.3 Potential for modulating the normal response to apoptotic
cells
Although structural conservation between LPS and apopotic-celI-associated epitopes
has been demonstrated in this work, one would expect that functional mimicry does
not necessarily occur as LPS is proinflammatory whereas apoptotic cells are believed
to be anti-inflammatory (Fadok, Bratton et al. 1998). It is possible that apoptotic
cells may provide an overriding signal to inhibit stimuli provided by "LPS-like"
structures or it could be that apoptotic cells only display structures resembling the
non-toxic portions of endotoxin. For example, it has been possible to demonstrate
that, by comparing certain structural analogues of lipid-A, to that of low-toxicity LPS
(from certain bacterial strains) the supramolecular requirements for LPS bioactivity
correlate with the type of aggregates the molecule allows itself to form
(Labischinski, Barnickel et al. 1985; Golenbock, Hampton et al. 1991). That is,
Lipid A samples which adopt a cylindrical conformation are biologically inactive,
whereas those which form a conical conformation are highly active (Schromm,
Brandenburg et al. 1998). This knowledge may in the future provide a means to
subvert the immune system against apoptotic cells, for beneficial therapeutic ends,
for example, switching environments that have high rates of apoptosis (such as
certain solid tumours) into an inflammatory setting.
It has already been shown in vitro that opsonisation of apoptotic cells with
immunoglobulin can result in both a failure to induce the TGF-|3 production, usually
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observed from macrophages during programmed ceil clearance, and a concomitant
rise in TNF-a production (Fadok, Bratton et al. 2001; Huynh, Fadok et al. 2002).
Indeed, initial attempts to recreate these results by opsonising apoptotic cells with the
panel of anti-LPS antibodies used in this thesis produced a similar effect. In the
event that LBP/p40 proves able to function as a ligand for CD 14 (or another PRR)
there is also potential to use this molecule as a target for therapy.
8.4.3 Working model
In considering the results of this work it is tempting to speculate that multi-cellular
organisms have evolved to "hide" certain groups of epitopes (intracellularly) from
the immune system (as opposed to the immune system simply looking for non-self).
What factors could determine whether a particular pattern can be exposed to the
extracellular milieu? Such segregation could be on the basis of overall electrostatic
charge or hydrophobicity, similar to the "hyppos" described by Polly Matzinger and
colleagues (Matzinger 2002). By this definition such molecules could be either
microbial, non-non-microbial, derived from intracellular host compartments or sites
inaccessible to the immune system under normal circumstances. This concept is in
keeping with existing evidence of how ACAMPs appear on the surface of dying-self,
such as exposure by loss of membrane asymmetry (Fadok, Voelker et al. 1992),
translocation of cytoplasmic compartments (Arur, Uche et al. 2003), or the premature
exposure of endoplasmic reticulum/ Golgi components at the cell-surface (Morris,
Hargreaves et al. 1984; Lane, Lucocq et al. 2002), as summarised in figure 8-3.
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8.5 Broadening the understanding of these findings
The central theme to this thesis, that apoptotic cells can expose epitopes bearing
structural resemblance to PAMPs, has been formed from studying the characteristics
of a relatively limited panel of antibodies. There is therefore great potential to
extend these studies further and to deepen the understanding of the observations
made thus far.
8.5.1 Investigating the potential for other LPS-binding proteins to
recognise apoptotic cells
In addition to screening new anti-LPS antibodies for apoptotic-cell binding capacity,
there is potential to return to the investigation of innate LPS-binding proteins as
much information exists regarding the location of amino acids involved in their
interaction with LPS. These molecules include "antimicrobial peptides"such as the
a-defensins, lipid-binding proteins found in serum such as phospholipids-transfer
protein, opsonins such as serum amyloid P, and membrane bound molecules
involved in signalling such as MD-2 (reviewed in Chaby 2004). Interestingly LPS
has been shown to bind to histones, further supporting the notion that LBP/p40
possesses an "LPS-like" epitope, as it too associates with histones (Augusto,
Decottignies et al. 2003). Thus, there is potential for testing the common structural
motifs required by these molecules for their association with LPS for use as
diagnostics or therapeutics in area of apoptosis research.
Finally, a number of LPS-binding proteins from prokaryotic organisms could be
screened for their reactivity towards dying eukaryotic cells. An example of
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preliminary attempts to explore the possibility that eukaryote-derived LPS-binding
proteins interact with apoptotic cells is detailed in the following section.
8.5.1.1 The T4 bacteriophage "docking system" and LPS binding
One well-characterised LPS-binding protein is that which forms part of the
bacteriophage T4 "docking system". In order for T4 phage to bind to their host
bacterium, firstly long tail fibres recognise outer membrane proteins before short tail
fibres extend and bind irreversibly to the core-region of LPS (Riede 1987). The
crystal structure of this LPS-binding-protein with its bound lignad has been solved
(Thomassen, Gielen et al. 2003), and a recombinant form employed as an LPS
decontamination system (see http://www.profos.de/technoIog_v.php). As part of
preliminary studies aimed at extending our understanding of "LPS-like" structures on
apoptotic cells, T4 phage were obtained with the intention of testing their ability to
bind apoptotic cells in preference to viable cells. The phage particles were supplied
freeze-dried in skimmed-milk powder. This preparation was biotinylated and tested
for the ability to bind apoptotic cells over and above a solution of biotinylated
skimmed milk (to represent a "carrier control"). Both preparations bound to
apoptotic cells. On contemplation, the viability of this result was quite apparent
given the numerous innate immune components present in milk. Indeed, subsequent
studies have revealed lactoferrin to be the major active component in milk
responsible for apoptotic cell binding (Andrew Devitt, John Pound and Chris
Gregory, unpublished) and lactoferrin itself is known to be an LPS-binding protein
(Na, Han et al. 2004).
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8.5.2 Rationalising flaws in the phage antibody approach to
identifying ACAMPs
Attempts to generate apoptotic-cell-binding phage antibodies resulted in the isolation
of cell-binding monoclonal phage antibodies with a much lower affinity for
populations of apoptosis-induced cells than viable populations (section 3).
In section 5.6 it was hypothesised that epitopes resembling PAMPs found within the
bacterial cultures used to propagate bacteriophage libraries might have resulted in the
loss of phage clones displaying antibody fragments with high affinity for ACAMPs.
The finding that lactoferrin from milk binds to apoptotic cells may have revealed an
additional fatal flaw in the way that these early experiments were performed as milk
powder was used for blocking both the phage library and the apoptotic cells during
selection. Thus it is possible that novel ACAMPs were being masked by innate
receptors present in the milk solution.
8.5.3 Concluding remarks
The view established in this thesis, that conserved molecular patterns exist associated
with both dying-self and microbes, sets a new paradigm for studying markers of
apoptosis. Whilst a functional role for "LPS-Iike" structures on apoptotic cells needs
to be evaluated further, studies using this approach might help in understanding the
progression of inflammatory, infectious and tumoural processes. Many aspects of
this model such as the possible conservation of conserved microbial structures other
than "LPS-like" moieties are readily open for investigation and may soon allow the
expansion of our knowledge of phagocyte interaction with apoptotic cells.
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Adjust to final volume with dH?0
1 M Tris-HCI pH8.0 5ml
0.5M EDTA 1 ml
1% agarose gel
Heat until agarose goes into solution
Add agarose (1% w/v) to 1xTBE
6xDNA loading buffer
Adjust to final volume with dH?0
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For 8ml 0.5M Tris-HCI 1ml
10% w/v SDS 1.6ml
Glycerol 0.8ml
2-Meracptoethanol 0.4ml
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Adjust to final volume with dhl?0
glucose 9g
1M Tris at ph 8.0 25ml
EDTA 20ml
Potassium acetate(3M K+/5M Ac-)
5M potassium acetate 50ml
glacial acetic acid 11.5ml
distilled water 28.5ml
TE




1x Phosphated-Buffered Saline (PBS)
For 1000ml
Adjust to pH7.4
Adjust to final volume with dH?0
sodium chloride 8.0g
potassium chloride 0.2g
potassium dihydrogen phosphate 0.2g
disodium hydrogen phosphate 1.145g
IxPBS-T
For 1 OOOmls




For 10Omls IxPBS 100ml








50 mM sodium phosphate buffer
For 1000ml
Adjust to pFI8.0
Adjust to final volume with dFi?0
sodium chloride 17.4g




Adjust pH to 7.2 using 1 M NaOH.
Adjust to final volume with dH?0
Bacto tryptone 1 Og
Bacto yeast extract 5g
sodium chloride 10g
Add antibiotics as appropriate
LB Agar
Add 1 5q of agar to 1 litre of LB Add antibiotics as appropriate
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NZY broth
For 1 litre
Adjust pH to 7.2 using 1M NaOH.
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For 100ml
Adjust to final volume with dH?0
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1.5M sodium chloride













2 x Hepes buffered saline (FIBS)
For 1 000ml
Adjust pFH to 7.05











































Figure A4-1 Maps of plasmid vectors used for expressing
recombinant ICAM-3. A; Domains 1&2 (D1-2) of ICAM-3 cloned into
pcDNA3.1 /V5-His-T0P0 for expression of histidine-tagged ICAM-3.








Figure A 4-2. Quality assessment of nickel-metal affinity purified
ICAM-3-Fc. Polyhistidine-tagged ICAM-3(His-l3) was expressed as a
secreted protein in 293T cells. A; Western blot of purified His-13.
Preparations were analysed by probing with an antibody to the C-
terminal V5 tag. B; The presence of proteins other than His-13 was





























































Figure A6-1. Binding of anti-LPS mAbs to purified LPS.
An ELISA against purified LPS from Pseudomonas aeruginosa (Ps.
aeruginosa) and Klebsiella pneumoniae (K. pneumoniae) was used to
confirm the reactivity patterns of mAb 15308. As stated by QED
Biosciences Inc mAb 15308 bound preferentially to LPS from Ps.
aeruginosa. However testing of mAb 15306 also showed reactivity
towards purified LPS in this system despite not being documented as
specific for these types of LPS by QED Biosciences
(http://www.qedbio.com/alpha_e_g.htm). Indeed, all three a-LPS
antibodies bound to both types of purified LPS at significantly higher
levels than to BSA in a concentration-dependent manner. MAb 15174
that is actually marketed as a Chlamydia trachomatis mAb also displayed
binding to these preparations. Isotype antibodies did not react with
these LPS preparations above the observed level for BSA (data not
shown).
Microtiter plates (Immulon II) were coated either with LPS purified from
the indicated bacteria or with BSA overnight at RT.
The binding of the anti-LPS mAbs to coated wells was then assayed by
ELISA (see methods section 2.11.1.1) at the dilutions indicated below
each bar. Results shown are the mean +/- S.D. of duplicate wells.
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Appendix A7-1. Example results of cell lines testing negative for
expression of the 67kDa form of LBP/p40 as determined by staining
with mAb MLuc5. The binding of mAb MLuc5 (anti-67kDa LBP/p40) to
viable BJAB (either wild type or LBP/p40 transfected) cells or Mutu I
cells treated with ionomycin for 16 hours was assessed by flow
cytometry. Bound antibody was detected with goat anti-mouse
secondary antibody labeled with FITC. Staining of apoptotic cells with
mAb 15308 was included as a positive control. Within the Mutu I
population, cells were identified as viable or apoptotic by their light








Figure A7-2. Neither anti-p-actin nor an isotype-matched antibody
to 15308 bind to the surface of apoptotic MCF-7 cells, as
determined by microscopy.
MCF-7 cells were treated with etoposide for 48-72 hours to undergo
apoptosis. Binding of the anti-p-actin antibody (clone AC15) and
isotype antibody to mAb 15308 (y3) was detected with goat anti-
mouse secondary antibody labeled with AlexaFluor-488 (green). In
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Figure A7-3. Control staining for studies investigating co-
distribution of 15308 reactivity and CI q on apoptotic Mutu I cells.
Mutu I cells were treated with ionomycin for 16 hours to undergo
apoptosis, and the epitopes recognised by mAb 15308 and CI q
examined by confocal microscopy. Negative control staining with
isotype-matched antibody to mAb 15308 (y3, panel G) or
biotinylated rabbit IgG (panel B) as a control protein for C1q was
performed at the same concentrations. Mouse antibodies were
visualised using goat anti-mouse secondary antibody labeled with
AlexaFluor-568 (red), biotinylated proteins were visualised using
streptavidin labeled with AlexaFluor-488 (green). Shown are the
confocal fluorescence images of two separate fields of view. A-D ;
images from a field of view examining control staining for Clq. E-F ;









Figure A8-1 . Downregulation of LBP/p40 expression by RNA interference.
To confirm or refute the sole reactivity of mAb 1 5308 towards endogenously expressed
LBP/p40 in its native form, attempts were made to downregulate LBP/p40 expression
using siRNA. HeLa cells were transfected with two siRNA oligonucleotide duplexes
(oligo) for LBP/p40. As a control, siRNA duplexes for Lamin A/C were included. A;
Immunofluorescence analysis and assessment by microscopy with a-Lamin-A/C and mAb
15308 revealed few cells to have reduced fluorescence in LBP/p40 siRNA-transfected
cells compared to control lamin A/C siRNA transfected cells. However little silencing of
Lamin-A/C was seen in lamin A/C siRNA transfected cells compared to LBP/p40 siRNA
transfected cell when probing with a-Lamin-A/C. B; Western blot analysis with both a
commercially available antibody to LBP/p40 (Lam-R) and 1 5308 demonstrated only a
modest reduction when using LBP/p40 siRNA duplexes used to transfect cells compared
to control lamin A/C siRNA transfected cells. A very strong signal was observed when
probing for p-actin as a loading control. As it is hard to gauge differences in such a
strong signal, the small differences seen when probing for LBP/p40 cannot be taken as
conclusive evidence of gene silencing. Taken together these results indicated that the
silencing procedure was not successful. At the time of these studies attempts made to
use stably knockdown LBP/p40 in order to circumvent interpretational problems
associated with turnover of this protein.
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